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SECTION A 
20 
Preface 
Introduction to the portfolio 
This portfolio presents aspects of my continuing professional development, in terms 
of clinical interest, research and service development. Since obtaining my BPS 
Diploma in clinical psychology in 1988,1 have worked in the area of alcohol misuse, 
in psychology services in genito-urinary medicine and HIV, and for the past five 
years in Drugs Services. Two years ago the Drugs Service merged with Alcohol 
Services to form a Substance Misuse Service. During the past nine years addictive 
behaviours have emerged as my main area of clinical and academic interest. I have 
included in this portfolio examples of my research work involving the assessment and 
the measurement of outcome in the treatment of opiate users, description of my work 
in developing a model for clinical psychology services in addictions and a review of 
literature in an area that is currently gaining considerable interest, namely, the links 
between trauma, post traumatic syndromes, borderline personality disorder and 
substance misuse. I 
SECTION B 
Research 
Throughout my professional career I have strived to maintain a strong research 
component to my work. Most of my research has been practical and clinically 
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relevant research, often linked to demonstrating the contribution a clinical 
psychologist can make in a service setting. Much of my work, including the studies 
in this portfolio, can be described as 'applied' research. My approach was 
particularly influenced by Dr Chris Barker, who supervised my BPS Diploma thesis 
and has continued to provide advice and support on methodological and statistical 
problems over the years. Barker, Pistrang and Eliot (1995) describe 'pure research' 
and 'applied research' as being on a continuum. This formulation enables the use of 
pluralistic methodology and a pragmatic stance to be taken in conducting research in 
a clinical setting. I have endeavoured to pass on Chris Barker's influence in the 
supervision of research projects of trainee clinical psychologists during the past nine 
years. 
Included in Section B are three research studies in the area of outcome measurement 
in the treatment of opiate users. I developed an interest in assessment and outcome 
measurement in the area of addiction early on in my career. I was working in the 
Alcohol Service and was struck by the lack of outcome measurement or evaluation 
of clinical interventions that was taking place. Exploring the literature in this area 
I soon discovered that there were very few standardised assessment and outcome 
measurement instruments available and very few reported studies of treatment 
outcome. The Addiction Severity Index (MacLellan et al., 1980) had been recently 
developed and provided the best instrument available, but after attempting to use it 
clinically, it became very clear that it was suitable for evaluative research but not for 
routine clinical use. With Tom MacLellans' permission I modified it into a simple 
form for use in routine clinical work which was published in a chapter on evaluation 
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relapse prevention interventions (Wanigaratne et al., 1990). This chapter also set out 
an evaluation framework for addiction services based on the work of Moos and 
Finney (1983). However, I left the Alcohol Service before this instrument and the 
evaluation framework could be validated and my interest in this area lay dormant until 
a colleague approached me about using the instrument in her MD research. The need 
for the validation of the modified ASI, led me to work on developing a new 
instrument that would be comprehensive and overcome the limitations of the ASI. 
While this work was being planned, Darke et al., (1992) published the OTI that 
claimed to overcome those limitations and fulfilled the objectives of a comprehensive 
outcome measure. This instrument was developed in Australia and needed validation 
across diverse populations, and also needed norms for a British population. 
Evaluating the OTI for routine use in a British clinical setting forms the backdrop for 
the three studies presented in this portfolio. 
Chapter 1 reviews the literature and outlines the issues relating to outcome 
measurement in the area of treatment of opiate addiction. Outcome measurement 
cannot be separated from the process of assessment. Information gathered at 
assessment is used for clinical decision making and outcome measurement. Measures 
that can predict outcome could benefit clinical decision-making. This chapter also 
examines factors that are linked to treatment decisions such as, motivation, severity 
of dependence, self-efficacy and expectations. It is seen that in the treatment of 
opiate users few of these factors have been studied in relation to outcome. The 
literature also shows that apart from the Severity of Dependence Scale (SDS), there 
are no validated instruments to be used with opiate users. Hence the argument is 
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made for development of measures to be used with this client group. 
Chapter 2 describes the development of an instrument to measure treatment 
expectations of opiate users. The work described in this chapter, as with the other 
two studies, uses both qualitative and quantitative methodology. The item selection 
of the measure was based on previous qualitative studies on opiate users. The 
predictive validity of the expectations measure is investigated in the study described 
in Chapter 4. 
Chapter 3 describes the evaluation of an assessment and outcome measurement 
framework developed incorporating the OTI. The main objective of the study was 
to look at the feasibility of using the OTI in routine clinical work. The work was 
carried out in three phases. The first phase involved pilot work with the OTI using 
a clinical sample, and modifying the instrument from the resulting feed-back. The 
second phase involved using the modified OTI to evaluate a discrete part of a service 
for opiate users. The third phase involved incorporating the OTI into an assessment 
and outcome measurement framework and evaluating it from a staff perspective. 
Chapter 4 describes the evaluation of an alternative framework for outcome 
measurement using the Plymouth Drug Outcome Questionnaire (PDOQ), (Hassard, 
1994). It also looks at factors predicting outcomes and predictive validity of a 
number of measures. Pluralistic methodology described by Barker et al., (1995) is 
used in this study and the study described in Chapter 3, to look at the staff 
perspective in the measurement of outcome. 
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Chapter 5 provides a general summary of the findings of the two studies and 
discusses their implications for outcome measurement in general. It also explores 
future directions in outcome measurement and avenues for future research in the area. 
SECTION C 
Case study 
The case study that I have selected for this section describes the development of a 
psychology service for Drugs Services. The early years of my professional career 
in the Alcohol Service was a period of tremendous learning and also a period of 
frustration. The frustration was generated by the culture within the service that did 
not allow a distinct role for clinical psychology. The multidisciplinary team worked 
on a 'generic worker' model and the contribution of the specific skills of different 
professions and individuals within the team felt like a secondary function. My 
experience of working in the department of Genito-urinary medicine was a complete 
contrast. In a predominantly medical setting the psychologists had a specific and 
clear role. When I was appointed to the post in the Drugs Service I was determined 
to define the role of the psychologists clearly and develop a service where the skills 
of psychologists that are obtained from an unique training is made available directly 
to the client who is able to use it and indirectly to other clients through other 
professionals. It was also my objective to ensure the utilisation by the service of the 
research and evaluation skills of psychologists. The NHS was going through a 
number of changes and the resulting environment with its emphasis on 
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multidisciplinary work, provided the opportunity to develop a psychology service 
based on a model. It is hoped that this model will be generalisable to other services 
in the area of substance misuse. 
SECTION D 
Literature review 
It not possible to work in the area of substance misuse and not be struck with the high 
incidence of reported sexual and physical abuse, and other incidence of trauma among 
the clients. The behavioural patterns or the personality profiles of clients manifest 
recurring themes. Clients whose drug use is chronic and problems extreme often fit 
descriptions of the 'dramatic' or cluster B description of personality disorders in 
DSM-IV (1994). These are difficult clients with whom to work, but the experience 
that these clients can benefit from cognitive behavioural work and the almost 
inevitable traumatic background in their histories inspired me to look at the links 
between trauma, post traumatic syndromes, personality disorder and substance 
misuse. The co-incidence of these phenomena in clients appears to be remarkable, 
yet there are few attempts to link them or develop models to explain these links, in 
clinical literature. 
Chapter 7 reviews the literature on the definitions of borderline personality disorder, 
post traumatic stress disorder and substance misuse. Examining the evolution of the 
definitions the chapter attempts to explore the hypothesis that they are part of the 
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same syndrome. Models to demonstrate the observed overlap of the categories found 
in the literature and possible aetiology are presented. The implications of such a 
formulation for interventions and directions for future research are also explored. 
27 
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SECTION B 
RESEARCH 
30 
Chapter 1 Assessment and outcome measurement in the treatment of opiate 
addiction: an overview 
1.1 Introduction 
In treatment settings the process of outcome measurement is inseparable from the 
process of assessment. If relevant information is not gathered at the initial 
assessment stage, subsequent evaluation becomes meaningless if not impossible to 
achieve (Wanigaratne, et al., 1990). Assessment is dictated by conceptual, 
theoretical and practical frameworks. In the area of the addictions, assessment 
was previously based on a reductionist model with the primary aim of diagnostic 
classification (Donovan and Marlatt, 1988). The emergent Biopsychosocial model 
(Schwartz, 1982) as the fundamental approach in the field of addictions demands a 
move away from reductionist assessments to an approach that will take into 
account the multiplicity of interacting variables that contribute to the individual's 
uniqueness and general level of functioning, as well as the persons attraction 
towards and susceptibility to an addictive behaviour (Peel, 1985). A multi-system 
assessment process, while providing the prospect of acquiring more comprehensive 
knowledge about the individual and his or her addiction, will also add a great deal 
of complexity to the assessment and therapy process for both the client and the 
clinician (Kratochwill and Mace, 1983). However, few researchers and clinicians 
have taken up the challenge of developing assessment systems within a 
Biopsychosocial framework. The Addiction Severity Index or ASI (McLellan, et 
al., 1980) is an example of an instrument that takes a broader view of addiction 
but it falls short of the comprehensive demands of the biopsychosocial model. 
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1.2 Factors influencing assessment for treatment 
Assessment for the treatment of opiate addiction is based on three main factors. 
i) Theories and models of addiction 
ii) Goals of treatment 
iii) Aims of service provision 
1.2.1 Theories and models of addiction 
Theories and models of addiction range from biological theories, psychological 
theories, psychodynamic theories to social theories. Assessment of an individual 
is either overtly or covertly based on a particular model or a combination of 
models, depending on the assessor or the setting in which the assessment is carried 
out. During the assessment process these models are used to make decisions about 
treatment, but different professions and different individuals in a treatment setting 
may subscribe to different theories and different models of addiction. This can 
lead to confusion and conflict between the assessment and treatment process. If 
different information based on different models is collected by different assessors, 
this has obvious implications for outcome measurement. Uniformity of assessment 
in a treatment setting is thus an essential prerequisite for effective outcome 
measurement. 
It is rare that a treatment setting subscribes to one theory or model of addiction. 
32 
Some settings may have a dominant model (for example a Twelve Step approach; 
Cook, 1988; Wells, 1987) whilst individuals working within that environment may 
hold differing views. Uniformity of assessment, nevertheless could be achieved 
by consensus in a treatment setting. A consensus on what information is collected 
during assessment can be reached if there is clarity regarding the prevalent 
theories and models of addiction. Overt statements on the rationale for collecting 
the information in treatment settings are rare. This is probably due to the lack of 
clarity about the models that underpin treatment. It will be argued in this chapter 
that clarity on theories and models upon which treatment is based is crucial not 
only for assessment and outcome measurement but also for the effectiveness of 
treatment. 
1.2.1.1 Classification of models 
There are numerous conflicting models and theories of addiction for example, 
disease model, moral model, psychological model, and a system of classification 
or a framework for organising these models will be of considerable use to 
clinicians as well as researchers. The conceptual framework proposed by 
Brickman et al., (1982) to organise models of helping and coping has been 
suggested as particularly relevant in the area of addictions (Maisto and Conors, 
1988). Using a framework of responsibility for developing the problem and 
responsibility for its solution, Brickman et al., (1982) arrived at a four category 
classification. They named these models a) Moral, b) Compensatory, c) 
Enlightenment and d) Medical and argued that whilst the models are internally 
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coherent, nevertheless each model is in some way not compatible with the others. 
It can be argued that in addictions such a high level of incompatibility may not 
exist and that it may be convenient to amalgamate them into two categories. A 
brief outline of the models or categories proposed by Brickman et al., (1982) can 
be presented as follows: 
A) The Moral Model 
Individuals are viewed as responsible for both the development and solution of 
their problems and are expected to exert will-power to resolve them. This model 
has had influence with regard to policy development in relation to addictive 
behaviours and media and public attitudes (Maisto and Caddy, 1981). External 
agents, for example treatment agencies, are not seen as able or obliged to help. It 
can be argued that much of the interventions that take place at treatment agencies 
(for example, assessments and information giving), emphasising the individual 
making a choice or informed decision, are directly or indirectly based on this 
model. 
B) The Compensatory Model 
This model sees individuals as not responsible for the development of their 
problems but nevertheless as responsible for the solutions. The model sees 
individuals as able to compensate for the circumstances that they find them-selves 
in by extra effort or by receiving and utilising help. The responsibility for using 
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help is seen to lie with the individual. In this respect this model has close affinity 
to the Moral model. Psychological interventions in the area of addictions, 
particularly cognitive behavioural interventions are based on the compensatory 
model. Marlatt and Gordon's (1985) cognitive-behavioural model of relapse 
prevention is the best example of this. This essentially 'self-control' approach to 
treatment aims to help the individual maintain changes in addicted behaviours 
achieved, by increased self-awareness; and a range of techniques which includes, 
self-monitoring and alternative coping skills; and life-style balance. This 
particular approach, over the last decade has become a major influence in the 
treatment of addictive behaviours. 
C) The Medical Model 
The Medical model views individuals as not responsible for the development of 
their problems or the solutions to them. The basic application of this model is 
the treatment of physical illness. The individual in essence is seen as a passive 
recipient of help from the expert for example, a doctor. 
D) The Enlightenment Model 
The individual is seen as responsible for the development of the problem but not 
responsible for the solution. The model gets its name from the perceived need to 
educate (enlighten) individuals about the nature of their problems and then to do 
whatever that is necessary to solve them. In the field of addiction this model 
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describes most closely the 'Twelve step' approach, although some authors (Maisto 
and Connors, 1989) suggest that the medical model best describes this approach. 
It is the nature of the field of addiction that it does not easily fit existing 
paradigms. The Brickman et al., (1982) system, whilst serving as a useful 
framework does not satisfactorily solve the problem of classifying the theories or 
models of addiction. In addictions the medical or disease model is seen by some 
as a 'metaphor' and the current formulations of the model have as many 
psychosocial elements in it as biological factors. On the other hand, some of the 
psychosocial theories are formulated within a disease metaphor: the self- help 
approach (dominated by the Twelve step movement, which according to the 
Brickman system as described above fits into the enlightenment model) has 
incorporated a large aspect of the medical model into its thinking. 
It is proposed here that for the sake of clarity and simplification that is required 
for assessment and outcome measurement from the outset, the Brickman system is 
collapsed to two categories. The moral and compensatory into `psychosocial 
theories' and the enlightenment and medical into ` disease theories'. This would 
enable the description of the main conceptual frameworks that have influence in 
treatment settings. It must be stated once again that this is an arbitrary 
classification for the purpose of simplifying theoretical positions for the purpose of 
assessment and outcome measurement in clinical settings. 
Dominant theories and models of addiction will be outlined in the following 
section. 
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1.2.1.2 Disease theories 
The disease model of opiate addiction which has dominated medical and scientific 
thinking since the 1920's is based on a psychiatric formulation that linked chronic 
addiction with psychoneurotic deficits in certain individuals (Acker, 1993). There 
is an underlying assumption that continued research will yield definitive answers 
regarding the nature of addiction, with clear implications for treatment. 
Researchers have attempted to answer some of the most common questions. 
For example: 
Is abstinence the only acceptable treatment aim, or can some clients resume 
episodic and controlled drug use? 
Will a genetic marker be found to explain why some individuals seem to fall 
easily into destructive patterns of drug use, whilst others exposed to the same 
drug, do not? 
Will further study of how perception and experience are modulated by 
neurotransmitter metabolism lead to treatment breakthroughs? 
The disease concept in addictions, seen by some only as a `metaphor' has a long 
history dating back to the 18'h century both in Europe and in America (Berridge 
and Edwards, 1987; Sonnedecker, 1963). The 'disease concept in addiction' sits 
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uneasily with accepted medical definitions of `disease' and has changed over the 
past 150 years with dominant political and socio-economic trends. The 'disease 
concept' has struggled with attempts at accommodating moral views, concepts of 
social deviance, biological determinism, philosophical views of free will and 
control and scientific inquiry. This produced hybrids of medical and moral theory 
with parallels only in 'functional' psychiatric illnesses. The disease concept 
subsequently developed a dichotomy within, that led to much confusion. An 
example of this is the dichotomy between Morphinist (an individual with a 
morphia habit) vs the morphinomaniac (an individual with a definite disease or a 
functional neurosis), with no clear distinguishing criteria between the two 
(Crothers, 1902; Kerr, 1988). It is worth noting that this dichotomy has re- 
emerged in the most recent diagnostic classification systems, but with clear 
distinguishing criteria (DSM-IV, 1994; ICD-10,1992). 
Despite its long history it is acknowledged that a consensus on the disease model 
of addiction does not exist (Acker, 1993) and questions remain on its utility even 
as a metaphor. Whilst some await research to confirm the standing of the model 
and argue its functional utility (for example a source to direct attributions of 
causality as a way of relieving guilt and responsibility), others argue that it erodes 
the human capacity to take responsibility for one's actions (Szasz, 1974). 
The disease model remains a dominant model both in Europe and in America and 
forms the basis for much of current opiate treatment. Hence an examination of 
the key elements and a brief outline of the evolution of the model is necessary 
in 
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any context of assessment and outcome evaluation. 
The phenomena of tolerance and dependence (the need to continue to take opiates 
to stave off withdrawal symptoms) which is central to the decease model had been 
described as early as the 18' Century (Sonnedecker, 1963). The autoimmune 
theories of addiction of Bishop (1913) and Pettey (1913) offered early scientific 
explanations of tolerance by hypothesising that the body developed an antitoxin 
that protected it from the toxic effects of morphine, necessitating steadily 
increasing doses to supersede the blocking effects of the presumed antitoxin. 
Withdrawal effects were explained by the antitoxins exerting their own toxic 
effects on organs. 
A psychiatric model of addiction emerged from the work of Lawrence Kolb (1925) 
in America. He argued that while any one could become dependent on opiates 
given continuous sufficient administration, only certain types of individuals who 
had pre-existing psychoneurotic deficits would develop problems with addiction. 
He contrasted "psychopathic" or "vicious" addicts with "normal" or "innocent" 
addicts. This model was both stigmatising and dichotomous and reflected 
dominant views of policy-makers and the American establishment (Acker, 1993). 
Addiction was defined as a kind of deviance that was indicative of an underlying 
personality disorder. This was a stigma-laden disease model. 
A new disease model has emerged in America in the 1970's with a functionalist 
description which emphasised behaviour as out of control and cited as predisposing 
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factors a combination of genetic, psychological and social factors; this is a 
'biopsychosocial' disease model (Schwartz, 1982). In the 1980's definitions 
included compulsiveness, loss of control, and continued drug use in spite of 
adverse consequences among diagnostic signs (Smith, Milkman and Sunderwirth, 
1985). This formulation has several implications: it focusses on behaviour rather 
than the physical sequelae of long term drug use; it justifies early intervention; 
and it is not drug specific. The description of the behavioural model is so broad 
that it could include any compulsive behaviour (Smith, Milkman and Sunderwirth, 
1985). 
In Europe, particularly in Britain the work of Griffith Edwards has been 
particularly influential in the development of the disease model. He integrated 
existing knowledge on addiction and different levels of explanation to develop the 
concept of a dependence syndrome (Berridge and Edwards, 1987; Edwards and 
Gross, 1976; Edwards, et al., 1977). The description of the link between 
psychological and biological dependence in the formulation of the dependence 
syndrome has helped delineate them from each other. Some believe that this 
description is arbitrary and underestimates the frequent co-occurrence of physical 
and psychological symptoms (Drummond, 1991). The dependence syndrome 
formulation also viewed problem drug-taking, and dependence, as separate 
dimensions. Physical dependence was described by the `neuro-adaptational 
model' based on tolerance and withdrawal. The avoidance of the withdrawal 
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experience is seen as providing the drive to continue to use, with or without the 
positive experience of the drug: 
"Addiction to opiates may be best pictured as both a psychological and 
biological condition, characterised by a desire to continue taking the drug 
in high dosage, a salience of this drug-seeking drive over other life 
considerations and a tendency to relapse. " (Berridge and Edwards, 1987) 
The concepts of neuro-adaptation and dependence syndrome forms the basis of 
current definitions of drug dependence in both the main disease diagnostic and 
classification systems in the world, the American DSM-IV and the WHO ICD-10. 
There are seven key elements to the original description of the dependence 
syndrome (Edward and Gross, 1976; Drummond, 1991). These can be outlined as 
follows: 
i) Increased tolerance to the drug 
ii) Repeated withdrawal symptoms 
iii) Subjective awareness of the compulsion to take the drug 
iv) Salience of drug seeking behaviour 
v) Relief or avoidance of withdrawal symptoms 
vi) Narrowing of the repertoire of drug taking 
vii) Reinstatement following a period of abstinence 
The assessment systems or the assessment process in most treatment settings are 
overtly or covertly aimed at detecting these elements in an individual. 
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1.2.1.3 Psychosocial theories 
A) Cognitive-behavioural theories 
Derived from the principles of social learning theory (Bandura, 1977), cognitive 
psychology, and experimental and social psychology the 'addictive behaviours' 
model sees addictions as 'overlearned habits' that can be analysed and modified in 
the same manner as any other habits (Marlatt, 1985). Taking substance misuse as 
an example, this model sees the development of the addiction taking place in a 
continuum, from experimentation, recreational use, problematic use to 
dependence. The continual, excessive use and 'loss of control' marks the end- 
point of dependence. According to this model an individual's position in each 
point of this continuum is governed by processes of learning. The determinants of 
addiction could include, situational and environmental antecedents, beliefs and 
expectations, the individuals family history and prior learning experiences, the 
consequences of the addictive behaviour and social factors (Marlatt, 1985). A key 
assumption in this model is that addictive behaviours are maladaptive coping 
mechanisms that has led to negative consequences for the individual in terms of 
health, social status and self-esteem. 
The key cognitive processes related to addictions are identified as a) self-efficacy, 
b) outcome expectancies, c) attributions of causality and d) decision making 
(Beck, et al., 1993; Marlatt, 1985). A number of models of addiction and 
intervention have been developed, based on these factors, for example self-efficacy 
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model (Annis, 1986); cognitive model (Beck, et al., 1993). The cognitive model 
of Beck, et al., (1993) describes addictive behaviours arising out of interplay 
between layers or levels of beliefs. Core beliefs or core schemas of an individual 
is activated by an critical incident to give rise to anticipatory beliefs related to the 
addiction which in turn gives rise to craving. Cravings then activates permissive 
beliefs to indulge in the addiction, which subsequently leads to the addictive 
behaviour. This explanatory model of the cognitive processes involved in the 
addictive behaviour enables the construction of individually-based intervention 
strategies. 
B) Excessive appetite theory 
The dominance of the disease model and the closely associated enlightenment 
model (Twelve step) have not fostered the development of alternative frameworks 
for understanding addictions. One of the few exceptions is the excessive appetite 
model developed by Orford (1985). This model attempts to provide a 
psychological explanation for addiction outside the neuro-adaptation model. The 
fundamental premise of this theory is that an attachment or an addiction to a 
substance or an activity can be formed by psychological processes rather than 
neuro-adaptation, tolerance and withdrawal as in psychobiological formulations 
(Orford, Daniels and Somers, 1996). Since the conceptualisation in substance 
addiction is very much tied up with the neuro-adaptation model, the advancement 
of alternative models has to rely on non-substance addiction and comparative 
studies between substance and non-substance addictions. Gambling and 
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comparative studies with substance addictions offer scope for this work. A 
structure for an alternative model has emerged from a study comparing drinkers 
with gamblers (Orford, Daniels and Somers, 1996). This model suggests that a 
process involving three sets of factors, primary, secondary and tertiary, 
contributes to the maintenance of an addiction and are independent of 
psychobiological factors. According to the model the primary factor is incentive 
motivation-focus on positive rewards as opposed to avoidance of withdrawal 
distress. This could involve memories of past reward, and expectations of future 
rewards (positive outcome expectancies). Evidence supporting this view has also 
come from research within the psychobiological framework where positive 
incentive seem to offer a better explanation for addictive behaviours than drive 
reduction (Bozarth, 1990; Jaffe, 1989). 
The secondary factors in this model, consistent with drive reduction formulations, 
are said to act to consolidate and strengthen attachment to an addictive object. 
New drives are set up as a result of strong and negative emotions associated with 
the addictive behaviour and are enhanced by the operation of cognitive defences 
(for example, denial and rationalisation) that prevent the person concerned from 
seeing his or her situation objectively. The tertiary factors in the model are 
described as factors associated with harm resulting from the excesses of the 
addictive behaviour (for example loss of self-respect, relationships and 
employment). This may set up a cycle for further increase in addictive behaviour 
(increase of incentive value and addiction lifestyle) or motivate attempts to change. 
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A study which had operationalised this model and measured attachment across 
12 areas (strong desire, preoccupation, acting against judgement, loss of control, 
non-social activity, acquiring money for the activity by special means, feeling 
addicted or dependent, feeling depressed or guilty as a result, being criticised by 
others, and feeling the need to change) by a twenty four item questionnaire found 
a very similar pattern of response between gamblers and problem drinkers 
(Orford, Daniels and Somers, 1996). The same study investigated the relationship 
between this measure and an instrument that was developed to measure the 
severity of dependence (SADQ: Stockwell et al., 1979) within a neuro-adaptational 
framework and found significant differences in all scales between gamblers and 
problem drinkers in a predicted direction. 
The psychological model outlined above appears to offers an alternative to the 
established neuro-adaptational model of addiction. Unfortunately few researchers 
have taken up the challenge of exploring addiction in different frameworks. 
Further research along these line would not only broaden our understanding of the 
addiction process but offer avenues for interventions for conventional addictions as 
well as new addictions. The present study attempts to develop such a measure for 
opiate addiction by adapting and modifying a measure developed by Orford (1991) 
for problem drinkers and gamblers. 
Evidence supporting psychological theories of dependence have ironically come 
from biological research into neural networks and neurochemistry, particularly the 
neurobiology of craving. Evidence for opiates activating neural mechanisms 
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effecting both positive and negative reinforcement processes have been found 
(Wise, 1988). The negative reinforcement process supports the avoidance of 
withdrawal theory and the positive reinforcement process supports the excessive 
appetite theory. The discovery of positive reinforcement mechanism also explains 
dependence in the absence of physical dependence (Bozarth and Wise, 1984; 
Deneau, Yanagitha, and Seevers, 1969). Biological animal studies of opiate 
addiction have concluded that `reinforcing effects of opiates has been temporally, 
procedurally, neuroanatomically, and neurochemically dissociated from their 
physical dependence producing effects (Bozarth, 1994). 
C) Motivational distortion theories 
This theory views repetitive behaviours such as chronic drug misuse changes the 
motivational system underlying that behaviour (West, 1991). The concept of 
`habit strength' based on conditioning theory is said to play a part here. This 
refers to the causal link between a stimulus which is a cue to action and the 
subsequent action. It has been argued that it may involve the enhancement of 
synaptic connections in the circulatory involved like automation of psychomotor 
skills. The action of the drug itself may act to distort motivation. Motivational 
distortion theories can explain why relapse and craving can occur in the absence of 
withdrawal distress and why it takes time for an addiction to form (West, 1991). 
One of the most salient clinical features of addiction is that with the increased 
motivational strength for drug related behaviour there is a severe attenuation of the 
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motivational properties of other reinforcers for example food and sex. The 
disruption of the previous motivational hierarchy where motivation for behaviours 
essential for survival and well-being become less important compared to 
motivation for drug-related behaviour, has been termed ` motivational toxicity' 
(Bozarth, 1990; Wise and Bozarth, 1985). The basis of this characteristic 
described as an aspect of the dependence syndrome (Edwards and Gross, 1976 ), 
is better explained by behavioural theories of positive reinforcement than, 
withdrawal avoidance theories (Bozarth, 1994). 
1.2.1.4 Psychodynamic theories 
An overview of psychological models in the area of addiction would not be 
complete without the inclusion of psychodynamic formulations and theories, 
because this perspective has influenced much of the thinking behind the 
psychological work carried out in clinical settings. It must be noted that this 
perspective is largely ignored in reviews and texts on addictions (for example, 
Bell-Glass, 1991; McMurran, 1994). 
On the one hand there has been minimal contribution from this perspective to the 
theoretical and conceptual developments in this field (Hopper, 1995), on the other 
hand in treatment settings it has had and continue to have a large influence. This 
paradoxical situation is due to the domination of relationship based models or 
philosophies of treatment in specialised treatment settings that was the tradition in 
the 60's and 70's. The assumption was that the addict will achieve abstinence 
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through a process of a therapeutic relationship with a drugs worker. Counselling, 
which became the main intervention in many treatment settings, was based on 
psychodynamic assumptions but often carried out by individuals with little or no 
training in psychodynamic therapy or counselling. It can be argued that much of 
this counselling took place under a 'pseudo-Rogerian' humanistic banner with 
little or no acknowledgement of the underlying psychodynamic processes. Like 
most other schools of psychotherapy at different times in their historical 
development, the humanistic counselling perspective has thus far had little to say 
on the specifics of addictive patterns, and could be seen as having no identifiable 
theory or model for addictions. However, Carl Rogers' concept of distorted 
symbolisation (Rogers, 1951) encompasses a broad sweep of ideas that indicate 
how the individual may acquire attachments to behaviours or items that are 
ultimately destructive to them, despite apparent early benefits in the individual's 
experience of them; this could be seen as a variant on more classical object 
relations theory, with a focus on the acquisition of guilt and its consequences for 
the otherwise contented organism (Dryden, 1990). It can be argued that this 
approach may not facilitate change in addicted individuals, although Rogers' own 
early research findings were to the contrary (Rogers, 1961). The psychodynamic 
processes for example transference, counter-transference, projection, projective 
identification, and denial, (Dryden, 1990) which appear to dominate the 
counselling work that goes on in many addiction treatment settings takes place 
without the supervision and theoretical framework such work requires. This lack 
of framework or clarity accounts for much of the `stuckness' that is seen in 
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psychological work in addiction treatment settings and is arguably damaging to 
both the patient and the counsellor. 
The area of addictions appear to be largely ignored by psychodynamic theorists 
because addicts are seen as difficult patients who are found to be rarely held in 
treatment for any length of time. Yet there is a vast amount of literature and 
theorising about borderline personality disordered patients from this perspective, 
despite these patients being seen to be difficult in similar ways. It is argued in 
this thesis (Chapter 7), that these two patient groups are the same, or if not that 
there is a large overlap between them. This link has only recently been implied 
by theorists from this perspective (De Zulueta, 1993; Hopper, 1995). 
The psychodynamic umbrella encapsulates a range of viewpoints or schools of 
thoughts. These range from the psychoanalytical school, analytical psychotherapy 
to transactional analysis. Theorising for the development and maintenance of drug 
addiction has largely come from the psychoanalytical school. The most recent 
formulation which encapsulate much of the past theory by Hopper (1995) suggests 
that: 
the main cause of the addiction syndrome is the unconscious need to entertain 
and enact various kinds of homosexual and perverse fantasies, and at the same 
time to avoid taking responsibility for it. It is hypothesised that specific drugs 
facilitate specific fantasies and using drugs is considered to be a displacement 
from, and a concomitant of, the compulsion to masturbate while entertaining 
homosexual and perverse fantasies". 
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The new and perhaps more salient aspect of the theory that Hopper (1995) 
presents is the link with traumatic experience: 
" The addiction syndrome is also hypothesised to be associated with life 
trajectories that has occurred within the context of traumatogenic process, the 
phases of which include social, cultural and political factors, encapsulation, 
traumatophilia, and masturbation as a form of self-soothing. " 
This aspect of the theory have implications for assessment and outcome 
measurement, whether the treatment is psychodynamic or not. It also links the 
psychodynamic perspective with an accumulating mass of evidence from other 
perspectives in psychology, neurochemistry and neurology linking substance 
misuse and personality disorders as aspects of a post-traumatic syndrome. 
Some of the other psychoanalytical views of addiction are outlined below: 
i) Addiction is associated with primitive or `psychotic' anxieties, and 
therefore, is intermediate between the perversions and the psychoses 
(Glover, 1932b). 
ii) Addiction is based on a compulsion to obliterate internal objects (Glover, 
1932b) and not on a search for bliss in terms of a fixation in an oral stage 
of development. 
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iii) Addiction is associated with homosexuality in two ways, sexualisation of 
aggression towards female and maternal objects and similar process 
towards male and paternal objects (Limentani, 1986). 
iv) Addiction is associated with if not actually a form of, masturbation, by 
virtue of it being a displacement from or replacement of it. This view 
originates from Freud's comments (Nagera, 1971) that `masturbation is the 
primary addiction and that other addictions 
..... 
are 
..... 
a substitute and 
replacement for it' and that both addiction and masturbation is characterised 
by withdrawal into fantasy life. 
v) Some drugs such as opiates are anti-aggressive or regressive and other 
drugs such as cocaine are anti-regressive or aggressive (Battegay, 1991). 
It can be said that it would be rare for a treatment setting to base its treatment 
overtly on the psychodynamic theories outlined above. Nevertheless much 
counselling and group work, particularly in therapeutic community settings is done 
with covert psychodynamic assumptions. 
In the context of the present study this approach does not produce clear criteria for 
assessment or the measurement of outcome. Nevertheless, history-taking by most 
workers in the area, gathers information on developmental aspects of the 
individual and addiction broadly based on psychodynamic assumptions. 
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1.2.1.5 Theories of addiction and the assessment process 
The theories and models of addiction described above, albeit not 
comprehensively, capture what forms the basis of most interventions in the area. 
They attempt to explain both aetiology and the maintenance of addiction. In 
general aetiological theories are used to formulate treatment or intervention and 
there is an assumed linear relationship. In addictions interventions may not 
directly follow aetiological process. In many cases interventions may be based on 
theories of maintenance of problems and desired outcomes. 
A necessary pre-requisite for assessment, although rare in practice, is to make 
explicit why the information is collected. In the absence of explicit statement of 
theoretical underpinnings, information collection loses precision. Engaging in the 
process of information collection with the assumption that it would be of relevance 
at some stage or would serve some purpose cannot lead to meaningful 
assessments; yet this is exactly what happens in many treatment settings. In 
services where there are multidisciplinary teams or workers who do not belong to 
a profession, there is undoubtably a risk of wide variations in what information is 
collected at assessment. In an attempt to reduce heterogeneity of information 
collection many services have devised 'assessment forms' or 'front sheets' as they 
are known. This undoubtably standardises the information collected, but they also 
have had the paradoxical effect of losing the focus of assessment. These forms 
often become part of the implicit 'tradition' in treatment settings and new staff 
joining the service are expected to pick up these forms and use them without much 
explanation of theoretical underpinnings (if there are any). It is argued here that 
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unless the theoretical basis of treatment provided within a setting is made explicit 
and without clarity as to what information is needed to make clinical judgments, 
assessment is reduced to a 'hit or miss' process. If the theory or treatment 
philosophy is made explicit to the client being assessed, this could lead to better 
co-operation and better quality of information collected. This could also help 
manage expectations that clients have about treatment which have implications for 
outcome. 
1.2.2 Goals of treatment 
Goals of treatment are the second most important factor that effect assessment and 
outcome measurement. In the treatment of addictive behaviours goals of treatment 
present a unique situation. Compared to other conditions these can be described 
as being in a dynamic state of change. In classical medical treatment the goals 
are either curative or palliative. 
1.2.2.1 Abstinence 
Abstinence became the objective of treatment from both moral and disease 
standpoints. Traditionally this was the only goal of treatment. The Enlightenment 
approach (Twelve step) that encapsulates much of the disease perspective 
maintains `abstinence' as the only acceptable goal of treatment. It also views the 
abstinent addict, not as cured, but in a state of remission. 
53 
The acceptance of abstinence as the only goal of treatment changed in the 70's 
with the publication of the studies on controlled drinking studies in problem 
drinking. The controversy that the studies sparked had a profound influence 
within the field. The net result has been the emergence of a much broader 
spectrum of treatment goals in addictions in general. 
In the area of treatment of opiate addiction the use of methadone as a substitute 
opiate since the 50's (Dole and Nyswander, 1965; Payte, 1991) has also 
contributed to the change of treatment goals. Methadone was initially seen as an 
opiate substitute to use in the detoxification process. The experience of using 
methadone with this purpose has contributed to a paradigm shift in treatment goals 
both in the USA and the UK (Dole, 1980; Payte, 1991). The treatment goal or 
choice of methadone maintenance is now established in the USA and is rapidly 
gaining acceptance in the UK. This is closest to a palliative goal of treatment in 
the medical world. 
1.2.2.2 Harm reduction 
The concept of reducing drug-related harm, which is associated with the concept 
of palliation, has by-and-large replaced abstinence as the main goal of treatment in 
the UK. The acceptance of this option in drug treatment settings became 
accelerated by two factors: the " heroin epidemic" and the "AIDS pandemic". 
The former refers to the dramatic increase of heroin use reported in the 1980's 
(Power, 1994) and the latter to the threat of HIV to public health worldwide. 
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The response to the increase in drug use in the UK was to shift the emphasis in 
treatment from specialised units which provided abstinence based intensive 
treatment programmes to less intensive community-based and treatment-linked 
general treatment settings. The Advisory Council on Misuse of Drugs (ACMD) 
report in 1982 recommended the implementation of Community Drug Teams 
(CDT's) which was to develop alternative models of treatment. This approach 
which was pioneered by `non statutory sector' organisations, incorporated a model 
of liaison work between drug users, general health care settings (primary and 
secondary) and specialist centres. The aim was to increase access to treatment to 
a larger number of individuals who were in early stages of their drug using 
careers. The CDT's which were to be assessment and liaison services soon found 
them-selves to be second level specialist treatment services because the task of 
persuading generic services to treat opiate users proved to much more difficult 
than that was envisaged originally. A concept of severity of problems requiring 
different levels of treatment emerged where patients whose problems were thought 
to be more severe were assessed and treated at specialist centres while CDT's 
commenced treatment with patients with less severe problems with the objective of 
persuading generic community-based services to take over their care. Abstinence- 
only outcome criteria for these patients conflicted with the aims of accessing and 
retaining them in treatment. Broader outcome criteria became necessary to deliver 
ACMD objectives. Reduction of drug-related harm in different domains of the 
patient's functioning. and behaviour (for example, physical health, psychological 
health, criminal activity) became more acceptable outcomes of treatment (Strang, 
1990). 
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In the mid 1980's the British health policy makers were alerted to the threat of 
the HIV pandemic and the route of transmission of the disease by the sharing of 
needles by Intra-Venous (IV) drug users. The report of the Advisory Committee 
on the Misuse of Drugs (ACMD) in 1989 had the following statement: 
" the first goal of work with drug misusers must be to prevent them from 
acquiring or transmitting the virus. In some cases this will be achieved 
through abstinence, in others abstinence will not be achievable for the time 
being and efforts will have to focus on risk reduction. " 
In the UK this statement had a dramatic impact on service provision to drug users 
and widened the goals of treatment even further. Harm reduction became in many 
services the main goal of service provision. Harm reduction can include a broad 
spectrum of outcomes. Outcomes that reduce the risk of HIV transmission became 
a priority. HIV risk reduction became a treatment goal. The reduction or 
elimination of needle sharing, use of clean needles, use of other routes of taking 
drugs other than injecting, use of condoms, adoption of safer sexual practices and 
reduction of activities such as sex working in order to obtain drugs became 
outcome criteria. 
Harm reduction is not a coherent model of treatment but an umbrella term for a 
range of service strategies that are aimed at different outcomes (Strang and 
Farrell, 1992). In the absence of pre-defined outcome criteria, harm reduction 
becomes meaningless as any treatment intervention can be justified in terms of 
reducing harm. 
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1.2.3 Aims of Service Provision 
The third factor that determines assessment and outcome measurement in practice 
is the aims of service provision in a particular service. This is of course 
determined by external factors: mainly the theories of addiction, government 
policy directives and the goals of treatment. The choice of a particular 
combination of theory and goals of treatment makes each service unique. The lack 
of clarity around these issues that was mentioned above undermines both the 
assessment process and outcome measurement. Some treatment settings are 
primarily aimed at abstinence and some are primarily aimed at harm reduction. 
Most services attempt to do both and much of the confusion and problems in 
assessment and outcome measurement are inherent in these settings. 
Some services aim to provide a comprehensive range of services that could range 
from harm reduction programmes such as 'low threshold methadone programmes', 
methadone detoxification, methadone maintenance, residential rehabilitation, 
counselling to psychodynamic psychotherapy. When there is a range of services 
the assessment process has to help make clinical decisions as to the most suitable 
treatment programme for the client. It was argued at the beginning of the chapter 
that the outcome measurement process has to be linked to the assessment process 
if it is to be meaningful. In services where there are a wide range of programmes 
it may be necessary to have a multi-level outcome measurement system. Such a 
system would mean that broad generic outcome measures will be taken at the stage 
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of initial assessment and more programme specific and sensitive measures are 
taken at various phases of treatment (Moolchan and Hoffman, 1994). 
1.3 Review of outcome measurement 
Outcomes are measurable changes attributable to treatment. In Britain and 
elsewhere, changes in health service organisation have reinforced the necessity of 
demonstrating the outcome of clinical interventions (Ziebland and Rogers, 1994). 
In the treatment of drug users outcome measurement has been much neglected 
compared to other areas of health care. In the current climate in Britain this 
situation could no longer be tolerated. The statistics showing the increase in drug 
use in the country and political pressure on the government to intervene, prompted 
a debate on the effectiveness of treatment of drug users. The awareness of the 
lack of sufficient and suitable outcome data came as both an embarrassment and a 
shock to the health service, research institutions and service providers. The 
minister of health at the time commissioned an effectiveness review and this body 
reported in 1996. At the same time the Department of Health commissioned a 
national research study of treatment outcomes. This study the National Treatment 
Outcomes Research Study or NTORS (Gossop, 1996) has been entrusted with the 
task of not only evaluating the outcome of treatment of opiate users in different 
settings with different treatment regimes and philosophies but also to develop an 
instrument to measure outcome. The first phase of the study was completed in 
1996 and it has received an extension to continue with the work for a further five 
years. Arguments for and against this approach will be discussed later. Criticism 
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for not systematically evaluating outcome and not developing suitable measures 
until this late stage must be accepted by all in the field, both researchers and 
clinicians. 
A number of hypotheses can be put forward to explain the complacency towards 
outcome measurement. The traditional treatment goal of abstinence can be put 
forward as one of the reasons for this. If abstinence was the only outcome of 
treatment, then a simple tally of abstainers at various follow up intervals was all 
that was needed. This was indeed what was done in outcome measurement for 
many years. Nevertheless for nearly two decades it has been recognised that this 
is an inadequate reflection of drug interventions (Gillam, et al., 1992). From an 
abstinence framework poor outcome was seen as the norm in drug treatment, after 
all, relapse is the commonest outcome in the treatment of addictions (Marlatt and 
Gordon, 1985). This can explain the attitude towards outcome measurement in 
treatment settings. 
In a context where relapse into drug use was the norm, `retention in treatment' 
became a goal and an outcome of treatment in many settings. This led to many 
services keeping patients on in treatment with no measurable change for long 
periods. Once the culture of `retention in treatment' as a treatment outcome was 
set within services it led to a resistance to measure any other outcome. 
The lack of consensus of what measures of outcome to take other than 
`abstinence', is another reason for the lethargy in this area (Darke, 1992; Ziebland 
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and Rogers, 1994). The conclusion by Edwards and Goldie (1987) " to a large 
extent, assessment of outcome is a value judgement that varies from individual to 
individual and from one professional group to another", sums this up. Outcome 
studies have focused on different outcomes in an arbitrary fashion. To illustrate 
this with a few examples of outcome measures in recent studies, the identified 
measures range from: `cessation of drug use and criminality' (Charuvastra et al., 
1992), ` mortality, drug use, abstention, intentions' (Gossop et at., 1989), 
`mortality, use of services, needle sharing, HIV, employment status & marital 
status' (Skidmore et al., 1990), `length of stay, readmission, drug use, abstention, 
HIV status' (Gillam et at., 1990), `use of services, abstention, drug use, illegal 
behaviour, employment status & client satisfaction' (McAuliffe, 1990), `mortality, 
re-admission, drug use, abstention, illegal behaviour, employment status, marital 
status, emotional & social function, & life style' (Winick, 1990), `internal & 
external attribution & personal responsibility' (Morojele and Stephenson, 1992), 
`drug use 
- 
urine tests, HIV status, illegal behaviour, sexual behaviour, needle 
sharing, clean injecting sites & client satisfaction' (Greenwood, 1992), `mortality, 
illegal behaviour, employment status, emotional & social functioning, & 
dependency on welfare' (Berglund, et at., 1991), ` drug use, length of stay in 
treatment, needle sharing, reasons for sharing & sexual behaviour' (Stimson, et 
al., 1989), to `adjective checklist & personality change' (Craig et al., 1990). 
One of the major negative consequences of this diversity of outcome criteria is the 
inability to compare relative efficacy of different treatment programmes. This is 
seen as a substantial problem in the area of opiate treatment evaluation research 
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(Darke, 1992). In his major review of opiate treatment outcome studies Darke 
(1992) groups outcome evaluation into five broad categories, which in essence 
outlines the evolutionary chronology of progress in this area. These categories, 
the domains they measure and the limitations in each area are outlined below. 
1.3.1 Studies utilising composite outcome criteria 
These studies measured performance in a number of areas with the aim of 
obtaining an estimate of the overall functioning of the individual including drug- 
taking behaviour. Measures were taken on opioid use, non-opioid drug use, 
criminality, re-entry into drug treatment, low alcohol use and employment. The 
method of evaluation in studies using this approach involved two levels of success 
(absolute and moderate) and measure success of failure on the basis of arbitrary a 
priori standards for example, no opioid use or some opioid use and whether clients 
were employed for more than 6 months out of the 12. The main limitation of this 
approach is the absence of continuous variable measurement which makes it 
insensitive to a degree of change in a single domain. The studies that used this 
approach include, Drug Abuse Reporting Programme (DARP) studies which were 
national longitudinal outcome studies in the USA (Bracy and Simpson, 1982; 
Simpson and Sells; 1982 Simpson, 1986) and Phoenix House studies looking at 
outcome following treatment in therapeutic communities (DeLeon et al., 1982, 
DeLeon, 1985; DeLeon, 1986; DeLeon, 1988). Opiate use is associated with a 
wide range of health, legal and social problems. The narrow range of outcome 
domains selected in these studies are a serious limitation in them. These studies 
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have not taken into consideration the literature that exists, pointing to the 
relevance of psychopathology, social functioning and health status of drug users 
both in terms of predicting outcome and changes in these domains, as outcomes of 
treatment programmes (Bell, et al., 1990; Gernstein and Harwood, 1990; Swift et 
al., 1990; Webster et al., 1977). 
1.3.2 Descriptive outcome studies 
These studies used a methodology that was an advance on the dichotomous and 
criterion-based composite methodology. Different descriptive measures were used 
to evaluate performance in different outcome domains for example, frequency of 
use of different categories of drugs and number of weeks of full time employment. 
This method, although it lacked strict standardisation, was more sensitive to subtle 
changes. The Treatment Outcome Prospective Study (TOPS) a large multi-centre 
follow-up study in the USA is the most significant study to use this methodology 
(Hubbard, et al., 1983; Hubbard, et al., 1986). The outcome domains used in this 
study were drug use, depression indicators, full-time employment and illegal 
activity. This study like the DARP and Phoenix studies mentioned above can be 
criticised for using only a limited number of outcome domains. 
1.3.3 Studies using global outcome measures 
This methodology involves deriving a total score from the performance on a 
number of variables rather than a classification of `success' or `failure' on the 
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basis of `a priori' criteria used in composite methodology. Two studies can be 
cited as good examples of this approach. Bale et als' (1980) study which used 
four variables (no heroin use in the previous month, no illegal drug use in the 
previous month, no convictions in the previous year and currently employed or 
enrolled in an academic institution), scored dichotomously to make up a four point 
global scale. Judson et al., (1980) used twelve variables (six drug use variables: 
heroin, other opiates, amphetamines, barbiturates, cocaine, tranquillises; alcohol 
use, arrests, being gaoled, living with an addict, employment and treatment) with 
each variable scored on a three point sub-scale to make up a thirty six point global 
outcome measure. The global measure approach has advantages over the 
composite approach and is more standard than the descriptive approach. Again the 
limitations in the studies using this approach is the restricted range of outcome 
variables used. 
1.3.4 Time-based studies 
This is a variation of the criterion based dichotomous measurement. Instead of 
measuring performance at particular points in time, this approach measures 
performance using the period of time since treatment as a variable. The best 
example of this is the `survival analysis' study of Fisher and Anglin (1987). To 
study the relative efficacy of three methadone treatment clinics in the USA they 
analysed the performance of treated individuals over time using four outcome 
domains (heroin use, crime, drug dealing and loss of employment). Failure or 
`relapse' in the four domains plotted against time gave the picture of `survival'. 
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The same criticisms of the composite methodology applies here. 
1.3.5 Studies using the Addiction Severity Index (ASI) 
The development of the Addiction Severity Index (ASI) (McLellan et al., 1980) 
marked a major advance on the existing approaches to outcome measurement in 
the area of addictions. It has undoubtedly set the standard in terms of the choice 
of domains for outcome measurement. The adoption of a broad range of outcome 
variables in it self is an advance on the studies reported above. It also uses 
continuous variables instead of categorical or criterion-based variables which 
maximises its sensitivity to measure behaviour change. It also has built in the 
construct of `severity' which is a global measure useful in both assessment and 
outcome measurement. The choice of seven outcome domains: drug use, alcohol 
use, medical problems, employment/support status, legal problems, interpersonal 
problems (family/social relationships), and psychological problems, was the 
broadest range of variables to be used in an outcome measurement instrument in 
the area and the only one to include physical health (Darke, 1992). This allowed 
for comprehensive analysis of treatment efficacy. The ASI was intended to be a 
clinical and research instrument thus linking assessment and outcome 
measurement. It was designed to be administered as a structured interview and the 
subjective estimates of problem severity is scored on a0-9 scale for each 
domain. The ASI has been used in a large number of studies (for example, Corty 
and Ball, 1987; McLellan, et al., 1981; McLellan et al., 1986) and these 
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studies have the advantage of the possibility of direct comparison to be made 
between various treatments. 
However, the ASI does have problems and limitations. One of the major 
methodological problems is the subjectivity of the scoring procedures. The 
severity in a outcome domain is not assessed on the basis of an objective scale but 
on the basis of estimates of the assessor and the assessed. This problem can be 
illustrated in the domain of physical health, where non-medical personnel are 
required to estimate the health problems of patients (Darke, 1992). The 
computation of composite scores is complex and is not suitable for clinical use. 
The composite scores, although more suitable for research purposes, rely on 
subjective impressions. 
1.3.6 The Opiate Treatment Index (OTI) 
The OTI was developed by Dark et al., (1991) by taking into consideration the 
gaps and limitations of the existing measures outlined above as a "comprehensive, 
standardised set of measures for the evaluation of opiate treatment". The main 
methodological issue it set out to address is the non comparability of findings of 
outcome studies. In doing this it also set out to tackle the `subjectivity' problem 
of the ASI. The OTI claims to have resolved many of the problems of the ASI 
and is now being recommended for routine clinical use (Darke, et al., 1992). 
The OTI is structured to contain six independent outcome domains. These 
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domains reflect an emerging consensus on variables for outcome measurement and 
is similar to that of the ASI. These domains are; a) drug use, b) HIV risk taking 
behaviour (needle sharing & sexual practices), c) social functioning, d) 
criminality, e) health status and f) psychological adjustment. The development of 
each of these scales is described in a series of publications by Shane Darke and his 
team (Darke, Hall, et al., 1991; Darke, Heather, et al., 1991; Darke, Ward et al., 
1991). The OTI has integrated the General Health Questionnaire (GHQ) 
(Goldberg and Hillier, 1979; Goldberg and Williams, 1988), a global measure of 
current psychological adjustment. 
The OTI appears to be a considerable advance in addiction assessment but it is still 
in its early stages of use and now requires evaluation across diverse populations. 
There are no studies evaluating it with a British drug using population. For use as 
a standard assessment instrument in a clinical treatment setting, the OTI also lacks 
measurements in other important areas such as motivation for treatment and 
relapse predictors. 
1.3.7 Plymouth Drug Outcome Questionnaire (PDOQ) 
The need for a brief and easy to administer measure that can be used by generic 
drug workers will be acknowledged by most clinicians working in the field. The 
Plymouth Drug Outcome Questionnaire (Hassard, 1994) is a response to this need 
within services in a British context. The dilemma of using `rough and ready' 
measures that fulfils immediate service evaluation needs, compared with using 
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measures with good psychometric properties which are complicated to administer 
is a difficult one for the busy clinician. The latter approach may have more 
serious and wider implications in terms of development of intervention and 
extending the knowledge base, nevertheless if all workers in a clinical setting 
cannot be persuaded use such an instrument routinely it will be of little value. 
This is a serious challenge to clinicians. 
The PDOQ is a composite measure adopting the dichotomous categorical scoring 
formula described in studies above for example the DARP studies (Simpson and 
Sells, 1982; Simpson, 1986) and the Phoenix House studies (Deleon, 1988; 
DeLeon, et al., 1992). Clients are scored on a2 point scale whether they meet 
the a priori criteria or not. The advance from the previous studies is the choice of 
outcome domains. In keeping with current trends the PDOQ adopts similar 
outcome domains to the ASI and OTI, namely reduction in drug use, physical 
health, HIV risk behaviours, crime and legal problems and social functioning. 
Higher overall score means better functioning. It takes under 5 minutes to 
administer if you are familiar with the questions. 
It is not validated against another measure, although the author argues for high 
face validity and only moderate reliability figures are published. Hassard (1994) 
calls for independent validation of the instrument before it is adopted for wider 
use. 
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1.3.8 The Maudsley Addiction Profile (MAP) 
The Maudsley Addiction Profile (Gossop, 1996) is the most recent development in 
the field in Britain. This instrument was developed as part of the National 
Treatment Outcome Research Study (NTORS) which is a multi-centre, longitudinal 
outcome study. This is the biggest ever study of this nature undertaken in Britain. 
The MAP is a comprehensive assessment and outcome measurement instrument, 
whilst retaining the outcome domains of the ASI and OTI, goes beyond to 
incorporate factors such as motivation and coping in its scales. The MAP 
includes; patient demographics, drug and alcohol use, severity of dependence, HIV 
risk behaviour, motivation and coping, health, psychological functioning, family 
and social relationships, legal status and criminal involvement and treatment 
history. NTORS is still at an early stage and only the initial profile data has been 
published to date (Gossop, 1996). The evaluation of the instrument and data on its 
utility in routine clinical work, would be eagerly awaited by those working in the 
field. 
In summary there appears at present, to be an evolution towards a convergence of 
opinion about the purpose and domains of outcome measurement. This is 
demonstrated in the overlap of outcome domains in the recent measures (ASI, 
OTI, PDOQ and MAP). 
This shows a general acceptance of the `biopschosocial' framework and `harm 
reduction' as a broadly accepted goal of treatment. Harm reduction can be better 
evaluated within this framework. 
68 
1.4 Measures that predict outcome 
There are a number of recent theoretical and conceptual developments in the field 
of addiction that are relevant to the measurement of outcome, which are not 
included in the OTI or the ASI. The study of these developments in relation to 
outcome, will extend our understanding of addictions. 
In each of the key areas outlined below there are instruments which can validate 
the conceptual framework, and assess individuals, or measure change in terms of 
the framework. Many of these instruments are lengthy with the number of items 
ranging from 10 to 100. The administrative difficulties restricts the utility of these 
instruments in clinical settings and makes them only suitable for research 
purposes. Their length also restricts the combined exploration of the models to 
study the extent to which they overlap. 
1.4.1 The severity of dependence 
The neuro-adaptational model of addiction has the severity of dependence as its 
key construct. The level of addictive behaviour is assumed to be proportional to 
the severity of dependence. The concept of dependence is used in both 
psychological and psychobiological formulations of addiction. The Leeds 
Dependence Questionnaire (LDQ), (Raistric, et at., 1994) is a 10 item measure of 
dependence developed with a bias towards a psychological formulation. This has 
been shown to have concurrent validity with other dependence measures, such as 
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the Severity of Dependence Questionnaire (Sutherland et al., 1987). More 
recently a5 item dependence measure, Severity of Dependence Scale (SDS), 
based on the same conceptual framework has been developed by Gossop, et al., 
1995. This measure requires further evaluation before it is recommended for 
routine clinical screening (Gossop et al., 1995). 
Measures of severity of dependence can be both predictor measures as well as 
outcome measures. The reduction of severity of dependence is an desired outcome 
of treatment. In treatment settings that subscribe to the disease model of 
addiction, a measure of severity of dependence should be an essential part of 
assessment. 
1.4.2 The process of change model 
The process of change model (Prochaska and DiClemente, 1986; Prochaska et al., 
1992) is a widely accepted model as a framework for understanding the addiction 
process in treatment settings. It has implications for both assessment and outcome 
measurement. Nevertheless a validated instrument based on the model with 
practical clinical utility is yet to be developed. There are two validated 
instruments that have been developed to measure change in terms of this model: 
i) The University of Rhodes Island Change Assessment (URICA) (Prochaska 
and DiClemente, 1986) with 40 items. 
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ii) The Stages of Change Readiness and Treatment Eagerness Scale 
(SOCRATES) (Miller, 1991) the shorter version of which has 20 items. 
These measures are by and large more suitable for research purposes. 
The more recent Readiness to Change Questionnaire (RCQ), developed by 
Rollnick et at., (1992) for use with problem drinkers has the promise of fulfilling 
the need for a practical measure for clinical use in this area. This measure is 
currently in need of validation across addictions. It also needs to be validated as a 
measure predictive of outcome as well as an instrument measuring the stage of 
change. A recent study by Budd and Rollnick (1996) has questioned the 
discriminant validity of stages of change of this measure and in doing so also 
raised issues regarding the stages of change model. 
1.4.3 The excessive appetite model (the degree of psychological 
attachment) 
Proposed as an alternative to the neuro-adaptational model, the Excessive Appetite 
(EA) model (Orford, 1985) views attachment to the addictive behaviour as more to 
do with the rewarding aspects of it rather than avoidance of unpleasant withdrawal 
effects. The Dissonance Questionnaire (Orford, 1991) was developed to validate 
the model, and has 40 items. Development of measures to test this model across 
addictions offers much scope for research. It has the potential of contributing a 
great deal to our understanding of addictions. 
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1.4.4 The process of relapse 
Relapse is the most common outcome of treatment in addictions (Mackay, et al., 
1991; Saunders and Allsop, 1987; Vaillant, 1983). There are a number of models 
that describe the process of addiction, (Annis, 1986; Beck et al., 1993; Marlatt 
and Gordon, 1985). The Marlatt and Gordon (1985) model is the most 
comprehensive and global model of the relapse process. Because of its 
complexity, a single predictive instrument that would assess an individual in terms 
of the model is yet to be developed. Nevertheless, there are instruments based on 
the models of Annis (1986) and Beck, et al., (1993) that focus on aspects of the 
Marlatt and Gordon (1985) model. The Inventory of Drug Taking Situations 
(IDS) and the Situational Confidence Questionnaire (SCQ) Annis (1986) has 100 
items and 40 items respectively. Instruments based on the Beck et al., (1993) 
model includes, Beliefs About Substance Use (BSU, 20 items), Craving Beliefs 
Questionnaire (CBQ, 20 items) and Relapse Prediction Scale (RPS, 50 items) 
(Wright, 1993). 
Again these instruments are more suited for research purposes. A validated 
instrument that could be used routinely in clinical settings is yet to be developed. 
Measurement of relapse predictors should be an essential aspect of any assessment 
process. 
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1.4.5 Expectations of treatment 
Expectations of treatment have been shown to be an important variable in 
determining treatment outcome in the area of mental health (Collins and Flyer, 
1986; Goldstein and Shipman, 1961; Wilkins, 1973). This area is largely 
unexplored in the field of addiction. 
Researchers have concentrated on expectancy as a predictor of relapse and largely 
ignored the role that expectations of treatment may play on outcome. Treatment 
in drug addiction is in no means homogeneous. It varies both between and within 
treatment settings. Models of treatment may vary from disease models to 
psychotherapeutic models. Treatment may involve substitute prescription alone, 
psychological interventions on its own or a combination of both. Measuring 
expectations of treatment at assessment may be invaluable in treatment allocation 
or matching. There is a strong case for investigating the relationship between 
treatment expectations and outcome. 
There are no validated measures of treatment expectations in the area of 
addictions. 
1.5 A framework for assessment and outcome measurement 
Translating the factors and issues relevant for assessment and outcome 
measurement reviewed above into practice in service settings, requires a structure 
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or a framework. Such a framework needs to be robust and flexible cope with the 
demands that could be placed on it and at the same time, acceptable to staff who 
has to use it routinely. The demand for information at assessment may stem from 
needs ranging from, clinical decision making, collection of service statistics, 
construction of patient demographic profiles, national epidemiological data to 
outcome measurement. With regards to outcome measurement, if change other 
than in drug use is accepted as treatment outcome, the necessity to assess the drug 
user's `total psychosocial situation' to look for fundamental changes in lifestyle 
resulting from changes in patterns of drug use, cannot be over emphasised 
(Berglund, et al., 1991). In the search for relevant outcome measures, the use of 
client and therapists ratings, family perception, client background variables and 
clinical evaluation have also been suggested (White, et at., 1991). Outcome 
measurement also demands that the process of information gathering has to be 
repeated at pre-determined intervals over the period of treatment and beyond. 
A structure or framework for assessment and outcome measurement in the field of 
substance misuse, that could cope with the above demands was proposed by Moos 
and Finney (1983). An adaptation of this framework by Wanigaratne et al., 
(1990) is outlined below (figure 1). The framework consists of four stages of 
information gathering: a) pre-treatment, b) during treatment, c) post treatment and 
d) follow-up. 
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A service can decide, according to its needs, philosophy and treatment objectives, 
etc what information is included at each stage. Assessment forms, evaluation 
forms, patient rating forms, outcome measurement forms and discharge forms can 
be seen as tangible aspects of such a framework. Computerised clinical 
information systems can greatly enhance the operation of such a framework in a 
service setting. 
Assessment During treatment Post-treatment Follow-up 
\\ 11 
\' 
Figure l. 1 Framework for cvaluating substance misuse interventions 
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1.6 The aims of the thesis 
The main aim of the studies reported in this thesis is to examine the current issues 
in assessment and outcome measurement in the treatment of opiate users. The 
emphasis will be on finding practical solutions to the needs in this area in busy 
clinical settings. The studies were carried out in a busy inner city London 
Substance Misuse Service, which is one of the largest services of its kind in 
Britain. It is a service that has pioneered many developments in service provision 
for drug users in Britain. It can be argued from an historical perspective that the 
findings will be of relevance to other drug services in the country. 
The focus of the studies was on practical aspects of outcome measurement. This 
was done by comparing two frameworks of outcome measurement based on two 
outcome measurement instruments, the OTI (Darke, et al., 1991) and the PDOQ 
(Hansard, 1994). The studies investigated the relative merits of these two systems 
in terms of clinical utility. 
The studies also examined measures that describe the addiction process that are 
relevant to assessment as aids to clinical decision making. Particular emphasis 
was placed on the predictive utility of these measures in terms of treatment 
outcomes. The development of an instrument to measure expectations of treatment 
is described. The utility of this measure in predicting treatment outcome was also 
investigated. The studies also aim to contribute towards the further development 
of an instrument to measure dependence from a non neuro-adaptational framework 
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and a practical measure to predict relapse. The utility of the brief severity of 
dependence measure (Gossop, et al., 1995) and the adapted Readiness to Change 
measure (Rollnick, et al., 1992) in predicting outcome was also investigated. 
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Chapter 2 Development of a scale for measuring expectations relating to 
the treatment of opiate addiction 
Abstract 
This chapter describes the process of development of a brief scale to measure 
expectations of treatment among intravenous opiate users. The scale was designed 
to address different domains of a person's life which may be affected by 
treatment. It measures the subjective probability of change in each area due to 
treatment. The scale was administered to a sample of clients in treatment for 
opiate addiction. The process of development of the measure employed both 
qualitative and quantitative research methods. Principal components analysis 
indicated that the scale consists of three components, relating to drug use, 
sickness/withdrawal and social /psychological factors. The limitations of the 
measure, the potential for its further development and its implications for 
assessment of opiate users seeking treatment are discussed. 
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2.1 Introduction 
Expectations of treatment has been established as an important variable in the 
treatment outcomes of psychiatric patients (Collins and Flyer, 1986; Goldstein and 
Shipman, 1961; Wilkins, 1973). In the field of addictions, researchers have begun 
to unravel the role that different types of expectations may play in determining 
treatment outcome (Rollnick, Morgan and Heather, 1996; Solomon and Annis, 
1989; Sutton, 1996). The terms 'expectations of treatment' and 'expectancy' have 
been used interchangeably in the literature. The term 'expectancy' is most often 
used in the literature as meaning credibility and self-efficacy, which leads to 
confusion. In this chapter the term expectations of treatment is used to include the 
relevant literature covered by the term 'expectancy'. 
There are a number of factors associated with the psychological construct of 
expectations of treatment. In the area of mental health, treatment expectations have 
been linked to compliance (Bowden et al., 1980) motivation (Logan, 1970), locus 
of control (Rotter et al., 1972), hopelessness (Fry, 1984), self-efficacy (Bandura 
and Adams, 1977; Williams, et al., 1989), perceived credibility of treatment 
(Borkovec and Nau, 1972) and preference (Wanigaratne and Barker, 1995). In 
terms of clinical utility, this construct is of considerable importance as a predictor 
of treatment outcome. Comparisons of different treatments for the same problem, 
focusing on credibility, have shown direct links between treatment expectations 
and outcome in the mental health field (Hardy, et al., 1995; Morrison and 
Shapiro, 1987). Hardy et al., (1995) found that treatment expectations in terms of 
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credibility had three clear factors: a) Principle credibility 
- 
pertaining to 
rationality of treatment, b) Initial credibility 
- 
expectations of treatment 
immediately prior to treatment and c) Emergent credibility 
- 
expectations arising 
from the experience of treatment. This study also considered outcomes of 
cognitive-behavioural and psychodynamic-interpersonal therapy and found that 
initial and emergent credibility of the assigned treatment predicted improvement 
for clients who received 8 sessions, but not for those who received 16 sessions. 
This points to a complex and variable relationship between treatment expectations 
and outcome. 
Whilst the importance of expectations of treatment in the process and outcomes of 
treatment is acknowledged in psychiatric patients, there appears to be little 
research in the area of addiction treatment. Farid and Clarke (1992) described 
treatment expectations among clients with alcohol-related problems and reported 
that the most frequently cited was an alcohol-free lifestyle. Research which has 
considered expectations in the area of addiction has generally focussed on 
expectations of the drug and/or expectations of changing one's pattern of 
consumption, rather than expectations of treatment per se. For example, Rollnick, 
Morgan and Heather (1996) developed a measure of the expectations of the 
outcome of reduced consumption among problem drinkers, designed to assess both 
the benefits and the costs of this change in behaviour. In their study of excessive 
drinkers, this measure was found to have good predictive validity. Simpson and 
Joe (1993) examined measures of motivation for change in drug use and treatment 
with respect to psychometric properties and prediction of early dropouts from 
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methadone maintenance. They found that expectations for reducing future drug 
use was one of the most significant predictors of treatment retention beyond 60 
days. 
A number of studies have considered the predictive validity of alcohol-related 
expectancies (what drinkers expect to get out of the substance). Brown (1985b) 
assessed alcohol-related expectancies in a group of alcoholic patients entering 
inpatient treatment. Scores on the Alcohol Expectancy Questionnaire (AEQ; 
Brown, et al., 1980), were found to predict outcome at a one year post-treatment 
follow-up. Specifically, strong expectancies were predictive of poorer outcome. 
This issue has also been considered in non-patient samples. For example, Stacy, 
Widaman & Marlatt (1990) and Stacy, Newcomb and Bender (1991) used 
structural equation modelling techniques and found that alcohol expectancies 
predict alcohol use in young adults over a variety of intervals. A measure of 
positive alcohol expectancies was found to be a better predictor of subsequent use 
than a measure of negative expectancies. Carey (1995) reported a study of 
alcohol-related expectancies among college students. She found that scores on the 
AEQ predicted both quantity and frequency of heavy drinking over a four week 
period. 
A number of studies by Schafer and his colleagues have considered cocaine 
expectancies. Schafer and Fals-Stewart (1993b) identified three cocaine 
expectancy factors and developed the Cocaine Effect Expectancy Questionnaire 
(CEEQ). This measure was developed with a non-clinical population and a study 
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of inpatients with psychoactive substance abuse disorders failed to confirm the 
original three-factor model (Schafer and Fals-Stewart, 1996). The latter study also 
failed to find a relationship between expected positive effects and treatment 
participation. According to Schafer and Fals-Stewart (1996) "these results serve 
as a reminder that the development of an instrument sets the parameters for its 
use". Therefore, in developing an instrument to be used with opiate misusers it 
was considered important to use data obtained from clinical groups. In the present 
study, initial item selection was based on qualitative data obtained from a survey 
of opiate users (Dale, Jones and Power, 1992). In addition, piloting of the 
measure and collection of qualitative and quantitative data was also conducted with 
opiate using subjects. 
Addictions include a range of human activities from alcohol, drug abuse and 
gambling to risky sexual behaviours. The emphasis in the past decade, both in 
research and treatment in addictions, has been the commonality between the 
various addictive behaviours. Despite the large areas of commonality in the 
aetiology and treatment approaches emerging between diverse addictive 
behaviours, there are aspects that are unique to particular addictions. Examples 
such as abstinence not being a treatment goal in eating addictions, research 
evidence supporting possibility of controlled drinking whilst not supporting 
controlled smoking, highlights these differences. In some addictions for example, 
stimulant use and gambling the only acceptable approach to treatment is a 
psychological one. 
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The current study focus on the treatment of opiate misuse. One of the unique 
features of treatment of opiate misuse is the option of substitute prescription. In 
the study of expectations in the treatment of opiate users this introduces an 
interesting set of variables. The availability of physical treatment as an adjunct to 
psychological interventions makes it in some ways comparable with treatment in 
psychiatric populations. Hence, an investigation of treatment expectation should 
explore the three types of credibility that have been shown to delineate the 
construct. 
The measurement of principle credibility in the Hardy et al., (1995) study was 
carried out using the Opinions about Psychological Problems Questionnaire 
(OPPQ; Pistrang and Barker, 1992), a validated instrument describing treatment 
rationales of different counselling approaches. There are no similar validated 
instruments in the area of opiate treatments. Initial credibility in the Hardy et al., 
(1995) study was measured by the credibility of therapy measure (Borkovec and 
Nau, 1972). This does not translate directly and appropriately to opiate treatment. 
Similar limitations exist in the measurement of emergent credibility. The latter 
can be of particular relevance in this field as most clients presenting for treatment 
have experienced some form of previous treatment. 
In this preliminary study aimed at developing an expectations measure in the area 
of opiate treatment, it seemed appropriate to develop a broad overall measure that 
covers all three types of credibility in the first instance, before specific credibility 
measures are developed. 
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Treatments for opiate misuse vary considerably in goals. Some treatments, such as 
low-threshold methadone programmes, may involve simply providing daily 
methadone and generally have a harm reduction aim. Other programmes focus on 
the user's lifestyle and social / psychological aspects to a greater or lesser extent. 
Thus it is important to identify which aspects of a user's life s/he expects to be 
affected by treatment. Therefore, in developing this measure of expectations, the 
aim was to identify different aspects which may be affected by treatment and to 
consider subjective probabilities of change due to treatment. 
This chapter reports on the development of a brief scale to measure expectations 
of treatment among opiate users. The process of item selection is described. The 
scale was administered to a sample of clients seeking treatment for problem opiate 
use and the results of qualitative and quantitative analysis of the data are 
presented. The utility of such a measure is discussed together with 
recommendations for future research. 
2.2 Method 
2.2.1 Item selection and pilot work 
Initial selection of the items was based on a information from a qualitative survey 
conducted by Dale, Jones and Power (1992). In this survey, users of methadone, 
both licit and illicit, were asked about ways in which methadone had helped them 
and the various experiences they had had with it. These statements were adapted 
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into the form of an expectations questionnaire, in which subjects were asked to 
rate the likelihood that treatment would help in various domains. Ratings were 
made on a7 point scale from 'not at all likely' to 'extremely likely'. The items 
covered drug use, injecting, sickness, health, financial, legal, social and 
psychological factors. These aspects broadly correspond to the domains covered 
by outcome measures such as The Opiate Treatment Index (Darke et al., 1991). 
The questionnaire was evaluated in terms of ease of administration and face 
validity, based on clients' self-reports and observation. Individuals arriving at 
'Drop-In' for an initial assessment were invited to take part. Four subjects 
participated. They were asked to complete the questionnaire, make comments and 
verbalise any thoughts that came to mind whilst doing so. 
This procedure identified items containing ambiguous words or phrases as well as 
difficulties of administration. It also highlighted inconsistencies in responding, for 
example, clients responded in two ways when they deemed an item inapplicable: 
they either omitted a response or responded with a rating of "1- not at all likely". 
In the course of the interviews two clients spontaneously made explicit references 
to a difference between expected effects of treatment and those they wanted or 
hoped for. Although the questions refer specifically to expectations, this 
distinction may not have been sufficiently clear. For example, one client gave the 
same written response to two items on the questionnaire, but his verbalisations 
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("certainly" and "hopefully") indicated some qualitative difference in the meaning 
of the written responses. 
Following this, the measure was presented to 12 clients of an inner city London 
outpatient Drug Dependency Service, which is one of the largest services of its 
kind in the country, for self-completion. This was primarily to assess ease of 
administration and clarity of items and instructions. Participants reported some 
difficulty with negatively worded items, such as 'the treatment programme will not 
help me at all'. Therefore all items on the scale are positively worded. Finally, 
any items identified as ambiguous were amended. 
2.2.2 The final measure 
The final measure used in the study had 11 items (appendix A). The instructions 
to the questionnaire read as follows: 
"Below are a number of expectations that people have had about treatment 
programmes. Please indicate how likely you think they are to happen to you. 
Please circle the appropriate number. " 
Each item started with the stem "The treatment programme will help me to 
-" 
and included the following items: 
i) 
- 
take less drugs, 
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ii) 
- 
feel more in control, 
iii) 
- 
avoid feeling sick, 
iv) 
- 
keep me straight and functioning, 
v) 
- 
to be safer and healthier, 
vi) 
- 
have less legal problems, 
vii) 
- 
inject less, 
viii) 
- 
save money, 
ix) 
- 
help me with relationship problems, 
x) 
- 
help me with psychological problems, 
xi) 
- 
help me with child care problems. 
The items were scored on a7 point scale, where I was 'not at all likely' and 7 
corresponded to 'extremely likely'. Scores higher than 4 indicated greater 
likelihood of the outcome being true, while scores of less than 4 indicated that it 
would be untrue. 
2.2.3 Participants 
The questionnaire was administered to clients receiving treatment in three different 
parts of the Drugs Service: a community service which provides treatment in a 
primary care setting, two satellite clinics linked with a probation service and an 
out-patient service. Eighty nine clients participated. The sample consisted of 59 
men and 15 women (gender was not recorded for 15 participants). The age range 
was 20 to 49 years, with a mean age of 33 years. The data was collected as part 
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of a general service evaluation and client satisfaction survey. Administrative staff 
approached clients in the waiting area and asked them to complete the 
questionnaires while waiting for appointments. Participation was voluntary and all 
responses were confidential and anonymous. 
2.3 Results 
2.3.1 Descriptive statistics 
The means and standard deviations of participants responses for each item of the 
questionnaire is presented in Table 2.1. It can be seen from the table that 
participants indicated that all outcomes were more likely to happen than not to 
happen. The highest means were obtained for items relating to avoidance of 
withdrawal symptoms ('avoid feeling sick and 'keep straight and functioning'). 
The lowest means were obtained for items relating to child care problems and 
relationship problems. Standard deviations indicate that these were also the items 
with the greatest variation in response. 
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Table 2.1 Means scores and standard deviations for 11 expectation items 
(N=89) 
Item Mean (s. d. ) 
Childcare problems 4.41 (2.54) 
Relationship problems 4.94 (2.22) 
Psychological problems 4.95 (2.05) 
Legal problems 5.48 (1.86) 
Take less heroin 5.50 (1.89) 
Inject less 5.70 (1.74) 
Save money 5.77 (1.57) 
Feel more in control 5.83 (1.36) 
Safer and healthier 5.94 (1.45) 
Straight and functioning 6.00 (1.35) 
Avoid feeling sick 6.15 (1.43) 
2.3.2 Questionnaire structure 
The questionnaire items were factor analysed using principal components 
extraction with varimax rotation. Three components of items relating to a) drug 
use, b) sickness and withdrawal and c) social/psychological factors, were found 
to have Eigen values of greater than I (accounting for 73.1 % of variance). Factor 
I had an Eigen value of 5.26 and accounted for 47.8% of the variance. Factor II 
had an Eigen value of 1.71 and accounted for 15.5 % of the variance and Factor 
III had an Eigen value of 1.29 and accounted for 11.8 % of variance. Table 2.2. 
presents the item loadings for the these three components. 
Examination of the loadings between items and factors indicates that the three 
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factors correspond to issues around use of drugs, more general 
social/psychological factors and items relating to withdrawal and sickness. Only 
one item loaded highly (greater than 
. 
5) on two components. This was the item 
relating to childcare problems. The items that loaded clearly on Factor I were: a) 
take less heroin, b) feel more in control, c) inject less and d) save money. Items 
loading clearly on Factor II were concerned with wider issues, namely a) legal, b) 
psychological and c) relationship problems. Factor III was clearly concerned with 
sickness and withdrawal. The items that loaded highly with this factor were: a) 
avoid feeling sick, b) straight and functioning and c) safer and healthier. 
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Table 2.2 Item loading for components extracted from varimax rotation 
and percentage variance accounted for by each component 
Item Factor I Factor II Factor III 
47.8% 15.5% 11.8% 
Take less 
. 
832 
-. 
092 
. 
156 
heroin 
Feel more in 
. 
741 
. 
324 
. 
291 
control 
Avoid feeling sick 
. 
115 
. 
089 
. 
890 
Straight & 
. 
226 
. 
091 
. 
908 
functioning 
Safer & healthier 
. 
494 
. 
345 
. 
566 
Legal problems 
-. 
021 
. 
780 
. 
168 
Inject less 
. 
866 
. 
181 
. 
127 
Save money 
. 
631 
. 
430 
. 
317 
Childcare 
. 
564 
. 
628 
-. 
043 
problems 
Relationship 
. 
169 
. 
877 
. 
114 
problems 
Psychological 
. 
233 
. 
841 
. 
093 
problems 
A) Internal Reliability Analysis 
Cronbach's Alpha statistic was calculated for the Ii items of the scale. The 
resulting value of Alpha was 
. 
89. This was also calculated for the three factors 
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separately. For Factor I, it was 
. 
83, for Factor 11 it was 
. 
83 (. 81 without item 11) 
and for Factor III it was 
. 
81. 
B) Item-Total Correlations 
Each item was correlated with the total score. All correlations were significant at 
p <. 005. Correlations ranged from 
. 
49 to 
. 
77. All except one item correlated at 
greater than 
. 
5. 
2.4 Discussion 
This chapter describes the development of a brief measure of treatment 
expectations designed for use with intravenous opiate users. The following section 
summarises the main findings and their implications. 
A) Item selection 
The items were scored on a7 point scale, where 1 was 'not at all likely' and 7 
corresponded to 'extremely likely'. Scores higher than 4 indicated greater 
likelihood of the outcome being true, while scores of less than 4 indicated that it 
would be untrue. It can be seen from the results that participants indicated that all 
outcomes were more likely than not to happen. The subjective probabilities of 
treatment helping with sickness and withdrawal were the highest, while the lowest 
expectations were of help with aspects of childcare, relationship and psychological 
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problems. Standard deviations indicate that these were also the items with the 
greatest variation in response. This may be partly due to the problem identified in 
the pilot study of subjects responding in one of two ways when an item was 
deemed inapplicable. Participants tended to leaving it blank or to respond 'not at 
all likely'. This was a common problem with the item relating to childcare, since 
many of the subjects did not have children. It is therefore recommended that this 
item is omitted from future versions of the questionnaire. 
B) Questionnaire structure 
Factor analysis indicated that the items related to three factors, broadly 
corresponding to drug use, sickness & withdrawal and social/psychological issues. 
The development of this measure involved a combination of qualitative and 
quantitative methods. It was hoped that by selecting the items based on opiate 
users' reported experiences, the validity of the measure would be enhanced. The 
sample of clients who subsequently completed the measure gave high subjective 
probabilities for these items, indicating that these were aspects that they expected 
to be affected by treatment. Pilot work indicated that clients distinguish between 
expectations and hopes. However, there were also indications that clients may 
give the same written response for what they expect to happen and what they hope 
to happen. Although the instructions stress that it is what the client expects to 
happen that is of interest, the high subjective probabilities may indicate that clients 
were responding based on what they hoped for from treatment. This distinction 
between expectations and hopes may be an important one and further research is 
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needed to explore the possibility that the disparity between these aspects could 
predict treatment outcome. 
C) Limitations of the study 
The main limitation of the study was that it was carried out on a sample of 
participants already in treatment. Their expectations of treatment is likely to be 
influenced by their experience of treatment so far. It is possible that the 
questionnaire measures emergent credibility. Administering the questionnaire to 
patients at different stages of treatment, for example at assessment, six months into 
treatment, etc may address this limitation. With a larger sample, cross-sectional 
analysis could also be used to address this limitation. 
The second limitation is that the expectations of 'methadone' was not differentiated 
from expectations of 'treatment'. This is a unique factor in the treatment of opiate 
users where substitute prescription of methadone may be seen as 'treatment'. It 
may be necessary to define 'treatment' in the questionnaire. Dale, Jones and 
Power, (1992) primarily examined the experience of methadone in their study of 
expectations. Inclusion of items on methadone or cross validation with a measure 
of expectations of methadone would address this limitation. 
94 
D) Prediction of outcome 
The ultimate aim of developing a measure of this type is that it would have 
predictive validity and, therefore, clinical utility. Before testing the predictive 
validity of the measure, it is important to consider previous findings. 
A number of studies have considered the predictive validity of measures of 
alcohol-related expectancies and produced evidence that expectations of the 
substance are important (Brown, 1985; Carey, 1995); however, when considering 
treatment outcome, it may be necessary to consider expectations of the treatment 
as well as expectations of the drug. In the field of mental health, treatment 
expectations have been found to predict outcome (Hardy et al., 1995; Morrison 
and Shapiro, 1987). Three types of credibility; principle, initial and emergent, 
were found in Hardy et al's 1995 study. A measure with predictive validity which 
would have clinical utility particularly in the assessment of patients prior to 
treatment should address principle credibility (rationality of treatment) and initial 
credibility (expectations immediately prior to treatment). 
In the treatment of opiate dependence the treatment rationales show considerable 
variation. In Britain this may vary both between and within treatment centres. 
Patient's expectations may be influenced by their past experience or what they 
have heard about treatment. In order to test the predictive validity of an 
expectations measure, clear rationales of treatment should be presented to the 
patient, prior to administration of the measure. The objectives of the expectations 
95 
measure were essentially to measure principle and initial credibility. The results 
of the present study may also reflect emergent credibility because of the sample 
used. The study reported in Chapter 4, exploring the predictive validity of the 
measure has addressed this limitation. It is important to note that the predictive 
validity of this measure can only be established by using measures of treatment 
outcome and the validation will be dependent on the psychometric qualities of the 
outcome measures. The sensitivity of a outcome measure will be of particular 
relevance. A composite measure with a forced choice "yes/no" criteria of scoring 
will be expected to be less sensitive to changes in behaviour than a measure with a 
continuous scale. The sensitivity of the outcome measure will determine the 
"size" of change over a period of time such as 6 weeks, 3 months, 6 months, etc. 
The ability of the expectations measure to predict outcome at different stages of 
treatment needs to be established with appropriately sensitive outcome 
measurement instruments. The congruence between the items of the expectation 
measure and the domains of the outcome measure should also be established prior 
to evaluating its predictive validity. If a composite outcome measurement 
instrument is used, a bias in the distribution of items towards a particular domain 
could influence the evaluation. 
Another factor that has been found to be related to treatment outcome is the 
discrepancy between the expectations of the patient and those of the therapist. For 
example, Baekeland and Lundwall (1975) conducted a study with alcoholics, 
heroin addicts, psychiatric and general medical patients and found that 
discrepancies between patient and therapist treatment expectations was one of the 
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factors that predicted dropping out of treatment. 
The process of developing a scale to measure treatment expectations in the area of 
opiate dependence has highlighted a number of areas for future research: 
expectancies of a particular substance, distinction between expectations and hopes, 
credibility or rationality of treatment, experience of past treatment and the 
discrepancy between the expectations of the patient and the therapist are all areas 
that needs to be included in a comprehensive measure, and predictive validity of 
such a measure needs to be established. The full potential of recent technological 
developments such as computer assisted clinical decision making systems for 
example CogniSys SM (1996) for substance misuse, can only be realised if there 
are measures with predictive validity that can be used during assessment. 
Measures of factors predicting outcome have implications, not only for the 
assessment process, but for treatment provision as a whole. 
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Chapter 3 Evaluating the utility of the OTI to measure outcome in routine 
clinical work 
Abstract 
This chapter describes the evaluation of the Opiate Treatment Index (OTI) for its 
utility in a British substance misuse treatment setting. The investigation was 
carried out in three phases. Phase I, piloting the instrument for suitability with a 
clinical population, phase II evaluation of interim methadone programmes using 
the OTI and phase III, evaluating its acceptability for routine use by clinical staff. 
Phase I resulted in a number of modifications to the OTI. The planned 
investigation for phase II was not completed because of changes in the clinical 
service which led to poor recruitment and retention of participants. Baseline 
results are reported and compared with available normative data. The results of 
phase III of the study showed that the OTI was not suitable for routine use in a 
busy clinical service and was not acceptable to staff for routine outcome 
measurement. The implications of these findings for outcome measurement and 
directions for future research are discussed. 
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3.1 Introduction 
3.1.1 Assessment and outcome measurement 
The need for assessment and outcome measurement to go hand in hand in hand 
was discussed in Chapter 1. The factors that affect assessment and outcome 
measurement were outlined. The limitations of the existing outcome measurement 
methods and instruments and the development of the Opiate Treatment Index 
(OTI) (Darke, et al., 1991) which claims to have resolved much of the difficulties 
were also discussed. In Britain, at present the need to measure treatment outcome 
and develop practical systems of measuring outcome has become urgent, with the 
Department of Health expressing its intention to move towards outcome based 
funding of services. In treatment settings outcome measurement must be, a) 
relevant to the target population, b) relevant to the treatment and intervention and 
c) easy to be carried out. On the face of it, the OTI meets the first two 
requirements and with the claim that it can be administered in under 30 minutes, 
appears to meet the third. The latter is a crucial factor because if the process of 
measurement is not acceptable to the clinicians then it is unlikely to be 
successfully implemented. 
3.1.2 The Opiate Treatment Index (OTI) 
The OTI (Darke, et al., 1991), described in Chapter 1, is a comprehensive multi- 
dimensional assessment and outcome measurement instrument. 
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The aims of the OTI are outlined as follows: 
i) To be a multi-dimensional instrument to reflect the heterogeneity of aims of 
treatment for opiate misuse. 
ii) To be based on `objective' criteria rather than impressions of interviewers. 
iii) To maximise the sensitivity of the instrument to measure behaviour change 
by the use of continuous measures rather than categorical measures. 
iv) To be of maximum utility for both clinical and research purposes. 
v) To have utility in a clinical settings as an assessment instrument which 
could be used by medical and non-medical staff. 
vi) To have high reliability and validity. 
The OTI claims to have achieved all the above aims and is recommended for 
general use (Darke, et al., 1992). The OTI is structured to contain six 
independent outcome domains. These domains reflect an emerging consensus on 
variables for outcome measurement and is similar to that of the ASI. 
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These domains are a) drug use, b) HIV risk taking behaviour (needle sharing & 
sexual practices), c) social functioning, d) criminality, e) health status and f) 
psychological adjustment. 
The initial psychometric validation of the OTI was carried out on 290 opioid users 
in Sydney, Australia. Darke et al., (1991) reports high test re-test reliability 
figures (range 0.78 
- 
0.92) and high inter-rater reliability figures (range 0.81 - 
0.93). The internal reliability figures for the different scales show a much more 
varied picture, with coefficient alpha's ranging from 0.38 for Criminality to 0.83 
for Psychological adjustment. The validity of the measure was established by 
correlational analysis of its scales with equivalent scales of the ASI, where 
significant correlations were found in all scales with the exception of the Crime 
scale. 
In recommending the OTI for international use Darke et al., (1991) argue that the 
demographics of the Sydney sample is comparable with that of international 
studies (Power, et at., 1988; Skidmore et al., 1990). The generalisability of the 
OTI is yet to be rigorously tested; to date it has not been validated on a British 
population; there are only two studies that report its use in the U. K. (Macleod et 
al., 1996; Wilkes and Armstrong, 1996) and these are not large-scale validity 
studies and do not attempt to produce British norms for the OTI. Reports of 
attempts at routine use of the OTI in drugs services in the U. K. are favourable 
(Macleod et al., 1996., Wilkes and Armstrong, 1996) but both these studies 
highlight the difficulties of obtaining follow-up data. Routine use require routine 
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re-assessments and this may be difficult to institute in busy clinics. A systematic 
evaluation of the utility of the OTI in a clinical setting in the U. K. has not yet 
been reported and the present study attempts to do this. 
The present study aims to test the utility of the OTI for routine use in a busy inner 
city London Drug Service. This was carried out in three phases: 
i) Piloting and adapting the OTI to suit a British population. 
ii) Using the OTI to measure the outcome of a discrete treatment area of the 
service, the Interim Methadone Programmes. Exploring the relationship 
between the outcomes and predictor measures. 
iii) Developing an assessment and outcome measurement system incorporating 
the OTI and evaluating this system for routine clinical use. 
3.1.3 The Aims of the study 
The aims of the study can be outlined as follows: 
i) Investigate treatment outcomes of a particular programme using a 
framework based on the OTI. 
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ii) Evaluate the OTI as a suitable instrument for programme evaluation and 
outcome measurement. 
iii) To investigate the utility of predictive measures. 
3.2 Phase I- Pilot study 
3.2.1 Introduction 
The OTI was developed in Australia and although it is recommended for 
international use, there are a number of terms and phrases which are based on 
Australian slang. In the absence of a British version it was decided to test its 
acceptability with a British clinical population, prior to modifying it. 
3.2.2 Method 
A) Participants 
The main purpose of the pilot study was to test out the general procedure and 
facilitate decisions about the measure, therefore there were no exclusion criteria 
and anyone who volunteered was interviewed. The participants were patients 
receiving treatment for opiate dependence in a busy inner city London Substance 
Misuse Service. Eight patients, 5 men and 3 women participated in the pilot 
study. 
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B) Procedure 
Clients were recruited by the researcher or via key-workers from all parts of the 
service, which included outpatients, daily programmes and satellite clinics. As 
there was no follow-up, subjects did not have to give their names and all 
information was confidential and anonymous. Subjects were paid in the form of 
£5 vouchers for their participation. 
The OTI was administered as a semi-structured interview. Any questions that 
subjects had problems with were noted by the researcher. 
3.2.3 Results 
3.2.3.1 Outcome of pilot study 
For most clients in the pilot study, the session took more than one hour. The OTI 
was relatively easy to administer, but it became apparent that a number of 
important points from the manual were not re-stated in the instructions on the form 
and were thus easy to miss out. This measure was being proposed as part of the 
service-wide assessment instrument and thus it was important that it be used in the 
same way by different individuals. The first outcome of the pilot work, therefore, 
was the production of a brief set of instructions for administering the OTI 
(appendix A). 
The next outcome of the pilot work involved modifying the measure to be used in 
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the evaluation. Decisions about modifications were based, not only on the pilot 
study but also on feedback from Drugs Service staff about their experience of 
using the assessment instrument. Thus modifications were based on research and 
clinical considerations. 
3.2.3.2 Modifications to the OTI 
A) Treatment history 
Three further questions were added. 
- 
Question on drug related contact in the last 6 months. 
- 
Question on why previous treatment did not work. 
- 
Question on why the client is seeking treatment now. 
B) Drug use 
The OTI asks about the recent episodes of use and records Q scores for each class 
of drug as well as a score for poly-drug use, i. e. the total number of classes of 
drug used in the past month. Additional questions were included, relating to each 
drug class: 
- 
Clients are asked to rate each drug in order of their main drug, next main drug 
etc. 
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- 
Whether the drug was prescribed or not was recorded. 
- 
Clients are asked to estimate how often they use each drug (times per 
day/week/month). 
- 
The route of intake for each drug was also asked. 
- 
Duration of this drug episode. 
- 
Age of first use. 
- 
Age addicted from. 
- 
Number of drug free periods. 
- 
Duration of drug free periods. 
For the questions on alcohol, the measures have been converted to terms more 
familiar to a British sample. A number of clients mentioned drinks not covered by 
the OTI, e. g. cider, therefore, an additional unspecified category of drinks was 
included. If appropriate, this is to be specified by the interviewer. 
C) Risk behaviour 
- 
Injecting: Again, the OTI simply asks about recent behaviour (the past month). 
As well asking about recent injecting and sharing, this was changed to: 
'Have you ever injected ?' 
'Have you ever shared a needle ?' 
Additional questions on: 
- 
Reasons for injecting, 
106 
- 
When the client last injected, 
- 
When the client last shared, 
- 
Which injection sites they use, were also asked. 
- 
Sexual behaviour: Instructions were changed in this section, and some 
additional questions (appendix A) were added. The format of the questions were 
changed but the scoring system was preserved. 
The OTI asks 'how many people, including clients, have you had sex with in the 
last month ?'- 'including clients' was dropped, as some staff felt this might cause 
offence. It could also cause confusion if taken to mean other clients of the Drug 
Service, rather than someone who has paid the interviewee for sex. 
The OTI contains 3 questions relating to condom use (with regular partners, casual 
partners, and clients). Before each of these questions 'do you have a regular 
partner ?' etc was added to avoid confusion and so as not to appear to make 
assumptions about the person's sexual behaviour. 
Instead of referring to 'clients' the phrase 'have you had to exchange sex for 
money and/or drugs ?' as this appears to be a more sensitive way to ask the same 
question. 
A question on the gender of the respondents regular/casual/paying partners was 
added. This seems to be important in terms of HIV transmission and also avoids 
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making assumptions. 
D) Criminal behaviour 
Again, instructions were change in this section. Instead of beginning by referring 
to 'crime', the interviewer will begin by asking about 'ways in which you may 
have had to finance your drug taking'. 
E) Social functioning 
What is defined as employment is different to the definition given in the OTI. 
This was changed to include only paid work. 
F) Health scale 
No modifications were made. 
G) Psychological adjustment (GHQ) 
No modifications were made. 
108 
3.3 Phase II 
- 
Evaluation of the interim methadone programmes 
3.3.1 Introduction 
This project involved evaluating the outcomes for all new clients taken into 
treatment into two programmes over a period of six months, using the modified 
OTI and the outcome predictor measures. 
The interim methadone programmes were selected because they form a discrete 
part of the Drugs Service, there are minimum requirements for taken into these 
programmes compared to the rest of the service and previous pilot work carried 
out to evaluate them. 
A) Interim Methadone Programmes 
Interim methadone programmes are one of the main service provisions to emerge 
in Britain with the treatment goal of 'harm reduction'. This was largely in 
response to the response to the 1989 ACMD report. Interim methadone 
programmes generally involve the daily provision of methadone to those who are 
on a waiting list for conventional treatment. 
B) Low-threshold Methadone Programmes 
Low-threshold methadone programmes constitute a relatively recent development 
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in the provision of drugs services and there has been little evaluation of such 
programmes to date. Low threshold programmes involve the provision of 
methadone without the usual restrictions and conditions of treatment. A priority of 
such programmes is getting in touch with drug users, especially those at risk of 
contracting and spreading HIV, to encourage them into some form of treatment 
and move towards less risky drug taking. 
Low threshold programmes have a philosophy of harm reduction often focusing on 
primary health care and HIV risk behaviours. There are few absolute 
requirements for clients for example, detoxification and urine testing are not 
mandatory. There is generally an acceptance that clients may use additional drugs 
and there is no fixed reduction programme. Clients may be encouraged to set 
their own goals. 
One of the first low threshold methadone programmes in the UK was set up in 
Portsmouth and described by Fleming (1989) in the DrugLink newsletter. 
Fleming reported that staff and clients prefer this system and that relationships 
between them were much improved. In addition the number of opiate users 
coming to the Clinic doubled, with a particular increase in the number of longer 
term users who had not been previously in contact with services. Although this 
programme was thought to have important harm minimization benefits, Fleming 
(1989) stated that it was not known whether this type of approach was more 
effective than others and pointed to the need for comparative research. 
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In the service in which the study was carried out there were two interim 
methadone programmes. The Low Threshold Methadone Programme (LTMP) and 
the Daily Dispensing Programme (DDP). Both programmes had a broad general 
goal of harm reduction, with primary healthcare and HIV risk behaviours being 
seen as being particularly important. Both aimed to provide easy access and a 
rapid intake facility for particularly chaotic drug users who may be ambivalent 
about their goals. Both programmes involved daily dispensing of oral methadone 
on site, thus providing daily structure. Clients on both programmes were assigned 
a named key-worker who was available on a regular basis. 
The structure of the programmes has changed considerably since the study was 
conceived. When the evaluation was planned there were important differences 
between the two programmes. The LTMP provided much more in terms of group 
support and regular education sessions. It also concentrated more on goal setting. 
The LTMP had a flexible time limit of approximately six months with the aim to 
move on generally between six and nine months, or at least to discuss the next 
stage of treatment at this time. In contrast, the DDP had no fixed time limit and 
involved fortnightly individual key worker sessions as opposed to daily group 
sessions. 
Some evaluation of these services has been conducted. Finch, et al., (1995) 
evaluated the LTMP in terms of outcome over a one year period. She measured 
the changes in risk behaviour and psychiatric indices. This was a prospective study 
in which data was collected at entry to the programme and at two month intervals 
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during the year. In terms of outcome the main finding was that there was a 
decrease in risk behaviour scores which was especially marked in the first two 
months. 
A small scale evaluation of the DDP has also been conducted by Weiner (1994). 
As an outcome measure, she used the Opiate Treatment Index (Darke et al., 
1991). Seven clients were interviewed at four weeks after entry and followed up 
six weeks later, at which time only four clients were seen. The only significant 
improvement observed was in illicit drug use, however, the findings should be 
treated with caution due to the small number of subjects and the fact that the 
follow-up group may not have been representative. 
In the conclusion to her report, Weiner (1994) recommended that the OTI become 
a part of the service as a monitor for assessment of clients and that future studies 
include greater numbers of clients and follow-up those who drop-out of the 
programme. It is against the background of these studies that the present study 
was conceived. 
3.3.2 Method 
3.3.2.1 Measures 
A) The Opiate Treatment Index (Dark, et al., 1991) 
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This is an outcome measurement instrument with six, independent domains: 
i) Drug Use 
For each drug class the average amount per day is recorded (03. Participants are 
asked when the three most recent days of drug use occurred and how much they 
used on the last 2 occasions. Intervals between the days of drug use (tl, t2) are 
taken as estimates of frequency of use. The number of use episodes on the last 
two occasions is as an estimate of quantity consumed (ql + q2). The average 
amount per day (Q) is computed as follows: 
Q= ql + q2 / tl + Q. The poly-drug use score is the number of drug classes 
endorsed. 
ii) HIV Risk-Taking Behaviour 
This measures behaviour that puts a person at risk of contracting or passing on 
Human Immuno-deficiency Virus. There are two sub-scales, a) drug use 
(injecting) and b) sexual behaviour. There are 11 items in total (6 injection and 5 
sexual behaviour). Scores range from 0-5 on both scales. Higher scores 
indicates a greater risk. 
iii) Social Functioning 
This scale measures the individual's level of social functioning. There are 12 
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items in this scale and scores range from 0-4 for each item. Higher scores 
indicate greater difficulties in social functioning. 
iv) Criminality 
This scale measures recent involvement in criminal activity. It contains 10 items 
and is divided into four areas of criminality. These areas are: a) property crimes, 
b) dealing in drugs, c) fraud and d) crimes involving violence. For each area, 
participants are asked to estimate how often they have committed crimes in the 
area during the last month. A total score is obtained by adding up the score of the 
4 crime areas. 
v) Health 
This scale is a symptom checklist relating to physical health, especially those areas 
within which drug users usually develop problems. The scale is divided into items 
addressing signs and symptoms in each of the major organ systems. There is also 
a section specifically on injection-related health problems. The score is the total 
for each section when added up. 
vi) Psychological Adjustment 
This is assessed using the General Health Questionnaire (G. H. Q. ) Golberg and 
Hiller, 1979. This measure has four sub-scales: a) somatic, b) anxiety, c) social 
114 
disfunction and d) depression. The score is the total for each section added up. 
Higher scores indicate poor psychological adjustment. 
B) Outcome Predictor Measures 
In addition to this, subjects were asked to complete a number of questionnaires: 
i) The Severity of Dependence Scale (SDS) (Gossop, et al., 1995) 
This is a 5-item questionnaire measuring severity of dependence, based on the 
neuro-adaptational model of addiction, with constructs derived from the 
dependence syndrome described by Edwards and Gross (1976). The severity of 
dependence can be both a predictive variable and an outcome measure. The 
scoring for this measure ranged from 0-3 for each item (maximum score = 15 
and minimum score = 0). 
There are no studies demonstrating the predictive validity of the SDS with opiate 
users. The hypothesis is that the higher the severity of dependence, the poorer the 
outcome. A negative correlation will be expected between high SDS scores and 
high outcome scores. 
ii) The Readiness Change Questionnaire (Rollnick, et al., 1992) 
This is an adaptation of a 12-item questionnaire based on the Prochaska and 
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DiClemente (1986) stages of change model. This is a measure of motivation, 
hence it could be both a predictive variable and an outcome variable. It has three 
scales representing pre-contemplation, contemplation and action stages of change. 
Participants are allocated to one of the above stages based on raw scores. Highest 
score determines the allocated stage. 
In terms of outcome it is hypothesised that those participants obtaining the highest 
score on the action scale will show better outcome than those obtaining the highest 
score on the contemplation scale. Similarly it is hypothesised that those obtaining 
higher scores on the contemplation scale will show better outcome than those 
obtaining the highest score on the pre-contemplation scale. It is also hypothesised 
according to the Prochaska, et al., (1992) model that the majority of participants 
will be in the action stage since they are commencing treatment. 
iii) The Relapse Questionnaire (Wanigaratne, 1997) 
This is a 7-item questionnaire, developed as part of the project, as a simple 
measure of relapse or failure to maintain change. It is based on the main 
categories of high risk situations of the Marlatt and Gordon (1985) model of 
relapse. Participants are required to respond in terms of their confidence to 
maintain positive changes in relation to categorical situational statements. Scoring 
ranged from 0 (0% confidence) to 5 (100% confidence), higher score indicating 
greater confidence to maintain changes (Maximum score = 35 and minimum score 
= 0). This measure assesses ubjects' confidence to maintain positive changes in 
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drug use in a variety of situations. 
Self-efficacy has been shown to be a good predictor of outcome as well as 
maintenance of change (Annis, 1986; Solomon and Annis, 1990). It is 
hypothesised that participants scoring high on this measure will show better 
outcome. A positive correlation between this measure and outcome is expected. 
iv) The Dissonance Questionnaire (Wanigaratne, 1997), adapted from Orford 
(1992) 
This 24-item questionnaire was developed as part of the project by adapting a 
questionnaire developed to measure the degree of addiction independent of the 
withdrawal experience. The constructs of this measure includes, a) Strong desire, 
b) preoccupation, c) acting against judgement, d) loss of control, e) non-social 
activity, f) acquiring money for the activity by special means, g) feeling addicted 
of dependent, h) feeling depressed or guilty, i) being criticised by others and j) 
feeling the need to change (Orford, 1991). For the purpose of the study the 
questionnaire was scored to yield an aggregate score 
,a 
higher score indicating a 
greater degree of addiction. The direction of the scale was reversed for 12 items. 
It is hypothesised as an outcome predictor measure, similar to the SDS, 
participants scoring high on the DQ will show poorer outcome. A negative 
correlation between the measure and outcome measures will be expected. 
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v) The Expectations Questionnaire (Byrne, Wanigaratne, et al., 1997). 
This was a measure developed as part of the project (Chapter 2) to measure 
expectations of treatment prior to clients entering treatment. Treatment 
expectations have been shown to be an important factor in predicting outcome in 
general. There are no standardised measures available to measure treatment 
expectations in the area of addictions at present. The questionnaire was designed 
using factors identified in a qualitative study of expectations (Dale, Jones and 
Power, 1992). 
The questionnaire comprised of 10 items. Participants are required to respond to 
series of statements based on the likelihood of occurrence. Items were scaled 1 
(not at all likely) to 7 (very likely). Higher score indicated more positive 
expectations. 
Copies of all measures can be found in Appendix (A). 
3.3.2.2 Design 
A repeated measures longitudinal design was employed, taking measures at 
baseline (entry into treatment within the first three weeks) and following 
participants up at three different points in treatment. Follow-up occurred at six 
weeks after the initial interview and then at two further times six weeks and 
twelve weeks later. 
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3.3.2.3 Participants 
The aim was to recruit three groups of participants: clients from the daily 
dispensing programme, clients from the low threshold programme and a 
comparison group. The comparison group consisted of clients who had been 
prioritized for treatment in out-patients and had therefore not been on the waiting 
list. Clients were prioritized if they had partners who were already in treatment, 
if they were pregnant, had young children, were HIV positive, sex working or had 
serious physical or mental health problems. Clients were only invited to take part 
if they were beginning a new episode of treatment. 
3.3.2.4 Procedure 
A) Recruitment of participants 
All new clients to the DDP and LTMP over a five month period were invited to 
take part in the study. They were offered "payment" in the form of £5 gift 
vouchers which were given at the second and fourth (mid-point and final) 
interviews. Participation was voluntary. In accordance with the guidelines on 
which ethical approval was granted for the project by the Ethics Committee the 
following procedure was followed. Participants were informed about the nature of 
the study, assured that the information they gave was treated in confidence and 
that participation did not affect their treatment in any way. Participants were 
asked to sign a consent form and given an information letter with details of the 
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research study. Participants were also told that they were able to withdraw from 
the study at any time and that this would not affect their treatment. Copies of the 
information letter and consent form given to subjects are included in Appendix 
(B) 
B) Participants 
A total of 15 participants were recruited to the study over the five month period. 
Of these, at the time of recruitment, 2 were in out patients, 4 were in the DDP 
and 9 were in the LTMP. The total client group consisted of 8 males and 7 
females. At the time of recruitment the mean age of the total population was 31 
years. The mean age of females was 30 years and for males 32 years. 
The number of participants recruited were far below the anticipated number. This 
was due to the service going through a period of re-organisation with a number of 
staffing problems. The programmes were closed for new clients for a period 
when recruitment was to take place. 
3.3.3 Results 
3.3.3.1 Mobility of participants 
During the study period partly due to the disruption of the service, there was 
substantial mobility of participants between treatment groups and a number of 
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clients left treatment or were discharged. Of the 15 recruited to the study only 6 
completed four interviews, 3 completed three interviews, 4 competed two 
interviews and 2 only managed one. The intended analysis of data with the aim of 
evaluating the interim methadone programmes was not possible due to the small 
numbers. The only meaningful analysis of outcome possible was by individual 
case study basis. This would not fulfill the aim of the study of evaluating the 
interim methadone programme. In keeping with the main aim of the study of 
evaluating the utility of the OTI the results reported focus on the comparison of 
the baseline data with the OTI norms and the process of using the OTI. 
3.3.3.2 Baseline data 
This section presents a description of the clients who participated in the study 
based on information collected at first interviews. Mean scores on the OTI scales 
are compared with the normative scores published in the OTI manual (Darke et 
al., 1991). The sample on which the OTI was standardized consisted of 290 
opiate users; 230 of these subjects were in some form of opiate treatment 
(methadone maintenance: 187; NA: 6; drug free counselling: 8) whilst 60 of the 
subjects were not in any treatment. 
The data was collapsed into overall scores, as opposed to scores for the different 
programmes, because of the poor recruitment achieved. 
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A) Type and length of drug use 
For 13 of the 15 clients, heroin was their main drug. For the remaining 2 clients, 
methadone was the main drug misused. Of those whose main drug was heroin, 11 
injected and 2 smoked or `chased'. The mean age of first use was 21.9 years 
(range 13 to 38 years), while the mean age at which clients felt they were addicted 
was 23.1 years (range 14 to 38 years). 
For those using heroin, the mean Q (i. e. occasions of use per day) score at 
baseline was 3.31. For those whose main drug was methadone, the mean Q score 
was 
. 
95. All subjects used at least one other drug. 
Overall, the mean poly-drug score at baseline was 5. The sample described in the 
OTI manual had a mean polydrug score of 4.1 (s. d. =1.6, range=0-8). Presented 
below are the numbers of subjects using different types of drugs in addition to 
heroin or methadone. 
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Table. 3.1 Pattern of drug use among participants 
Drug Number of 
subjects 
Tobacco, 14 
Alcohol 
Crack 
Tranquilizers 7 
'other' 7 
anna is 
Amphetamines 4 
Hallucinogens 
Drugs mentioned under the category 'other' included Temazepam, DF118's, Anadin 
extra, Prozac and Rohypnol and Ecstacy. 
B) I1IV risk Behaviours 
The extent of HIV risk taking showed considerable variation at baseline. The higher 
drug risk scores reflect the fact that the majority of clients were injecting regularly. 
Although clients did not report sharing needles, many re-used their own without 
cleaning them with bleach. The high standard deviations in the sex risk scores 
indicate that, while a number of clients had not been sexually active in the past 
month, others scored quite highly on this measure, either through having multiple 
partners (usually while sex working) or through not using condoms with regular 
partners. 
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Table. 3.2 OTI risk behaviour scale results 
Drug risk 
(Diaz=30) 
Sex risk 
(hoax=25) 
Total I-IRBS 
Overall 
norms 
C) Criminality 
The mean crime score at baseline was 0.6. However, this is slightly inaccurate as the 
frequency of crime reported was not always recorded. One of the clients reported 
breaking and entering and forging prescriptions in the past month, but the frequency 
of these crimes was not recorded. The crimes endorsed were shoplifting, drug 
dealing and possession of weapons (knife). OTI: Mean=1, (s. d. =1.7), range=0-10. 
(n=275) 
D) Social functioning 
The mean social functioning score at baseline was 25.4. Higher scores on this 
measure indicate poorer social functioning, the maximum score is 48, the minimum 
score is 0. The mean score from the OTI norms was 20.5 (s. d. =7.2), range=4-47. 
E) Health 
The scores presented below represent the mean number of symptoms endorsed in each 
category. The mean health score from the OTI sample was 12.6. 
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Table. 3.3 The OTI health scale scores 
Overall 
Card io respiratory 2.67 
MMax=9 
Ciastro/intestinal 3.33 
Max=5 
enera 6.53 
Max=14 
Genito/urinary 1.13 
Max=4 
Gynaecological 
. 
86 
Max=2 
Injection related 
hMax=5 
uscu ose eta 1.07 
MMax=3 
Neurological 
Max=10 
Total scores 19.93 
Max =52 
F) Psychological Adjustment 
The GHQ has four scales measuring, a) somatic symptoms, b) anxiety, c) social 
dysfunction and d) depression, respectively. The commonly used cutoff points are 
4/5 for case criteria. The mean GHQ score from the OTI sample was 8.6. 
Table 3.4 The GIIQ score of the participants 
Overall 
GIIQ- 3.4 
GIIQ-b 3.73 
GIIQ-c 2.87 
H 
-d 3.07 
Total score 13.07 
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From this brief comparison it can be seen that the subjects from the interim 
methadone programmes had considerably higher scores on many of the domains than 
the published norms. This is particularly the case in relation to general health and 
psychological adjustment. 
3.3.3.3 Outcome predictor measures 
The baseline scores of the predictor measures are presented in Table 3.5. Due to the 
attrition of participants it was not possible to carry out planned statistical analysis to 
establish the relationship with changes in OTI scores. 
Table. 3.5 Means and standard deviations of outcome predictor measures 
Measure Mean s. d. Range 
Severity of Dependence 9.6 2.4 6-14 
RCQ 
- 
Pre-contemplation 10.2 1.9 8-13 
RCQ 
- 
Contemplation 15.8 2.9 6-14 
RCQ 
- 
Action 15.8 6.0 11-16 
Relapse Questionnaire 15.5 9.7 2-35 
Dissonance Questionnaire 122.4 17.4 96-145 
Expectations Questionnaire Total 47.3 12.0 35-69 
EQ-Drug 22.3 5.1 12-28 
EQ-Sic 17.2 3.5 11-21 
EQ-Soc 11.0 6.1 3-21 
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The only comparison of the means obtained with published normative data possible, 
is that of the SDS. The mean SDS score of 9.6 is higher than the means of a London 
Heroin using sample found by Gossop, et al., (1995). 
The RCQ was adapted from a questionnaire developed for problem drinkers and 
hence there are no norms. 
The RQ was developed for the study. The means of the sample (15.5) from a 
maximum of 35 shows a level of confidence of 42%. This is a low level of self- 
efficacy. This may be an indication of the high attrition rate found in the study. The 
method of scoring adopted was to re-code the percentage scores in the form to a5 
point scale. To calculate a total confidence score and average it would be a better 
method of scoring. This would yield a direct average confidence level as a 
percentage. 
3.4 Phase III Evaluation of an integrated assessment and outcome 
measurement framework for routine use 
3.4.1 Introduction 
To ensure the objective of developing an assessment / outcome measurement 
instrument of clinical utility, any such instrument has to be linked to the routine 
clinical work and evaluated within that context. The third phase of the project of 
evaluating the OTI was carried out by integrating it within the assessment framework 
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and developing new forms for routine clinical use. This framework was evaluated 
by means of a pilot project involving senior clinicians using it and by a service wide 
training/evaluation session. 
The main aims of this phase of the project were: 
i) Develop assessment/outcome measurement framework with integrated 
paperwork. 
ii) To evaluate this framework in terms of practicality of its use and staff feed- 
back and satisfaction. 
iii) To develop a template for the introduction of new information technology to 
the service. 
3.4.2 Method 
3.4.2.1 Measures 
A) General Assessment Instrument 
A general assessment instrument (appendix A) was developed which had the aim of 
gathering information needed on patients on a broad range of areas. The information 
needed can be categorised as follows: a) administrative, b) demographic, c) clinical 
decision making, d) giving information and advice to patients, e) outcome 
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measurement, f) regional database returns, g) home office returns and h) prognostic 
indicators. 
There is considerable overlap between the above areas of data items. Collecting 
information on all the relevant areas without repeating data items required an 
amalgamated assessment instrument from which specific sets of data for example, 
Regional returns could be extracted with relative ease. If all the data from an 
amalgamated assessment instrument was entered into a computer information system, 
specific information for example, clinical summary, regional return, outcome 
information etc could be generated by the system in the form of reports. Developing 
a robust and flexible "pencil and paper" (manual) assessment/outcome measurement 
system is an essential prerequisite for an information system for a clinical service. 
The data structure of the amalgamated assessment instrument developed is tabulated 
below (Table 3.6. ). The main target areas of information are coded as follows: 
i) (A) Administrative 
ii) (D) Demographic 
iii) (C) Clinical decision making 
iv) (I) Giving information and advice to patient 
v) (0) Outcome measurement 
vi) (N) Regional database returns 
vii) (H) Home office returns 
viii) (P) Prognostic indicators 
ix) (R) Research 
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Table 3.6 Data structure of the assessment instrument 
Page Item No: Item category Target area Comments 
Al-A3 Name A, D, N, H, C 
A4 
- 
A6 Address 
A7 NHS Number 
A8 D. O. B. 
A9 Gender 
A10 Ethnic Origin 
All Housing 
A12-A14 Living Arrangement 
A15 Children 
A16-Al8 Employment 
A19 Referral info 
A20-A22 G. P. 
A23-A26 Assessment info 
2 B1-B7 Treatment history C, I 
B8-B13 Prescribing Plan 
3 Cl-C... Drug use C, O, R OTI 
3 D1-D5 Alcohol use C, O, R OTI 
4 El-E5 Sexual behaviour C, O, R OTI 
5 FI-F10 Criminal behaviour C, O, R OTI 
6 G1-G12 Social Functioning C, O, R OTI 
7 H1-H14 General health C, O, R OTI 
H15-1123 Neurological 
H24-H28 Injecting problems 
H29-H32 Genito-urinary 
H33-H34 Gynaecological 
H35-H43 Cardio/respiratory 
H44-H46 Musculo-skeletal 
1147-1151 Gatro intestinal 
8-11 11-128 General Health Questionnaire C, O, R OTI 
12 J1-J4 Dependence C, O, R Outcome 
measure/predictor 
variable 
13 K1-K12 Readiness to Change C, O, R Outcome 
Questionnaire measure/predictor 
variable 
14 L1-L7 Relapse Questionnaire C, O, R Predictor variable 
15 M1-M24 Dissonance Questionnaire O, R Predictor variable 
16 NI-N12 Expectations Questionnaire O, R Predictor variable 
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Questions A-C 
These are basic screening and administrative questions that are included in the 
Regional and Home Office database forms. 
3.4.2.2 Participants 
The participants for this project were staff working in the drugs service. 
Senior members of staff (n=4) acted as volunteers to use the 'new forms' over a 
period of two weeks to assess new patients referred to the service. 
All members of staff (n= 18) participated in the training feed-back event. 
3.4.2.3 Procedure 
A) Senior clinicians 
Senior clinicians were briefed regarding the development of the new assessment 
instrument and were given both verbal and written instructions on how to carry out 
the assessment. Each assessment pack was accompanied by a letter (appendix A) 
outlining the background and purpose of the new assessment and contained the 
instructions. The clinicians were required to fill out an evaluation questionnaire after 
assessing each patient. 
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B) Staff of the drugs service 
All staff of the Drugs Service, including clinical and administrative staff were made 
to participate in a training afternoon involving the general assessment instrument. 
This was part of an overall strategy to train all staff in the service to use a new 
service-wide assessment instrument and an information system. The staff were 
required to gain experience of using the instrument by administering the instrument 
to each other in pairs and feed-back. Their comments and feed-back on the 
instrument were recorded. 
3.4.3 Results 
3.4.3.1 Evaluation with senior staff 
Number of patients interviewed =7 
Time taken to complete assessment Mean = 50.4 minutes range 40 to 70 minutes. 
Number of sessions mode = 1. 
A) Qualitative Feed-back 
i) Aspects that were difficult that could be changed 
"Sexual behaviour. " 
"Criminal activity. " 
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"Dealing /fraud. " 
"Crimes involving violence. " 
ii) Aspects that were helpful 
"Organization of the interview 
- 
gives a framework to work with. " 
"Helps you to remember to ask in detail about specific areas. " 
"General Health Questionnaire. "
"Injecting allowed for plenty of discussion. " 
iii) Changes to the assessment recommended 
"Information on drug free periods. " 
"Previous treatment / why it did not work. " 
"Why wanting treatment now. " 
"Lined continuation sheets for extra notes. " 
"More formal treatment plan / action plan post assessment. " 
"Drug use layout too cramped. " 
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3.4.3.2 Staff group evaluation session 
A) Group session 
The participants then split into pairs and took part in a role play of trying out the new 
assessment form. 
Total number of staff participating = 18 
A lively feed back discussion followed. The main conclusions and themes to emerge 
from that discussion are outlined in the following statements: 
i) Staff felt it was unsuitability for use at the first meeting because of the in- 
depth nature of the questions. 
"Too much information to ask at drop-in /initial meeting if treatment does not follow 
immediately (ie. if client is put on a waiting list). " 
"A screening instrument similar to the summary form which covers essential 
information for prioritization (for example, mental state, HIV status, pregnancy and 
partner in care) should be developed for drop-in assessments. " 
"The proposed in-depth assessment should be used at the commencement of 
treatment. The information could be collected over a number of sessions. " 
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ii) The structure of the instrument was felt to be problematic with staff finding 
the flow of information unsuitable. 
"Problems in the flow of information for example prescribing plan, injecting and 
sharing, sexual behaviours, not following a logical order. " 
iii) The feeling that a great deal of sensitivity and skill being needed to ask 
questions included in the OTI. 
"Process of obtaining information in difficult areas that are nevertheless crucial for 
outcome measurement (for example, needle sharing, sexual behaviour, condom use, 
criminal activities, etc) requires sensitivity and skill. " 
iv) There was consensus of opinion for the collection of assessment and outcome 
measurement information in a standardised manner. 
"For reliable outcome measurement information should be gathered and recorded in 
a standard way. " 
v) There was a positive attitude towards the use of the outcome predictor 
measures (RCQ, EQ and RQ). 
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"The self completion information currently obtained is of poor quality and of 
relatively little use and could be replaced by the self completion questionnaires of the 
new assessment form. " 
vi) Instead of using the assessment instrument across the service, there was a call 
for flexibility according to the needs and the nature of different parts of the 
service. 
"The Needle Exchange should use/adapt only the relevant sections of the assessment 
form. " 
B) Written Feed-back 
i) Aspects that were difficult that could be changed 
- 
OTI-Drug use 
"Layout of section too cramped. " 
"It doesn't specify whether the questions refer to use over the past month as in other 
sections. " 
"The way some questions are phrased caused difficulty. " 
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"Main drug caused no problem 
- 
second or third main drug? caused confusion in 
clients. Clients have different criteria, eg. if based on frequency cigarettes could be 
every one's main drug, if it is based on preference it could be a drug that is not used 
often but would if they could. " 
"Why rate 1-5 for each of the two rows, rather than 1- 10 for all specified drugs? " 
"Why ask how much after asking about the third most recent day of use, instead of 
how many times? as in previous questions? Does this refer to an average session or 
that particular day? " 
"Duration of this episode sounds awkward 
-? How long have you been using at this 
level? sounds better. " 
"Age from which addicted also caused problems with clients. Clients don't feel they 
are addicted to other drugs besides Heroin. Clients do not necessary accept that they 
are addicted based on their frequency of use. A way round this problem could be ? 
do you feel you are addicted/dependent/have a problem with 
...? before asking what 
age this occurred. " 
"The alcohol section does not include cider. Does not ask first use or problematic 
use. There is no space to record if this is a client's main problem. " 
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- 
OTI-Injecting 
"? misprint in question 4. How many different people have used a needle before..... " 
- 
OTI-Criminality 
"Re-phrase all questions avoiding the word crime! for example, "ways you may have 
supported your habit.... " 
- 
Other questionnaires 
"Negatively worded items constantly problematic. " 
ii) Aspects that were helpful 
- 
OTI 
"Recent drug use most helpful; most clients had little difficulty remembering when 
and how much they used except in cases where the most recent use was several 
months ago or more. " 
"The structure i. e. layout and response options of the injecting social and crime scales 
were very good 
- 
quick and easy to administer. " 
"Health section was also quick and easy to administer. " 
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3.5 Discussion 
3.5.1 Phase I 
This part of the study clearly indicated that, despite the recommendation for 
international use (Darke, et al., 1991), the original version of the OTI was unsuitable 
for direct use with a British population without modification. Modification of 
standardised questionnaires has a number of implications and is not recommended 
from a psychometric perspective. A stem of a question or how a question is asked 
is crucial to the response obtained. Darke et al., (1991) them selves cites the 
example how the question on criminality is asked to explain the poor correlation 
between the OTI and the ASI in the criminality scales. Changing stems of questions 
is unsound methodology indeed. On the other hand when using an international scale, 
if difficulties arise because of linguistic and cultural differences, serious consideration 
must be given to re-phrasing the question whilst preserving the construct. In a 
structured interview style may also be an important factor. The feed-back and the 
evaluation of the original OTI required a number of modifications. As far as possible 
this was done while preserving the original constructs. The fact that there were a 
number of limitations highlighted in Phase III of the study regarding the modified 
version, indicates that a more radical adaptation of the OTI is needed before it is 
recommended for general use in Britain. If such modification were made then British 
norms for it must be established. 
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3.5.2 Phase II 
The aims of this study were to investigate the outcomes of the interim methadone 
programmes in the service using the OTI and predicting outcome. Because of the 
small numbers recruited and the changes in treatment programmes, it was not possible 
to do this as planned. However, some conclusions may be drawn, based on the 
information collected. 
3.5.2.1 The client group served by the interim programmes 
A comparison of subjects' OTI scores with the published norms appears to confirm 
that clients of the interim programmes are experiencing relatively more problems 
relating to their drug use. All the clients who took part were polydrug users, most 
injected their drugs and several reported sharing needles. In addition to heroin, the 
most commonly used drugs were crack, alcohol and tranquilizers. One unexpected 
finding was that most of those clients using crack reported injecting it. This 
highlights the importance of including questions about route of administration. This 
finding also has important implications for risk behaviours. All of those clients who 
used crack saw their use as recreational. This indicates that, even when someone has 
stopped using heroin, it cannot be assumed that safe injecting is no longer an issue. 
In relation to risk behaviours, several clients reported sharing and/or re-using needles 
but no-one reported sterilising them before re-use. Of the 6 women interviewed, 5 
were sex working. While they generally reported always using condoms with their 
140 
clients, they tended not to use them with regular partners. Indeed, only one subject 
interviewed reported using condoms with a regular partner. 
The clients interviewed for the study reported less crime than those in the OTI 
sample, though this must be treated with caution as the data collected was incomplete 
and also because it is particularly difficult to get reliable self reports of criminal 
activity. However, the types of crime endorsed showed agreement with findings of 
Dobinson and Ward (1985; 1986). They reported that the most common types of 
criminal behaviour IDUs engaged in were drug dealing, property crime and fraud. 
The clients interviewed showed a poorer level of social functioning compared to the 
OTI norms. They also reported more health problems, but perhaps the most striking 
difference was in psychological adjustment. Overall, the clients interviewed had 
much higher GHQ scores than the OTI sample. 
It is difficult to make any conclusions based on apparent differences between groups 
because of the small numbers of subjects and also because of the heterogeneity of the 
groups. 
3.5.3 Prediction of outcome 
The questionnaire measures included in the study were intended as predictors but it 
was not possible to look at the impact of these factors statistically as planned. 
Correlational analysis between the measures was also not attempted because of the 
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small numbers recruited. Such an analysis will be important to establish how these 
various factors relate to each other and the extent of overlap. 
The only measure that was validated for use with this population was the Severity of 
Dependence Scale (SDS). The means for the participants of the study was higher than 
the means obtained for a London opiate using population by Gossop et al., (1995). 
The high severity of dependence of the study population may explain the high attrition 
rates found. It is in keeping with a hypothesis that severity of dependence will be 
negatively correlated with outcome. It not possible to draw any firm conclusions 
regarding this because of the small numbers in the present study. 
The means of the Relapse Questionnaire (RQ) shows a general low level of 
confidence (42%). Whilst it is possible to speculate that this may also be predictive 
of the high drop-out rate, without further validation of the questionnaire and statistical 
analysis on the relationship with outcome, no conclusions can be drawn form this. 
The items of the questionnaire were based on the taxonomy of high risk situation 
proposed by Marlatt and Gordon (1985). This measure could benefit from some 
qualitative research to ensure that it is covering those risky situations that are most 
salient to clients. Further research is needed to establish face validity, construct 
validity and reliability of this measure. 
Further research is also needed to validate the dissonance questionnaire. 
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3.5.4 Research issues raised by the evaluation of the interim methadone 
programmes 
A) Measures 
Based on this experience of using the OTI there are a number of recommendations 
that can be made. The development and modification of the outcome measures was 
closely tied to the development of the assessment instrument for clinical use in the 
Drugs Service. However, having been involved in this development and using this 
instrument for research, it became clear that there are different requirements for an 
outcome measure used clinically and one used for research purposes. The OTI may 
be an excellent research tool, however some parts of it would be extremely difficult 
to be used for routine clinical assessments. This is particularly true of the drug use 
section. Not only do the units of measurement differ for each category of drug, but 
the person administering the measure must calculate aQ score for each class of drug. 
This is very time-consuming and is often difficult to do if there is incomplete 
information. Furthermore, it is difficult to see how meaningful a single Q score 
would be in someone's case notes. 
In retrospect, many of the modifications to the OTI were unnecessary in research 
terms. Many of the questions added to this measure would seem to be primarily of 
clinical usefulness and these questions caused the most difficulties. For example, 
asking clients about their main drug, next main drug etc, may be useful clinically but 
is very difficult to define precisely. Asking `what is your main drug ?' made sense 
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to most clients but asking about `next main drug' etc, did not. Clients often asked 
what was meant by this, i. e. the preferred drug ?, the one used most frequently ? (if 
the latter was the case then tobacco would be everyone's main drug). It was also 
very difficult to define `drug free periods' and clients gave very varied responses to 
this. 
The changes that were made that should remain in the research instrument include the 
changes to the format of the crime and sexual behaviour sections. These changes 
made the questions easier to ask and less `accusatory' while still preserving the 
scoring system. The additional categories of drugs (crack) and alcohol (unspecified) 
should also be retained. Route of administration of each drug should be recorded as 
changes in this may be an important outcome. Finally, recording age of first use and 
age from which `addicted' may be useful as these may be predictors of outcome. 
3.5.5 Phase III 
The results of this phase of the study clearly indicate the difficulties of using the OTI 
in routine clinical work. The claims by Darke et al., (1991) that they have achieved 
the aims of maximum utility for both clinical and research purposes and utility in 
clinical settings as an assessment instrument which could be used by medical and non- 
medical staff, are not backed up by the results. 
The claim by Darke et al., (1991) that the OTI could be administered in under 30 
minutes was not supported by this phase of the study, and this was also the case in 
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phase II. The administration of the OTI took twice as long as claimed by Darke et 
al., (1991). It took an average of 55 minutes for the clinicians to complete it which 
is almost identical to the time researchers took to complete it in phase II. This fact 
alone clearly makes it unsuitable for routine clinical use. Even if it took only 30 
minutes it would still be difficult to use in busy settings. 
The clinicians used a version of the OTI modified after the pilot study. The results 
indicate that they still found the language and the phrases of the OTI unacceptable. 
The comments indicates that further modifications are needed to the phrases or the 
stems of OTI for it to be acceptable for use with a British population. Again the 
recommendation for its use internationally is not supported. 
The clinicians also found the structure of the OTI to be problematic. The flow of 
questioning and the sections were noted. The drug use section was particularly 
problematic. If all this is to be taken on board the OTI will require substantial 
modification. If this was to happen then it would have to be re-validated as an 
instrument. 
The results also indicated that the clinicians found aspects of the OTI helpful, 
particularly giving a structure to the assessment process. They also found that some 
scales for example, injecting, gave scope for more in-depth discussion. This should 
have the effect of scope for intervention, for example, safer injecting advice. 
With regards to the difficulties encountered in terms of the acceptability of the 
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assessment structure for routine clinical use, it was not possible to take the process 
further by mapping it on to an information system and evaluating it for its utility with 
the support of information technology. An information system that was 
commissioned for the purpose was not ready in terms of its development for this to 
be taken forward. It is difficult to envisage clinicians entering data directly to a 
computer while conducting an assessment interview in drug service settings although 
it is not beyond the realms of possibility, as this is now the case in many other 
settings. If appropriate user-friendly software is developed staff attitudes may change 
and the use of the OTI in routine clinical work may be a possibility. The results of 
the study indicates that unless data was directly entered into an information system 
during assessment, the use of the OTI for assessment was not suitable. 
3.5.6 Conclusions 
The conclusions that can be drawn from the three phases of the investigations are as 
follows: 
i) The recommendations for use of the OTI as an international instrument and 
for routine clinical work is not supported. 
ii) The OTI needs substantial modification before it is suitable for use with a 
British drug using clinical population. 
iii) It is suitable for use as a research instrument to evaluate treatment 
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programmes and the claims in this area are supported. 
iv) The time taken for its administration is double that claimed by its developers 
and it is unlikely even with the support of information systems that it will 
have utility routinely. 
v) The outcome domains of the OTI are seen by clinicians as appropriate and 
useful. 
vi) A shorter, easy-to-administer instrument, with the same domains as the OTI 
may be more appropriate for routine clinical use. 
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Chapter 4 Measurement of outcome in the treatment of opiate addiction using 
the Plymouth Drug Outcome Questionnaire 
Abstract 
This chapter describes the evaluation of the Plymouth Drug Outcome Questionnaire 
(PDOQ) in a busy inner city London Drugs Service. Treatment outcomes were 
measured in 41 clients at 6 weeks and 3 months, after being taken into treatment and 
compared with baseline measures. The PDOQ scores were also compared with case 
note entries and the objective outcome measure of urinalysis. 
Five measures, Severity of Dependence Scale, Readiness to Change Questionnaire, 
Expectations Questionnaire, Relapse Questionnaire and Dissonance Questionnaire 
were used as outcome predictor measures. The PDOQ was also investigated from a 
staff perspective with regards to its acceptability and utility for routine clinical use. 
The results indicated that there were significant improvements in outcome as 
measured by the PDOQ at 6 weeks into treatment and this was maintained at 3 
months. These improvements were not correlated with changes in urinalysis results 
and case note analysis. The predictor measures, with the exception of pre- 
contemplation scale of the Readiness to Change Questionnaire that predicted dropping 
out of treatment, failed to show any significant relationship to outcome. Staff 
attitudes towards the instrument showed equivocal results, whilst finding the PDOQ 
easy to use and helpful, they also indicated ambivalence about using it routinely and 
about outcome measurement in general. 
The implications of the findings for outcome measurement in this area and directions 
for future research are discussed. 
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4.1 Introduction 
It was established in the previous study that the Opiate Treatment Index or OTI 
(Darke, et al., 1991) whilst being an excellent research instrument was not suitable 
for routine clinical use. Despite Darke et al's claim that it can be administered in 
under 30 minutes, our findings showed that on average it took 55 minutes to 
administer. This makes it a tall order to expect clinicians to administer it routinely 
in busy settings. It is therefore necessary to find alternative instruments that would 
fulfill the need for outcome measurement in clinical settings. 
4.1.1 Plymouth Drug Outcome Questionnaire (PDOQ) 
The Plymouth Drug Outcome Questionnaire (Hassard, 1994) was developed as a 
response to the current need for outcome measurement in busy clinical settings in a 
British context. Hassard (1994) note that the 30 minutes that is given as average 
time taken to administer the ASI and the OTI is not practical in clinical settings unless 
extra resources are available for this purpose. The need for a brief and easy to 
administer measure that can be used by generic drug workers will be acknowledged 
by most clinicians working in the field. The dilemma of using `rough and ready' 
measures that fulfils immediate service evaluation needs, compared with using 
measures with good psychometric properties which are complicated to administer is 
a difficult one for the busy clinician. The latter approach may have more serious and 
wider implications in terms of development of intervention and extending the 
knowledge base, nevertheless if all workers in a clinical setting cannot be persuaded 
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to use such an instrument routinely, it will be of little value. This is a serious 
challenge to clinicians. Taking up this challenge Allan Hassard and his colleagues 
(Hassard, 1994) adopted what they call "from the bottom up" approach to outcome 
measurement to fit the requirements and limitations of their service. They attempted 
to make a virtue of the limitations of their service with the confidence that these are 
shared by most services in Britain. 
The PDOQ is a composite measure adopting the dichotomous categorical scoring 
formula described in Chapter 1 (DARP studies 
- 
Simpson and Sells, 1982; Simpson, 
1986) and the Phoenix House studies (DeLeon, et al., 1992; DeLeon, 1988). Clients 
are scored on a2 point scale whether they meet the a priori criteria or not. The 
advance from the previous studies is the choice of outcome domains. In keeping with 
current trends the PDOQ adopts similar outcome domains to the ASI and OTI 
namely, reduction in drug use, physical health, HIV risk behaviours, crime and legal 
problems and social functioning. Higher overall score means better functioning. It 
is claimed that it takes under 5 minutes to administer if you are familiar with the 
questions. 
It is not validated against another measure, although the author argues for high face 
validity and only moderate reliability figures are published. Hassard (1994) calls for 
independent validation of the instrument before it is adopted for wider use. The 
present project aims to evaluate the PDOQ in a busy clinical setting and compare its 
usefulness with other measures including the OTI. 
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4.1.2 Staff perspective 
The paucity of outcome measurement in the treatment of addictive behaviours, 
particularly in Britain was discussed in Chapter 1. Hypothesis about the lack of 
outcome measurement in the area and some of the key factors effecting outcome 
measurement in the treatment of opiate addiction was also discussed in Chapter 1. 
Attitudes, perceptions and the compliance of staff working in treatment settings are 
all critical factors in determining outcome measurement. Researchers appear to have 
paid very little attention to this particular aspect of outcome measurement. 
Staff feed-back formed a key element in the study evaluating the utility of the OTI 
(Chapter 3). The results of the study highlighted the need to further investigate the 
staff perspective on outcome measurement. The present study evaluating the PDOQ 
placed a greater emphasis on staff feed-back. 
The inextricable link between assessment and outcome measurement was discussed 
in Chapter 1. A framework for outcome measurement requires that the outcome 
measures are taken at assessment and are repeated at subsequent intervals. In Chapter 
3, the range of other information collected at assessment was described. This 
information is collected for clinical decision-making and for administrative purposes. 
Measuring factors that predict outcome could be of significant benefit for the clinical 
decision making process. Factors such as motivation, severity of dependence, 
expectations and self-efficacy were described as important to the clinical decision 
making process and need for studies linking these factors to outcome was discussed 
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in Chapter 1. The investigation of these factors and their relationship with outcome 
was one of the objectives of the study described in Chapter 3. Due to the attrition 
of participants in the study, it was not possible to conclude these investigations. The 
present study makes an further attempt to investigate predictor factors using the same 
framework. 
4.1.3 Present study 
An investigation into an alternative framework of outcome measurement was carried 
out in a second study using a range of methods including the Plymouth Drugs 
Outcomes Questionnaire (Hassard, 1994), urinalysis and case note analysis in the 
same service as in the previous study. 
The evaluation emphasised staff perception and attitudes about the instrument. It also 
investigated staff attitudes and perception about outcome measurement in general. 
4.1.4 The aims of the study 
The aims of the present study were: 
i) To evaluate the usefulness of the PDOQ. 
ii) To evaluate a practical system of measuring outcome closely linked to routine 
work of the clinic. 
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iii) To investigate the acceptability and attitudes of staff regarding the use the 
measure. 
iv) To investigate factors predicting outcome. 
4.2 Method 
4.2.1 Measures 
4.2.1.1 Demographics 
The demographic and client profile information was obtained from the assessment 
schedule in the clients case notes. 
4.2.1.2 Outcome measures 
i) The Plymouth Drug Outcomes Questionnaire (PDOQ) Hassard (1994) 
The PDOQ is a 20-item questionnaire developed as an easy to administer measure for 
routine use in drugs services. It has a dichotomous 2 point scoring system that yields 
a composite score. The composite score represents the overall level of function of 
the drug user measured across a number of domains. The higher the score the 
greater the level of functioning. The domains that outcome is measured on includes; 
a) stability (keeping appointments, registering with a G. P, ), b) reduction in drug 
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use, c) physical health, d) HIV risk behaviours, e) crime and legal problems and 
f) social functioning. The PDOQ has demonstrable sensitivity to change (Hassard, 
1994). 
ii) Template for case note analysis 
The case note analysis was done using the same scoring method as the PDOQ with 
reports of behaviours or drugs in the urinalysis scored as 0 or 1 and a composite 
score obtained. Treatment outcome was also measured by analysing client case notes 
with a template consisting of the following headings: 
i) Reported drug use 
ii) Urinalysis results 
iii) Attendance/ phase of treatment 
iv) Reports of health, legal problems, HIV risk factors, and social functioning. 
4.2.1.3 Outcome predictor measures 
i) The Readiness Change Questionnaire (RCQ) Rollnick, et at., (1992) 
This is an adaptation of a 12-item questionnaire, originally designed for problem 
drinkers and based on the Prochaska and DiClemente (1986) stages of change model. 
This a measure of motivation, hence it could be both a predictive variable and an 
outcome variable. It has three scales representing pre-contemplation, 
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contemplation and action stages of change. Participants are allocated to one of the 
above stages based on raw scores. Highest score determines the allocated stage. 
In terms of outcome it is hypothesised that those participants obtaining the highest 
score on the action scale will show better outcome than those obtaining the highest 
score on contemplation scale. Similarly it is hypothesised that those obtaining higher 
scores on the contemplation scale will show better outcome than those obtaining the 
highest score on the pre-contemplation scale. It is also hypothesised according to the 
Prochaska, et al., (1992) model that the majority of participants will be in the action 
stage since they are commencing treatment. 
ii) The Severity of Dependence Scale (SDS) Gossop, et al., (1995) 
This is a 5-item questionnaire measuring severity of dependence based on the neuro- 
adaptational model of addiction. Its constructs are derived from the dependence 
syndrome described by Edwards et al., 1978. The severity of dependence can be 
both a predictive variable and an outcome measure. The scoring for this measure 
ranged from 0-3 for each item (maximum score = 15 and minimum score = 0). 
There are no studies demonstrating the predictive validity of the SDS with opiate 
users. The hypothesis is that the higher the severity of dependence, the poorer the 
outcome. A negative correlation will be expected between high SDS scores and high 
outcome scores. 
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iii) The Relapse Questionnaire (RQ) Wanigaratne, (1997) 
This is a 7-item questionnaire, developed as part of the project as a simple measure 
to predict relapse or failure to maintain change. It is based on the main categories 
of high risk situations of the Marlatt and Gordon (1985) model of relapse. This 
measure assesses participants' confidence to maintain positive changes in drug use in 
a variety of situations. 
Participants are required to respond in terms of their confidence to maintain positive 
changes in relation to categorical situational statements. Scoring ranged from 0% to 
100%. Higher score indicating greater confidence to maintain changes. 
Self-efficacy has been shown to be a good predictor of outcome as well as 
maintenance of change (Annis, 1986; Solomon and Annis, 1990). It is hypothesised 
that participants scoring high on this measure will show better outcome. A positive 
correlation between this measure and outcome is expected. 
iv) Expectations Questionnaire (EQ) Byrne, Wanigaratne, et al., (1997) 
This was a measure developed as part of the project (Chapter 2), to measure 
expectations of treatment, prior to clients entering treatment. Treatment expectations 
have been shown to be an important factor in predicting outcome in general. There 
are no standardised measures available to measure treatment expectations in the area 
of addictions at present. The questionnaire was designed using factors identified in 
a qualitative study of expectations (Dale, Jones and Power, 1992). 
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The version of the questionnaire used in this study comprised of 10 items. 
Participants are required to respond to series of statements based on the likelihood of 
occurrence. Items were scaled 1 (not at all likely) to 7 (very likely). Higher score 
indicated more positive expectations. 
It is hypothesised that participants with more positive expectations will show better 
outcome. A positive correlation between this measure and outcome measures are 
expected. 
v) The Dissonance Questionnaire (DQ) Wanigaratne, (1997), adapted from 
Orford, (1991) 
This 24-item questionnaire was developed as part of the project by adapting a 
questionnaire developed to measure the degree of addiction independent of the 
withdrawal experience. The constructs of this measure includes, a) Strong desire, b) 
preoccupation, c) acting against judgement, d) loss of control, e) non-social activity, 
0 acquiring money for the activity by special means, g) feeling addicted of 
dependent, h) feeling depressed or guilty, i) being criticised by others and j) feeling 
the need to change (Orford, 1991). 
For the purpose of the study the questionnaire was scored to yield an aggregate score, 
a higher score indicating a greater degree of addiction. The direction of the scale was 
reversed for 12 items. 
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It is hypothesised as an outcome predictor measure, similar to the SDS, participants 
scoring high on the DQ will show poorer outcome. A negative correlation between 
the measure and outcome measures is predicted. 
4.2.1.4 Staff opinions questionnaire 
Clinic staff opinions about the PDOQ and the method of outcome measurement was 
carried out using a brief structured interview (Appendix A). 
4.2.1.5 Staff qualitative interview template 
Staff opinions were further investigated by in-depth interviews of staff. These 
interviews were tape-recorded and analysed using thematic analysis according to 
Grounded Theory techniques (Patton, 1990). 
The questions asked at the interviews were based on the following template: 
Please keep in mind one client you recently assessed. 
i) What factors were you mainly looking for to base your assessment on ? 
ii) How did you decide this client was suitable/not suitable for treatment ? 
iii) Did you feel your client had certain expectations from you/the treatment ? 
iv) Did you have certain expectations from your client (as to how he /she would 
benefit or perform during treatment ? 
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v) What factors do you base your decision on whether a client is benefiting from 
treatment ? 
vi) What do you consider to be a 'successful' treatment outcome ? 
vii) What do you think your client views as a successful treatment outcome ? 
viii) How do you feel about outcome studies ? 
ix) Do you feel they are useful from your perspective ? 
x) Have you used the Plymouth outcome questionnaire ? How did you feel about 
lt 
xi) Have you got any suggestions as to what you would like to happen in terms 
of research in treatment outcome, that might benefit you in doing your job ? 
xii) Any questions /remarks about this interview ? 
4.2.2 Participants 
4.2.2.1 Clients 
The participants of this study were 41 clients taken into treatment in all parts of the 
Drugs Service. The parts of the service included the main outpatient service, a 
satellite clinic, Community Health and Drugs Service and the interim methadone 
programmes included in the previous study. There were 18 women (44%) and 23 
men (56) %. The mean age of participants was 33.6 years, (s. d. =8.11), range 24 to 
54 years. 
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4.2.2.2 Key-workers 
Staff from all parts of the service who were key-working the clients who volunteered 
to participate in the study volunteered to participate in the key-worker interviews 
about the clients' progress. They also answered a questionnaire on the PDOQ. A 
total of 7 members of staff participated in the key worker interviews. 
4.2.2.3 Qualitative staff interviews 
Three members of staff participated in in-depth qualitative interviews. 
4.2.3 Design for outcome measurement 
A repeated measures longitudinal design was employed, taking measures at baseline 
(entry into treatment) and following subjects up at different points in treatment. 
Follow-up was carried out at 6 weeks and 3 months. 
4.2.4 Procedure 
4.2.4.1 Participant recruitment 
Specific parts of the service were targeted for participant recruitment for specific 
periods to facilitate data collection and to minimise disruption to routine functioning 
of the service. All new clients taken into treatment in specific parts of the service 
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targeted for participant recruitment were approached, and their voluntary participation 
requested. 
In accordance with the guidelines on which ethical approval was granted for the 
project by the Ethics Committee of the Camden & Islington Community Health 
Service NHS Trust (appendix B), the following procedure was followed. Subjects 
were informed about the nature of the study, assured that the information they gave 
was treated in confidence and that participation did not affect their treatment in any 
way. Subjects were asked to sign a consent form and given an information letter with 
details of the research study. Subjects were also told that they were able to withdraw 
from the study at any time and that this would not affect their treatment. Copies of 
the information letter and consent form given to subjects are in Appendix (B). 
Those clients agreeing to participate in the study were given a pack containing the self 
completion questionnaires (Expectations Questionnaire, Dissonance Questionnaire, 
Maudsley Severity of Dependence Scale, Change Questionnaire and Relapse 
Questionnaire). They were instructed to fill out the questionnaires in the presence of 
the researcher who was available to answer any questions regarding the measures. 
Once the questionnaires were completed the participants were instructed place them 
in an envelope and seal it. Confidentiality of their responses from their key-workers 
was reiterated. It was also ensured that the participants were aware that their case 
notes and urinalysis will be looked at as part of the study. 
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4.2.4.2 Key-worker interviews 
All clients taken into treatment are allocated key workers who co-ordinate their care. 
The key worker of the participating clients were identified and approached for their 
voluntary participation in the study. All key-workers agreed to participate. 
The key-workers were interviewed using the PDOQ by the researcher for each client 
at the beginning of an episode of treatment, at six weeks and at three months. The 
items in the questionnaires they could not answer were marked as missing data. 
Comments about the questionnaire at the time of the interview were noted. 
4.2.4.3 Key-worker questionnaire 
The key workers were also given an evaluation questionnaire about the PDOQ 
(appendix A). 
4.2.4.4 Staff qualitative interviews 
Four members of staff from different part of the service was identified and requested 
to participate in a tape recorded in-depth interview with a researcher. Three members 
agreed to participate, one declined. 
The interview was conducted using the methodology described by Patton (1990) with 
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the interviewer posing the questions outlined above, but using the questions as a 
guide, rather than imposing a structure to the interview. The questions were asked 
in an open ended manner. 
The instructions to participants were as follows: 
"This interview is confidential: tape recording will be erased after transcribing, no 
names will be used, the interviewer is only person who will be able to link name with 
data and this remains confidential. It will not be reported to anyone in or outside the 
department, only the ideas voiced in the interview will be used anonymously. " 
4.2.4.5 Case note analysis 
Clinical case notes of all the participants were analysed by a researcher using a 
template designed for this purpose (appendix A). Measures were taken of notes at 
assessment, at 6 weeks and 3 months after commencement of treatment. 
4.3 Results 
4.3.1 Participant characteristics 
Forty-one patients receiving treatment for their opiate addiction participated in the 
study. The demographic details and their profile was recorded from their case notes. 
Some case notes had information on some categories missing: these are indicated in 
163 
the statistics outlined below. 
A) Ethnicity 
The majority of the participants in the study were White. 46% identified them-selves 
as White British, 6% as White European, 10% as Scottish, and 3% (n =1) as Irish. 
3% (n=1) identified them self as Mixed Race and 3% (n=1) identified them self as 
British Asian. Data on ethnicity was missing in 30% of the participants. 
B) Children 
16% of the participants indicated that they had one or more children. 
C) Accommodation 
The largest percentage of the participants (28%) was of No Fixed Abode (NFA). 
21 % had council accommodation, 10 % had hostel accommodation and 8% had private 
rented accommodation. The following categories had 3% (n=1) each; squat, living 
with family and owner occupier. 23% of the participants had no accommodation 
entries. 
D) Method of use 
The majority of participants in the study were Intra-Venous (IV) drug users, 43 % of 
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the participants falling into this category. 15 % indicated that they smoked heroin. 
8% indicated that they inhaled (chased) heroin. 8% of participants used methadone 
or codeine linctus which they took orally. Data on method of use was missing in 
25 % of the participants. 
E) Amount of use 
38% of the participants indicated on assessment that they used 1 gramme of heroin 
a day and 21 % of the participants indicated that they used 0.5 grammes of heroin a 
day. 8% had indicated that they took 100 mis (100mg) of methadone a day, one 
participant reported taking 600 mis of codeine linctus a day. 
F) Age of first use 
The mean age of first use indicated by the participants was 21.3 years, (s. d. =6.2), 
range 13 to 36 years. 
G) Age addicted 
Similar responses to age of first use was given by the participants with a mean age 
of 23 years, (s. d. =5.6), range 14 
- 
36 years. 
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H) Use of other drugs 
The participants of the study indicated a pattern of poly-drug use. The number of 
participants indicating use of other drugs and their percentages are presented in Table 
4.1. 
Table 4.1 Numbers and percentages of other drug use by participants 
Drug Number Percentage 
Tobacco 8 20% 
Alcohol 14 35% 
Crack 8 20% 
Cocaine 8 20% 
Tranquillizer 12 30% 
Amphetamine 5 12.5% 
Hallucinogens 5 12.5% 
Missing 10 25% 
It is probable that the percentage of subjects smoking tobacco is an under-estimation. 
Most clients smoke and this question is often not asked. 
4.3.2 Outcome predictor measures 
The descriptive statistics of outcome predictor measures are presented in Table 4.2. 
The mean Severity of Dependence score of the participants (N=41) was 9.8 
(s. d. 
=2.5). This is higher but comparable with the means for a London heroin using 
population found by Gossop et al., (1995). The scores are almost identical to the 
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scores obtained by the participants in the previous study. 
The Readiness to Change Questionnaire (RCQ) scores obtained showed the following 
means: pre-contemplation, 9.6 (s. d. =4.1), contemplation, 16.3 (s. d. =3.1) and 
action, 15.9 (s. d. =3.9). These means are comparable to the baseline means of the 
previous study. The pre-contemplation means are slightly lower, with the other two 
being slightly higher. 
The mean Relapse Questionnaire score was 51.5 (s. d. = 25.3). The 51 % confidence 
score is higher than the 42% score obtained in the previous study. 
The mean total score of the Dissonance Questionnaire was 115.5 (s. d. = 17.7). This 
was much lower than the mean of the previous study of 122.3. 
The mean total score of the Expectations Questionnaire (N=41) was 42.4, 
(s. d. 
=6,2). This is lower than the mean (47.1) obtained by the participants the OTI 
study (Chapter 3). The mean score on the EQ Drug-use scale was 17.4, (s. d. =2.8), 
which was lower that obtained by participants in the OTI study. The mean score on 
the EQ Sickness scale was 13.2, (s. d. =2.1), which again was lower than the means 
for this scale in the OTI study. The mean score for the EQ Social scale was 11.8, 
(s. d. 
=2.7), which is identical to the scores for this scale obtained in the OTI study. 
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Table 4.2 Descriptive statistics for outcome predictor measures (n=41) 
Measure Mean s. d. Range 
Severity of Dependence Scale 9.8 2.5 4-15 
Readiness to Change Questionnaire 
- 
Pre-contemplation Scale 
9.6 4.0 4-19 
Readiness to Change Questionnaire 
- 
Contemplation Scale 
16.3 3.0 7-20 
Readiness to Change Questionnaire 
- 
Action Scale 
15.9 3.8 4-20 
Relapse Questionnaire 51.5 25.3 3-97 
Dissonance Questionnaire 115.6 17.7 77-147 
Expectations Questionnaire 
- 
Total 42.4 6.3 26-50 
Expectations Questionnaire 
- 
Drug-use Scale 17.4 2.8 11-20 
Expectations Questionnaire 
- 
Sickness Scale 13.2 2.1 6-15 
Expectations Questionnaire 
- 
Social Scale 11.8 2.7 5-15 
4.3.3 Outcome measures 
The descriptive statistics of the results of the outcome measures are presented in 
Table 4.3. and presented in a graphical form in Figure 4.1. 
Table 4.3 Means, standard deviations and significance levels for differences 
between baseline and six weeks, and between six weeks and three 
months 
Baseline 6 weeks 3 months 
Measure Mean s. d. Mean s. d. Mean s. d. Sig 
B/6w 
Sig 
6w/ 
3mths 
PDOQ 7.6 4.1 12.7 3,8 13.2 4.7 0.00 NS 
Urine total 2.7 1.2 2.5 1.2 2.1 1.5 NS NS 
Case score 5.1 2.4 4.5 2.0 4.1 2.1 NS NS 
Level of 
methadone 
66.5 20.6 61.9 19.7 48.6 22.7 0.02 0.03 
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PDOQ 
The scores on the PDOQ has a range of 0 to 20, with higher scores indicating a 
higher level of functioning or better outcome. The participants had a baseline mean 
of 7.6 (s. d. = 4.1) which increased to 12.7 (s. d. = 3.8) at six weeks. The mean 
score increased to 13.2 (s. d. = 4.7) at three months which was a smaller increase 
compared with baseline and six weeks. 
The comparisons of means of the PDOQ between baseline and six weeks using the 
Wlicoxon sign test (Wilcoxon, 1947, Siegel and Castellan, 1988). The Wilcoxon test 
was used because of the ordinal nature of the data and to avoid the assumption of 
normal distribution of the responses that is necessary for the use of more robust 
parametric tests for comparison of means such as the t-test (Robson, 1973). It was 
also selected because of the small sample size and its suitability for "repeated 
measures" or "matched subject" design that the study utilised. The Wilcoxon test 
showed the difference to be highly significant (z=4.7, p=. 000). The difference 
between the means between baseline and three months also remained highly 
significant (z=4.1, p=. 001). The difference in the means between six weeks and 
three months were not significant. 
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A) Urinalysis 
The scoring template allowed for a range of scores from 0 to 7, a higher score 
indicating the presence of a greater number of substances in the urine. Since all 
participants were prescribed methadone, if they were complying with treatment the 
expected score would be 1. The results showed a mean score of participants at 
baseline was 2.7 (s. d. = 1.2) which decreased to 2.5 (s. d. = 1.2) at six weeks. The 
mean score further decreased to 2.1 (s. d. = 1.5) at three months. The difference 
between the means were not statistically significant. 
B) Case note analysis 
The template for case note scoring allowed for a range of 0 to 12, a higher score 
indicating a higher level of functioning or better outcome. The mean score at 
baseline was 5.1 (s. d. = 2.4), the mean at six weeks was 4.5 (s. d. = 2.0) and the 
mean at 3 months was 4.1 (s. d. = 2.1). In general, case notes were found to be not 
detailed enough to measure change. Data on PDOQ domains (sexual behaviour, 
criminal activity, interpersonal relationships, housing) are entered at the initial 
assessment and subsequent mention was rare. The means show a decreasing trend 
from Ti to T3. This trend is in the opposite direction to the PDOQ means. 
C) Level of methadone prescribed 
The level of methadone prescribed between baseline six weeks and three months 
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changed in the expected direction with a decrease from a base line mean of 66.5 mis 
(s. d. =20.6), the six week mean of 61.9 mis (s. d. = 19.7), to three month mean of 
48.6 mis (s. d. =22.7). The comparison of the differences in means between six 
weeks and assessment was found to be significant (Z=2.4, p=. 02). The differences 
between the means of six weeks and three months was also found to be significant 
(Z=2.1, p=. 03). 
4.3.4 Comparison of methods 
The level of agreement between the PDOQ and case notes was analysed using 
Kendall's Tau a non parametric correlation test. There was a significant but negative 
correlation between six week PDOQ and case note score (Kendall's Tau=-. 4, p=. 02) 
and three month PDOQ and case note score (Kendall's Tau= 
-. 
5, p=. 001). 
4.3.5 Drop-out rates 
Ten out of the forty one participants had dropped out of treatment at 3 months. 
4.3.6 Predictors of outcome 
4.3.6.1 Relationships between the variables 
The relationship between the predictor variables were analysed using Kendall's 
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correlational test for non parametric data. The Kendall's rank order correlation 
coefficients and their levels of significance are presented in Table 4.4. 
Table 4.4 Correlations between Severity of Dependence (SDS), Dissonance 
Questionnaire (DQ), Expectations Questionnaire (EQ), Relapse 
Questionnaire (RQ) and the Readiness to Change Questionnaire 
scales (RCQ: Pre-Contemplation, Contemplation and Action). 
SDS 
DQ 
-. 
01 
EQ 
. 
36** 
. 
08 
RQ 
. 
10 
-. 
3** 
. 
19 
PRE 
-. 
07 
-. 
15 
-. 
19 
-. 
02 
CONT 
. 
07 
. 
20 
. 
13 
. 
08 
-. 
5*** 
ACT 
. 
14 
-. 
2 
. 
06 
. 
23* 
-. 
3** 
. 
23* 
SDS DQ EQ RQ PRE CONT 
p> 
. 
05*, p> 
. 
01**, p> 
. 
001*** (N=40) 
Table 4.4 shows a varied pattern of relationships between the predictor variables. 
The statistically significant results are described below. The trends in the 
relationships are explored in the discussion section. 
Significant relationships were found between the Dissonance Questionnaire and 
Relapse Questionnaire. These two variables were negatively correlated. This 
indicates that self-efficacy regarding maintaining changes vary in an opposite direction 
to the degree of psychological attachment. This finding is in keeping with the 
hypothesis regarding these measures. 
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A positive correlation was found between the Expectations Questionnaire and the 
Severity of Dependence Scale, indicating that severity of dependence and expectations 
of treatment vary in the same direction. This finding is in keeping with Gossop, et 
at., (1995) finding that high SDS scores are linked to clients seeking treatment. 
Correlational analysis involving the different scales of the Expectations Questionnaire 
only showed a significant correlation between the Social scale and the Severity of 
Dependence Scale (Kendall's Tau=. 34, p=. 01). It appears that the Social sub-scale 
make a significant contribution towards the relationship between the two measures. 
The responses of the participants to the Readiness to Change questionnaire showed 
a highly significant relationship in the expected direction. Pre-contemplation scores 
were significantly and negatively correlated with contemplation and action scores. 
This confirms the robustness of the structure of the measure. Contemplation scores 
were positively correlated with action scores. The action scores were positively 
correlated with the Relapse Questionnaire scores, indicating that self-efficacy and 
positive motivation vary in the same direction at time of entry into treatment. 
Action scores were negatively correlated with Dissonance Questionnaire scores 
indicating that the higher the psychological dependence, the lower the motivation for 
change at the time of entry into treatment. 
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4.3.6.2 The relationship between the predictor variables and treatment 
outcome 
The relationship between predictor variables and outcome was investigated using 
multiple regression analysis to establish the extent to which each of variables 
independently predicts outcome. The predictor variables together with the dependent 
variable (change in PDOQ scores) were entered into a forced entry multiple 
regression. This method indicates the predictive power of each variable, taking into 
account all the other variables. None of the predictor variables showed a significant 
relationship with outcome measured by the PDOQ. 
Correlational analysis between changes in PDOQ scores and the predictor measures 
failed to show any strong associations. 
Participants who dropped out of treatment showed significantly high pre- 
contemplation scores (Kendall's Tau=. 4, p=. 02). This result is in keeping with 
theory (Prochaska, et al., 1992) regarding the pre-contemplation stage of change. 
This was the only measure used in the study that predicted outcome. 
There was a negative correlation between clients dropping out of treatment and the 
Relapse Questionnaire scores, but it failed to reach significance at 
. 
05 level (Kendall's 
Tau=. 3, p=. 06). 
Correlational analysis of the data of high scorers on the predictive measures also 
failed to show strong associations with changes in outcome measures. 
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4.3.7 Staff Feed-back on the measure 
4.3.7.1 Quantitative measures 
Number of staff participated = 7. 
Mean years of experience working with drug users = 8.4 years (s. d. =9.8, range 2.5 
to 30). 
Mean case load = 18 (s. d. =8.6, range 10 to 35). 
Mean taken to complete the PDOQ = 4.4 mins (s. d. =1.3, range 3 to 7 mins). 
Mean usefulness rating = 2.6 (s. d. =0.98, range 1 to 4), (max=5, min= 1). 
Mean satisfaction rating = 2.4 (s. d. =1.3, range 1 to 4), (max =5, min=1). 
4.3.7.2 Qualitative feed-back 
A) Ease of administration 
All participants indicated that they found the PDOQ easy to use. There were no 
negative comments on it's ease of use. Participants also indicated that the questions 
were easy to answer. 
B) Most helpful aspects of the questionnaire 
A number of areas were indicated as helpful by the participants. These included the 
PDOQ helping to monitor client's progress through treatment, helping to focuss on 
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different areas of client's functioning, helpful as a risk assessment tool, providing a 
snap shot measure and helpful in obtaining a profile of participants case load. The 
comments on the helpful aspects of the questionnaire seem to mainly focus on the 
functionality of the questionnaire rather than aspects of it. 
"It can help track progress of clients through treatment. " 
"It allowed to look at clients progress. " 
"It can help to get a profile of your case load. " 
"Helpful to focus on different areas of the clint's functioning. " 
"A tool for risk assessment. " 
"Questions on crime and being registered with a GP was helpful. " 
"It provided a snap-shot measure. " 
C) Limitations and unhelpful aspects 
All participants commented on the lack of sensitivity and the limitations of 'all' or 
'nothing' answers. This limitation appeared to provoke a strong response from the 
participants. This response was mainly a one of 'frustration' that small but significant 
changes in clients behaviour according to the participant's clinical judgement had to 
go unrecorded because of the 'all or nothing' responses required. There was a sense 
of underestimation of positive outcome because of the lack of sensitivity of the 
instrument. The other limitations highlighted included the phraseology of the 
questionnaire, non inclusion of domains that were considered relevant and the 
subjective judgements required by the key-worker. 
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"Frustrating having to give yes/no answers 
- 
not sensitive enough. " 
"Questions too elliptical 
- 
could be better phrased 
- 
e. g. did the client appear 
healthy?. " 
"Some questions too ambiguous 
- 
e. g. did the client report GP being helpful?. " 
"Some of the wording and phrases are awkward. " 
"No questions on mental health. " 
"No questions on how clients structure their time. " 
"Some of the questions relied on subjective judgement of the key worker - e. g. was 
the clients personal relationships improved?. " 
D) Recommended changes 
The recommendations for change were mainly based on the limitations highlighted 
above. Increasing the sensitivity of the instrument was the main recommendation. 
Reducing the ambiguity of the questions and suggestions of other areas of outcome 
measurement were also recommended. 
"Make it more sensitive to change. " 
"It could be more specific. " 
"Some questions were insensitive 
- 
e. g. stable monogamous relationship. " 
"Change 
- 
did the client report the GP being helpful?. " 
"A question on weight gain would be helpful. " 
"Specific questions on Hep. B and Hep. C will be helpful. " 
"Questions regarding mental health functioning of patients. " 
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"Questions regarding how clients structure their time. " 
"Questions regarding behavioural change. " 
"Questions regarding changes in compliance, lifestyle and deviant behaviour. " 
"Question on personal relationships does not make any sense. " 
"Does the client use condoms? This day and age you will always get an yes answer! " 
"Clean injecting equipment requires definition. " 
E) Other comments 
Other comments about the instrument included suggestions for a more efficient way 
of administration and an observation regarding the quantitative nature of the 
instrument. 
"Self administration of questionnaire will be easier than structured interview. " 
"Takes up time and adds to your work load. " 
"It is very quantitative rather than qualitative, it might give you a rough picture of 
what is happening, there is no way to qualify the answers. Yes and no answers are 
very simplistic. " 
F) Routine use 
Paradoxical and perhaps the most surprising responses emerged when participants 
were asked whether they would use the PDOQ routinely in their work. Whilst 
responding that it was easy to use and identifying a number of positive aspects to it, 
179 
most participants responded that they would not use it routinely or were ambivalent 
about its use. Negative attitudes about filling forms and the perception that this 
would add to the 'work-load' were the main themes to emerge. 
"No. Dislike filling questionnaires. " 
"Yet another chore; unlikely to use it routinely. " 
"Might use it. " 
"May be not. " 
".. probably 
- 
may be. " 
"No. Duplication of assessment information. " 
"Too many questionnaires to fill out 
- 
takes up staff time 
- 
adds to existing 
pressures. " 
G) Comments about outcome measurement 
The responses indicated a wide variation in attitudes and perceptions regarding 
outcome measurement. Whilst some participants saw it as essential, most participants 
felt the need for 'qualification ' or purpose of their use. In general outcome 
measurement was seen as 'outside' routine clinical work. 
"Essential 
- 
helpful in needs assessment. " 
"Could be useful to monitor trends. " 
"Outcome measurement is of limited use. " 
"There is a place for outcome measurement, it can be useful, but not on its own. " 
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"Outcome measurement is more relevant for research, not for routine clinical work. 
It is to do with financial considerations in the present climate 
- 
not about patient 
care. " 
"We need to take it into account; if not, we will be failing in our duty to care for 
clients. " 
"Outcome measurement is useful but it depends who we are measuring outcome for, 
is it for the clients or the purchasers? Depends on the agenda. If it is an outside 
agenda you have to be careful what information is given out because they may not 
understand the full picture and pick on measures out of context. Different measures 
for different agendas. The agenda must be explicit. " 
H) Alternative methods of measuring outcome 
Informal and qualitative approaches were suggested as alternative methods of outcome 
measurement. Clinical reviews were seen as the routine method of monitoring 
outcome. 
"Care programming approach, regular review. " 
"Better questionnaires. " 
"Interviewing clients. " 
"Research. It would be more helpful if a researcher met the clients at different 
stages, at regular intervals. " 
"Six month reviews. " 
"Movement of clients within the service. " 
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"Scrutiny of discharge sheets, discharge criteria is relevant to outcome. " 
"Client review is a measure of outcome. " 
"Regular monitoring of own case load. " 
4.3.8 Qualitative staff interviews 
The core themes that emerged are described below. The participants are identified 
as A, B, and C. 
A) Factors that are taken into account on assessment 
First impressions and how the client makes the assessor feel emerged as an important 
factor. Whether the client can be managed in that setting and the safety of the 
assessor were also factors: 
"I think the first thing before going into the actual assessment room is to see 
the client in the waiting room and I form a first impression, what do they look 
like, how are they dressed, what mood do they convey, facial characteristics. 
In the formal assessment situation I would be aware of those first impressions 
and see whether I would alter them or not. With the actual format of the 
assessment form there are set pieces of information I would ask the client, and 
obviously those need to be elaborated on, I might need more information to 
flesh out what they are saying. I suppose one thing that comes up when 
seeing clients is whether I am getting a truthful account from this client or 
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is this client saying the right things that would get him into treatment. I guess 
that is something I would question myself from time to time, what' s going 
on in the client's life? I would also be aware of how this client is making me 
feel, a sort of instinctual response to the client... " (B) 
"The second inquiry is to what drugs that person is taking. I could talk about 
the assessment form and the different criteria if you'd like or about my own 
feelings around it... " (C) 
"Well, the client I had in mind was referred by a GP. One of the first things 
that came to my mind was whether that person is going to be manageable in 
a community setting. This client is actually rather difficult, their behaviour 
alerts me to whether they would benefit from our community treatment, so 
I'm watching that. Also whether they might be dangerous to be managed or 
how difficult they seem, dangerous. Secondly, their forensic history seems 
important. About criminal behaviour and how that person reacts in certain 
situations. This client has a long history and he appeared very anxious to get 
what he wanted. That triggers a counter-reaction from me because I find that 
very difficult. When someone is very demanding I immediately think 'oh my 
God. I respect clients until I'm taught otherwise by the client. Sometimes 
clients just come to try and get a script because they have an impending court 
case. And I'm also quite scared sometimes; I'm sure a lot of our clients carry 
firearms or knives which I find very unsettling. I'm sure they use them when 
they want something and they are not getting it. All those factors would have 
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an influence on my decision whether a client could benefit from our program 
in community care. They would obviously need some care or a script or 
whatever but it would not be the right setting. This particular client has a 
history of violence and he was very demanding, looked agitated and was 
shouting. He had been to the doctor's clinic and he was also there very 
demanding, in front of the queue and all that. These things I keep in my 
mind, about motivations and about suitability. I think there is a dilemma in 
our situation because as we are able to access clients more easy and get them 
into treatment when they obviously need it, but then it is to decide whether 
they should go to the DDU or come to us for treatment. We haven't decided 
yet for this particular client. If he were to stay we would have to have much 
more boundary setting and a treatment plan of not very long duration I should 
think. " (C) 
A clear difference of what is looked for in an assessment dependent on the profession 
of the assessor also emerged. An expected physical focus by a medical practitioner 
combined with a more global psychosocial outlook emerged. 
"I firstly assess their physical health, and secondly the impact of their drug 
use on their physical health. So my assessment is much more comprehensive 
than you would commonly find, and so I have a pro forma that is used for 
every patient. Two reasons for that: one, so there is consistency, whether it 
is me or a locum. Secondly, to ensure it is thorough and thirdly, it forms a 
data store of previous information about drug use, about their general health, 
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about their access to health services, about whether or not they have been 
immunised, needle sharing, it is very comprehensive. Also their social 
history, civil status, dependents and everything about drug use. If you are 
needle sharing and if you are using IV and injecting into your groin or your 
neck then that carries health risks that I need to be alert to. The obvious risk 
is HIV, but also strokes, septicaemia,... Education history and legal history 
also gets recorded, are they on probation, are they currently awaiting trial? 
Medical history, what illnesses have they had, are there any physical 
complaints they have at the moment, are they short of breath, are they feeling 
sick in any way. We counsel every patient about Hep. b and Hep c., we 
discuss HIV testing, but sometimes it might be better to approach it at a later 
date... (A) 
B) Influences on decisions about treatment? 
Institutional policies, multidisciplinary teams' opinions, the client's level of 
functioning and the clients' level of chaos, all emerged as factors. Experience of 
treatment outcome with similar clients was also noted as a factor influencing 
decisions. Assessors concept of a realistic plan (which implies highly subjective 
criteria) again based perhaps on outcome of past clients' treatment emerged. 
"Well, first of all, it is not really my decision, I feed back this information to 
the clinical meeting, I guess that I am very much aware of the client I am 
seeing now in comparison with the clients I have seen in the past and what has 
185 
been the outcome with those. Sometimes, the criteria for different kinds of 
treatments vary greatly anyway. For example, now we haven't been able to 
get clients on a daily dispensing program recently, so we have taken clients 
on with GP's who in the past we would not have taken on because they were 
too chaotic, and which in the past we would not have taken on. It is on a 
probationary period, to see whether they are okay, and if it works out well 
then they will obviously stay. I think the main thing that determines the 
decision to take on is the levels of chaos in the client, very much bearing in 
mind that when clients are going to go to GP's they are not going to cause any 
problems, if they are going to disenchant GP's, they are going to say we find 
it too difficult to work with them, so we have to bear in mind that clients have 
to be fairly good at time-keeping and are going to behave in the waiting room 
and that sort of thing. There is also a category of clients who have problems 
that need more support than could be provided in that situation, for instance 
clients with mental health problems might not be suitable for that kind of 
treatment. " (A) 
"I think it has to be a realistic treatment plan. I would see a successful 
outcome of a treatment plan when a person would hopefully have made some 
changes. It would be naive to expect that a person would succeed first time 
around. For this person, as he has been in treatment several times, it 
definitely lowers my expectations. I'd probably set goals which are not too 
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high. If I think it's not going to work, then it is up to me to make a decision 
as to what would be more useful. " (C) 
The medical practitioner as would be expected focused on physical factors in making 
treatment decisions. 
"If someone is highly likely to be HIV + to me, if they seem high risk, say 
something like if they are symptomatic, if they share needles, and they are 
intoxicated... then its not the appropriate time to say, by the way, what about 
testing... that might be too frightening, so we deal with the acute. Also, are 
they using large amounts of drugs, are they using safely or injecting in the 
neck, this is not the person you would just give a script and see every 
fortnight for a key worker session, that is someone who might have a poor 
educational history, not aware of the health risks they are running anyway. 
One of the interesting things that has emerged from what we do is seeing for 
instance whether a person has ever been offered a vaccine, because a large 
number of these patients do not have GP's and many of them come from quite 
turbulent social backgrounds. They don't have even 0' levels, so their lack 
of education could make them less aware, and secondly they don't have access 
to general practitioners, so they don't have access to information on those 
things. If you are aware that a patient never had access to information about 
safe using, for instance, then they might be more suitable for a program with 
methadone maintenance with slowly decreasing the dose. " (C) 
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C) Client's and key-workers expectations about treatment 
Managing or "lowering" expectations of clients, resisting pressure from clients, 
reducing high or "unrealistic" expectations of clients, emerged as key factors. 
"In a way, when I go to the clinical meeting, it is their decision, and that's a 
safeguard against feeling pressure through expectations from the client... 
There is this thing that sometimes clients can have unreal expectations from 
what they can achieve from treatment, and I am not sure whether that's to do 
with their lack of experience with methadone treatment or whether they are 
not facing up to reality or whether they are pressured to come into treatment, 
I don't know... 
Through experience my expectations are very low with clients. I don't think 
... 
Well, my experience with clients' relapse, and not sticking to methadone 
and all that... they find it very difficult being clean, reducing... you know, so 
I think I have never experienced the ideal scenario, you know, sticking to the 
script, not using on top, reducing... it has never come to that... I have an 
expectation from someone who's on methadone because from my experience 
I think methadone is a useful thing in-so-far as there is often a definite change 
in someone if they go on to a methadone script after they have been using 
heroin regularly, often they appear to be better, it seems to be very 
stabilizing. I'm also aware that if they are not using on top it's a dramatic 
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change in their life style, so I would say I have certain expectations for fairly 
immediate improvements. " (B) 
"The type of detox patients might be looking for could be unrealistic. I saw 
someone last week, he was using 250 mg and he wanted to just go and have 
a ten day detox. I told him that he certainly could do that, but we needed to 
discuss whether that would be fine, it was a huge amount of drug to just detox 
like that, maybe it would be very hard to do, maybe he would be very 
uncomfortable. And if he then would go straight from the detox without 
anything organised, he would still be living with people who are drug using, 
and there might be many things that would make it difficult for him to remain 
drug free. If he failed, that might make him feel a failure, unable to deal with 
it, so perhaps there is a better way of beating the problem... I try to see what 
they are hoping for and what is likely to come out of the treatment they have 
chosen. 
I think that one of the things we commonly make the mistake of, we want to 
decide what is best, we want them to do what we say. I fear that's a waste 
of time. Most patients have a good idea of what they want and what prevents 
us from looking at that is that we think that we know better, ha... and one of 
the commonest reasons why people want to detox is because they feel that 
there is so little availability of long-term prescription, and they want stability. 
I can't imagine anyone would say, yes, I will give you a prescription for the 
next twenty years, and they know that too. And because we as doctors feel 
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we can't possibly do so, people should be drug free, we make the decisions 
for them 
..... 
I think we have an honest obligation to look at detox with patients, what do 
they want from it, and look at it realistically. Very often it is tempting for us 
to encourage people to detox because we want to believe that this patient will 
become drug free, and our treatment works. But I think we should focus on 
whether this detox is really what the patient possibly can achieve. For some 
people detox is exactly right, for others you might have more success by 
slowly decreasing their drug use first. Detox is very hard, and the impact of 
failing is profound, not only on the patient but on the doctor as well. The 
doctor becomes angry with the patient for failing. And then they get 
punished, because of the limited funding, the doctor will say, you had your 
chance... " (A) 
A confusion between motivation and expectations of clients seem to emerge with a 
suggestion that 'motivational interviewing' should be used as a form of assessment 
of expectation. 
"I suppose motivational interviewing would be a very good way of doing it 
(measuring expectations). Coming at it from different angles, mostly. 
Sometimes direct questioning. If they are clear about it, in some ways that 
makes it easier, as in some ways I think that for some that is the main reason 
and that they are deluding themselves that they want to come off. In terms 
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of harm reduction, yes, I think they could still benefit, but it seems important 
that is the reason they are doing it. 
I think it could cause problems for both us and the doctor if the motivation is 
not clear. Obviously, during assessment the first thing I do is assessing the 
criteria of motivation, and perhaps look at doing some more work. For 
instance, sometimes we see clients who want a script and when they find out 
they will not get it today or tomorrow, they will go away and you don't get 
a chance to do more work with the person. " (C) 
Giving clients information on treatment as a way of managing expectations emerged 
as an intervention. 
"I don't think I want more information, but very, very clear information. If 
someone would honestly say to me they want treatment for a court case then 
that is fine and I can work with that, as you know that when they are more 
stable you might have a chance to do some more work with them. Stability 
is really the ultimate realistic goal. Harm reduction is most important. If a 
person is injecting, if we get him a script, they might stop, which is definitely 
improvement, it gives you a foothold in to treatment. But what I think, in a 
sense we set this up for ourselves, because we expect them to come of their 
drugs and that is what they say, but in fact that isn't the truth half or even a 
quarter of the time. If you can find out what is really going on and it is 
honest, then we've got something to work on. 
Yes, of course, for instance what happens in the DDU, there are strict rules, 
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you have got to be stable in three weeks, no drugs in urine,... And if the 
motivation is right that is fine, but if you haven't got it right, that's when it 
gets difficult for the client. Then they feel that they are not ready yet and 
treatment is failing, and they have the pressure of court cases, it is very 
frustrating... I mean, there is some change according to this Prochaska & 
DiClemente model, but most of the time it results in relapse. I think most of 
our clients are in a pre-contemplation stage, and they don't know it. They 
think they are going to change, but they are not. It is all about motivation 
really, we have got to be able to tease out their true motivations at 
assessment. Most people do not really know what they want, getting the 
script seems to be the only thing. We're not being judgmental, we're not 
saying no, they can't have a script, but perhaps the treatment we are offering 
is not the best solution. We really need to make the person see their real 
motivations for themselves, and that can be a long-winded process. Direct 
questions need to be asked, it is more positive for the person. We're not 
saying this is what you get and if you are not happy with that, out you go. " 
(C) 
D) Treatment outcome 
Lack of knowledge of outcome studies and outcome measurement emerged. Outcome 
measurement was felt as if it was some thing not connected to routine clinical work. 
The general expectations of outcome seem to be very low and this may be reflected 
in the views of outcome measurement. 
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"I think it's important that there is follow up and that treatment gets assessed 
and there are these indicators to say what is going on and the way to go 
forward, I think that's important, but I don't really know any outcome 
studies... 
As I said, I don't have any real experience with outcome studies, so my views 
about it are quite theoretical... it' sa good thing... " (B) 
"Most of them are only interested in getting a script and getting the 
methadone. I don't think they have a sense of a long-term treatment outcome 
generally. Getting the script is foremost in their mind, getting it as soon as 
possible. And probably because they need to do it for some reason, like they 
have another court case pending or need to prove to somebody else that they 
are doing something. There is probably, whilst your assessing them, a point 
where they think that they really ought to make some changes, but getting the 
methadone script is most important, because of court cases or whatever. " (C) 
E) Views about the PDOQ 
The ease of use of the PDOQ was highlighted, but it was contradicted by comments 
about its lack of sensitivity, limitations of its scope, its inability to get a fuller 
picture. 
"Well, the work involved seems, it can be done quite quickly. It's very 
quantitative rather than qualitative, it might give you a rough picture of what's 
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happening to a client, there is no way to qualify answers really. There are 
only answers as yes and no, which makes it quite simplistic really. You could 
complete it in a few minutes... there is resistance to doing lengthier work... " 
(s) 
"Measures like the Plymouth are not really subtle enough to access all these 
layers. In a sense, it is a tool, it is a way of doing it with some definite 
markers and steps, but it doesn't really allow for the human element. People 
are vastly different. It is also a tool for psychologists. It is all very well us 
sitting here and saying they should be doing this or that, while they have been 
using for twenty years. Perhaps personality tests might be more useful..., 
psychological addiction is where it's really at, you could deal with physical 
addiction quite easily. We'd like to think that we address this in our 
treatment, but I'm not sure whether we really do. It all depends on the person 
who is working. Unless they get a lot of supervision and education..., some 
people don' t agree with that, some even have philosophical arguments why 
you shouldn't do that. But there doesn't seem to be a common philosophy... " 
F) Alternative methods of measuring outcome 
The usefulness of an objective researcher evaluating outcome as an alternative method 
to proposed method was expressed. A multidisciplinary assessment and outcome 
measurement system to obtain a better picture also emerged as a suggestion. 
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"I would find it more useful if the researcher was to meet with the client at 
different stages, maybe at regular intervals, to see what they want, are they 
getting what they want, to get more information about that... and also to see 
after treatment, how are people doing after treatment, what were there views 
while they were receiving treatment, could it have been better,... 
Rather than giving the clients set questions to answer or questionnaires to fill 
in, researchers could perhaps listen to the story the client has to tell, let the 
initiative come from the client, rather than looking at what the researcher 
wants to find, what's important for them 
... 
The users voice is never really 
asked for 
... 
" (B) 
"A multi-disciplinary team is very good, and people with different skills, and 
then an assessment gets done, that would give a much better picture. " (C) 
G) The need for an information system 
The need for an information system for the service for assessment and outcome 
measurement emerged. Differing views of its functions were expressed eg. to match 
clients to staff. 
"Particularly in terms of matching key workers with clients. I mean, and this 
is not a criticism, people's approaches in terms of assessment are wildly 
different, there is no consistency, some work more psychologically, and in 
this sense it would be good to be able to look at clients and match them with 
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the best key worker for them. " (C) 
H) The lack of direction of the service 
The importance of a coherent philosophy of treatment for assessment and outcome 
measurement was commented upon. 
"I also feel that lack of direction in services is extremely important. Drug 
services almost sprang up here and there, and there is not really a sense of a 
unifying, common goal.... " (A) 
I) Causes of drug use 
Childhood trauma and disruption are seen as common causes in the development of 
drug addiction. Therapy to resolve these issues are seen as real treatment. 
"I accept there are common causes, one of the things I look at in social 
history is where they grew up. A huge number have been raised in children's 
homes, a huge number have a history of violence at home and sexual abuse, 
these are very common to our patients. Therefore, I feel that a lot of them 
self-medicate with their drug use to cover up psychological pain, whereas if 
psychotherapy was freely available, they might not have done so. It is also 
a catch-22 situation: psychotherapy could now be beneficial to address that 
emotional pain, but it is questionable whether they could benefit from therapy 
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while intoxicated. I would like to see that change... " (A) 
J) The disease model and addiction 
Paradoxical views about the model that is assumed to underpin treatment in the unit 
emerged. The comments covered a whole range of models from biological, 
psychological, neuro-adaptational, psychoanalytical, to sociological models. This 
highlights the confusion that is around models that underpin treatment approaches. 
"I would say it is a 'dis-ease model', but not for conventional reasons. What 
most people mean that there is something pathologically ill, or genetic or 
predisposition, which means people do not have any control over their use, I 
do not believe that about substance misuse. I see it as a disease process in the 
sense that the medical profession can do something to help the disease, and 
one of the main things we can do is to show our clients that they do have a 
power. I feel that one of the difficulties in working with substance misuse is 
that to a certain extent it is glamorised. One of the problems of medicalising 
substance misuse is that it is too easy to assume traditional medical power 
dynamics with the patient. We place far too much emphasis on our own self 
importance, which is 'de-skilling' to patients, as after two months we expect 
vast improvement, as if we are these God-like creatures who during an hour 
a week will convert your life from pain and distress to a drug-free existence. 
No, no, no 
... 
you will make those changes, with all the help we can muster 
along the way, but I am not going to punish you for not completing your 
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treatment or for missing a session. Often, people are employed in this field 
to work without looking at their true qualifications, people who are perhaps 
good nurses but not specifically trained to counsel patients. There is no 
evidence whether an extensive amount of counselling even works in that 
sense, and yet we insist that it is part of the treatment program. Our patients 
say, what I would actually like is to be able to have a steady supply of 
methadone so I don't have to score eight times a day and inject eight times a 
day. I don't feel able to now investigate my reasons for using... 
We have this odd double standard about patients. On the one hand, we say 
they are not socially skilled, badly educated, 
... 
but then we provoke them with 
a punitive regime. One positive urine test and you're out, etc. And then they 
become angry and violent, and we say, you're not respecting the boundaries, 
and you're out again. Arguably a lot of patients started using because they 
wanted to escape such a harsh regime in their social context, and when they 
want to get away from it, we offer them exactly the same conditions... it's all 
wrong... " (A) 
4.4 Discussion 
The main findings of the study can be summarised as follows: 
i) The PDOQ is an instrument that can be used to measure outcome in a busy 
clinical service. It shows sensitivity to change. It is easy to administer and 
takes approximately 4 minutes to administer. 
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ii) It was not possible to validate the PDOQ using a case note template. 
Negative correlations between case note scores and PDOQ was found. This 
cannot be taken as a reliable result because of the quality of the entries in the 
case notes and a lack of a predetermined framework for entries. 
iii) The PDOQ failed to be validated in relation to objective criteria of drug 
urinalysis. 
iv) Significant changes in outcome following treatment was measured by the 
PDOQ. These changes were in line with clinicians experience and confirms 
that the PDOQ is sensitive to change. 
v) The predictor measures used failed to predict outcome, with the exception of 
the RCQ pre-contemplation scale which predicted dropping out of treatment. 
vi) Relationships between the outcome measures were found which is of clinical 
and theoretical interest. 
vii) Staff, whilst finding the instrument easy to use and of practical use, showed 
ambivalence about using the PDOQ routinely, and about measuring outcome 
in general. 
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4.4.1 The PDOQ 
The results of the study supports the claims made by Hassard (1994) about the ease 
of use of the PDOQ and the time taken to administer it in busy clinical settings. The 
results support claims of its clinical acceptability and practical nature, compared to 
the OTI (Darke, et al., 1992). The results also support the claims of psychometric 
properties, in that it can measure change. The changes in the total outcome scores 
between initial assessment, six week, and three month assessments, are in keeping 
with general clinical impressions, and previous studies on similar populations (Finch 
et al., 1995). The highly significant changes in total outcome scores between the 
initial assessment and six week assessment is in keeping with the treatment goal of 
stabilisation following commencement of treatment. This supports the claims of high 
face validity of the instrument. 
The present study failed to demonstrate the validity of the instrument against the 
objective measure of urinalysis results. Urinalysis, inspection of injection sites, and 
measures of physical health, are among the few non-reactive (objective) measures 
available to measure treatment outcome in this area (Ziebland and Rogers, 1994). 
Other measures relies on self-reports or observations by clinicians, both of which can 
be subject to bias. Validation against a hard measure such as urine test results would 
have lent credibility to a measure of clinical impression and observation such as the 
PDOQ. It can, nevertheless be argued that, urinalysis is a measure of drug use, 
which is one of seven outcome domains measured by the PDOQ. The maximum 
composite score of 20, has 3 drug use items. The majority of the PDOQ items 
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measure harm reduction and stability. The expectation of a reduction in drug use in 
opiate users within three months of commencing treatment may be seen by some 
clinicians as optimistic. On the other hand within services there is a strong 
expectation from patients to achieve this outcome. It is the policy of the service in 
which the study was carried out, that clients are expected to 'stabilise' and achieve 
a reduction in drug use within a six week period. This outcome is to be demonstrated 
by urine test results. It is also the policy of the service to progressively reduce the 
prescription of substitute opiates. The results of the study indicates that a progressive 
reduction of methadone prescription takes place, despite a lack of reduction in drug 
use. It appears that the PDOQ measures stabilisation being achieved by patients as 
a result of treatment, but not a reduction in drug use. The relevance of validation of 
a composite instrument by objective measures is questioned here. 
The validation of the PDOQ with case note entries yielded paradoxical results. A 
significant relationship was found but it was in the opposite direction to what was 
expected. In the absence of an institutional framework (template) for outcome 
measurement within the service, following the initial assessment, entries in the case 
notes by clinicians, in general, focus on major events or changes. Subtle changes in 
the outcome domains over a three month period is unlikely to be recorded. The 
expectation that the PDOQ domains would be captured from the case notes, in the 
existing clinical culture, was not justified. 
Further validation of the PDOQ, in addition to the measures used above, should be 
made against another validated instrument such as the OTI. 
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The feed-back from staff, clearly indicated that the use of the PDOQ was more 
acceptable than an outcome measurement framework based on the OTI (Chapter 3). 
In general they found it easy to use and practical. The lack of sensitivity of the 
measure, requiring all or nothing, yes/no, answers was commented upon by the 
majority of the staff participating in the study. Staff felt "frustrated" that one or two 
lapses in injecting or drug use, which seem a considerable improvement on a patients 
previous level of functioning could not be taken into consideration. Staff were 
expressing a preference for a rating scale. The problems involving the use of rating 
scales and the limitations of the ASI (Darke, et al., 1992; McLellan, et al., 1980) due 
to this factor was discussed in Chapter 1. The OTI, which was designed to overcome 
the problem, is seen by clinicians as being too elaborate and not practical to be used 
in busy clinical settings; on the other hand, a practical measure designed to meet 
clinical needs is seen as too insensitive. Perhaps, the two methods evaluated in this 
study represent two extreme positions and a more flexible measure needs to be 
developed. 
Staff also made a number of suggestions to change to change the phraseology of the 
PDOQ. The addition of a number of other domains was also suggested. The results 
of the study provides sufficient information to further develop the measure. 
Staff attitudes towards using the measure routinely, despite rating it as easy to use, 
showed a great deal of ambivalence. Attitudes towards outcome measurement in 
general were found to be very mixed. Unless staff see a positive benefit to their 
clinical work and patient care from routine outcome measurement, it is unlikely to be 
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adopted in clinical settings. This issue will be discussed further in Chapter 5. 
Incorporating an outcome measurement system, with an assessment system, in 
conjunction with a clinical information system, can be suggested as a possible way 
forward. 
4.4.2 Other outcome measures 
The use of urinalysis and case note analysis to validate the PDOQ was discussed 
above. The trends observed in these results are of interest in it self. These trends 
include increase in impure urine scores between six weeks and three months and no 
change in case note score during that period. These results paints an accurate picture 
of what goes on in treatment. These results have to be viewed in relation to the 
treatment objectives of the service. If clinicians were to get regular feed-back on 
these and trends in other outcome domains, on a regular basis in a graphical form, 
for example by a clinical information system, it could have the effect of clarifying 
treatment objectives and delivery. 
The mean dose of methadone prescribed showed a decreasing trend between the initial 
dose and the subsequent measures. This is an expected trend and is consistent with 
the policy of the clinic. It was noted earlier that a corresponding reduction in illicit 
drug use was not achieved. This indicates that detoxification or progressive reduction 
in substitute prescription is the background treatment philosophy in the service. The 
expectation of the outcome of a reduction in illicit drug use is not supported by 
treatment outcome data from the USA, where it has been demonstrated that only 
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'maintenance' at an appropriately high level of substitute prescription achieves this 
outcome (Dole and Nyswander, 1965; Ward et al., 1992). 
4.4.3 Outcome predictor measures 
The enigmatic result of this study was that none of the predictor measures used, with 
one exception, predicted outcome. On the face of it the results are counter to the 
hypothesis surrounding the various measures used. More detailed analysis of the 
results paints a different picture. 
The Readiness to Change Questionnaire (Rollnick, et al., 1992) was developed to 
measure motivation for change with problem drinkers and was predictive with 
outcome. This questionnaire was adapted for use with drug users in this study. 
There are no published studies of use of this instrument with drug users. The results 
of the various scales in the RCQ showed expected trends, with most participants 
scoring higher on the contemplation and action stages than the pre-contemplation 
stage. The scores of the contemplation and action stages were similar and this is 
consistent with findings in a recent study with the alcohol version of the questionnaire 
(Budd and Rollnick, 1996). The result that a high pre-contemplation score predicted 
dropping out of treatment is a validation of that scale. The finding that contemplation 
and action scores did not predict better outcome in this study needs explaining. There 
are a number of possible explanations. One possibility is the questionable validity of 
the measure being adapted for use with an opiate using population. The relationship 
between motivation and treatment outcome, with this population may not be as 
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suggested by the stages of change model (Prochaska and DiClemente, 1985; 
Prochaska, et al., 1992). 
It is possible that the results can be explained in terms of the primary focus of the 
measure when taken at entry into treatment. Motivation to change drug use is the 
primary focus. The significant changes in outcome measured by the PDOQ was in 
areas other than in drug use. The outcome of treatment in terms of a reduction in 
drug use was not achieved in the three month period of the study. The weak 
relationship between the contemplation and action scales, and the change measured 
by the PDOQ, will be entirely consistent with the predictions of the scales. The 
clients scoring high on the contemplation and action stages remaining in treatment 
compared to clients scoring high on the pre-contemplation scale can be interpreted as 
confirming the predictive validity of the RCQ. A significant reduction in drug use 
in three months after commencing treatment by opiate users may be viewed by some 
clinicians as an optimistic expectation. A longer period of follow-up is needed to 
establish whether motivation at commencement of treatment predicts the ultimate 
achievement of treatment goals in opiate users. The validity of the structure of the 
RCQ and the stages of chänge model has been recently questioned (Budd and 
Rollnick, 1996; Sutton, 1996). The pattern of correlations between the scales found 
in the study, with significant negative correlations between pre-contemplation and the 
other two scales, supports the structure of the measure. It can be argued that on the 
whole, the results of the study confirm the validity of the adaptation of the RCQ for 
use with opiate users. 
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It is assumed that a stage of change is relatively stable and will remain so throughout 
treatment. This assumption has been challenged by Sutton (1996) and Budd and 
Rollnick (1996) who argue that responses denoting a particular stage is not stable and 
that clients fluctuate along a continuum of motivation in terms of readiness to change. 
Further research is needed to establish the relationship between stages of change and 
treatment outcome in opiate users, particularly to establish the stability of the 
measure. The latter can be achieved by repeating the RCQ at follow-up intervals. 
The severity of dependence measure was the other standardised measure used in the 
study. The result obtained showed that the scores were comparable with that of a 
London heroin using sample used to standardise the measure (Gossop, et at., 1995). 
There are no published studies linking the SDS measure with treatment outcome. It 
was hypothesised that higher SDS score to be negatively correlated with positive 
outcome. This was not supported by the findings of the study. The arguments 
regarding the focus of the assessment can be applied to explain this result. This 
measure focuses particularly on the dependence on drugs, and the outcome of 
treatment in the period under consideration did not achieve a reduction in drug use 
as measured by objective criteria of urine results. 
Expectations of treatment have been found to be an important factor influencing 
outcome in areas in mental health. There has not been much investigation of this 
factor in relation to addiction treatment. The rationale and process of the 
development of an expectations questionnaire, and it's psychometric properties was 
discussed in Chapter 2. The utility of such a measure is its predictive validity in 
206 
terms of outcome. This was tested in the present study. The results of the multiple 
regression analysis failed to show a significant link between this measure and 
outcome. The hypothesis that higher expectations scores will predict better outcome 
was not supported. The argument that the focus of the measure is on drug use cannot 
be used here since it has items on a broad range of outcome domains. Further 
research is needed to test the measure's validity over a longer period of time and its 
stability by repeating it at regular intervals. The relationship of this measure with 
other measures used is of interest and will be discussed in the next section. 
The dissonance questionnaire is being developed to measure the severity of addiction 
from a psychological perspective, independent from the avoidance of withdrawal 
conceptualisation. It is based on the work done by Orford (1991) and was adapted 
for use with opiate users. The questionnaire is in early stages of its development and 
was used in the study as part of this process. A negative but significant relationship 
with outcome was hypothesised. The failure to show a significant relationship with 
outcome in the present study could be due to the properties of the measure or the 
sensitivity of the outcome measure. Further research is needed to establish the utility 
of this measure. 
The relapse questionnaire was developed as a simple measure of self-efficacy based 
on Marlatt and Gordon's (1985) taxonomy of high risk situations. The participants 
in the study showed a mean confidence score of 50% which is not a high. The 
profile of the patient sample shows that they were a severely dependent sample who 
had a long history of drug use. Hence it can be expected that their confidence as to 
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the outcome of treatment was be very high. A 50% overall confidence level may not 
be high enough to be linked to positive outcome. 
4.4.4 The relationships between the outcome measures 
Correlational analysis between the measures showed a number of interesting 
relationships. These relationships are of theoretical interest in a number of conceptual 
spheres in the field of addictions. 
The participants' responses to the Dissonance Questionnaire (DQ) and to the Severity 
of Dependence Scale (SDS) showed virtually no relationship (correlation coefficient 
=-. 01). The DQ is based on a measure that was designed to measure psychological 
attachment to the addictive behaviour or degree of dependence from a psychological 
perspective (Orford, 1991) and the SDS was designed to measure 'the degree of 
psychological dependence' (Gossop et al., 1995). It can be argued that the SDS is 
based on the withdrawal relief model of dependence and that it has been validated 
against the SODQ, a measure based on the same model (Sutherland, et al., 1986) and 
that the DQ was designed to measure dependence from an alternative model of 
addiction. The finding can be interpreted as supporting the arguments for alternative 
conceptualisations of addiction: psychological dependence based on physical 
dependence and psychological dependence based on positive reward frameworks. On 
the other hand, with problem drinkers Orford (1991) found significant correlations 
with a version of the Dissonance Questionnaire and the Severity of Alcohol 
Dependence Scale (Stockwell et al., 1979). Orford (1991) also found deferential 
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correlations with different clusters of items in the Dissonance Questionnaire. The 
question whether findings from problem drinkers can be generalised for opiate users 
regarding alternative models of dependence needs to be answered. It is clear that this 
area needs further research and has the potential of extending our understanding of 
the nature of psychological dependence. 
The SDS was significantly positively correlated with the EQ. This indicates that the 
higher the severity of dependence, the greater the expectations of treatment. This is 
in general consistent with clinical observations. The utility of both these measures 
is in its predictive validity. Nevertheless, this finding has some clinical implications 
that was picked up on by the qualitative. interviews with staff. It appeared that staff 
anticipating this high expectation, intervene to manage those expectations, so in 
essence reduce expectations of treatment. It appears that staff were keen to establish 
'realistic' expectations. This is in keeping with providing a community-based 
outpatient service, where the availability of drugs and negative social influences are 
predominant. It would be a different scenario in an inpatient or residential setting. 
It is possible to argue for the utility of the combination of the two measures in 
assessing patients for suitability for treatment in such settings. Predictive validity in 
terms of outcome in different settings needs to be established by further research. 
Significant negative correlations were found between the DQ, the RQ, and the action 
scale of the RCQ. This relationship is consistent with the theoretical frameworks of 
the three measures. The DQ was designed as a measure of psychological attachment 
to the addictive behaviour. It can be expected that the higher the level of attachment, 
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the lower the level of self-efficacy to maintain changes regarding the addiction. The 
negative correlation with the action scale confirms the picture. This finding also 
points to a link between motivation and self-efficacy. The link between the two 
measures is further confirmed by the significant positive correlation found between 
the RQ and the action scale of the RCQ. 
The changes in the predictor variables during the course of treatment may also throw 
further light on how these factors interact. Investigations are needed with these 
measures using them as both dependent and independent variables. This would 
undoubtably expand our understanding of the process of treatment. 
4.4.5 The staff evaluation 
The results of the evaluation of the use of the PDOQ from a staff perspective have 
a number of important implications. The results clearly indicates that, compared to 
the OTI, the PDOQ is definitely more acceptable to staff, who in general found it 
practical and easy to use. Despite its ease of use the staff interviewed felt that given 
the choice they would not use it routinely. Most staff felt that the process of filling 
in a form, although it took less than 5 minutes to do so, was an added burden and did 
not see any real benefit for their work. The staff felt that outcome measurement was 
a demand that came from outside or it was for research purposes. They expressed 
a feeling that they had a sense of how their patients were progressing. 
Clinical review meetings were thought to be the most beneficial method of tracking 
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progress to the staff and for the patient. Care planning was a process close to the 
clinical review process and this was seen as the best measure of outcome. An outside 
researcher Interviewing staff and patients was seen as an alternative method of 
measuring outcome. 
Staff expressed a sense of inevitability that a system of outcome measurement would 
be imposed upon them from outside. There were only a few members of staff who 
expressed any enthusiasm for the process. 
4.4.6 Qualitative interviews 
A number of themes of specific and global importance emerged from the in-depth 
qualitative interviews. These will be discussed in the next chapter. 
The results indicate that unless a clear shift in staff attitude is achieved, a system of 
outcome measurement (how ever simple and practical) will not be taken on aboard 
by staff. It is suggested that one of the main barriers to outcome measurement is the 
confusion regarding the philosophy of service provision discussed in Chapter 1. 
When there is confusion about the objectives of treatment, whether its aim is 
abstinence or harm reduction, it seems inevitable that staff feel resistant to look at the 
effects of their interventions. This issue will be discussed further in the next chapter. 
One possible solution to make a framework of outcome measurement into part of 
routine work, may be its incorporation into a clinical information system with which 
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clinicians have to interact in their daily work. If such a system gives feedback about 
client progress by pressing a button, this is likely to be reinforcing to staff. This 
solution will also be explored further in the next chapter. 
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Chapter 5 General discussion 
5.1 Summary and implications of results 
The main aim of the project reported in this thesis was to investigate outcome 
measurement in the treatment of opiate addiction. Three studies, one reporting the 
development of an outcome predictor measure and two evaluating different outcome 
frameworks were, reported. All studies utilised a pluralistic methodology using both 
quantitative and qualitative approaches. The results and their implications were 
discussed in each study. This chapter links the findings of the three studies and looks 
at their wider implications. 
The key findings of the studies can be outlined as follows: 
i) The OTI was not suitable for use with a British population without 
modification. 
ii) The OTI is not suitable for routine clinical use in busy clinical 
settings. 
iii) The OTI is not acceptable to clinical staff as a routine measure. 
iv) The OTI is best used as a research instrument. 
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v) The PDOQ was accepted as suitable for routine clinical use as a practical 
measure. 
vi) The PDOQ is sensitive to change in measurement domains. 
vii) The claims made by the developers of the PDOQ are confirmed. 
viii) The PDOQ's lack of sensitivity was seen as its major limitation. 
ix) Despite the PDOQ's ease of use and general acceptability, staff expressed 
ambivalence about using it routinely. 
x) Staff perceptions and attitudes regarding outcome measurement is a major 
obstacle for implementation of routine outcome measurement. This needs to 
be further investigated and interventions with staff needs to be developed if 
outcome measurement in this area is to be taken further. 
xi) There was poor outcome regarding reduction of drug use. 
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xii) There was general consensus regarding the outcome domains included in the 
two measures as relevant domains, with suggestions for further domains. 
xiii) Case reviews emerged as a method of outcome measurement preferred by 
staff. 
xiv) Case note analysis was not a reliable method of outcome measurement. 
xv) Computerised information systems are essential for maintaining a framework 
for assessment and outcome measurement. 
The service in which the study was carried out can be considered to be fairly typical 
of a large inner city Drug Service in the U. K., hence the findings from this study 
could be generalised to similar services and smaller services in the country. 
5.2 Assessment and outcome measurement 
The key factors influencing assessment and outcome measurement in the field of 
addictions were described in Chapter 1. They were, to reiterate, a) theories and 
models of addiction, b) goals of treatment, and c) aims of service provision. The 
findings from the studies in this volume needs to be discussed within the context of 
these factors. 
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5.2.1 Theories and models of addiction 
The results indicate that the service operated within a 'biopsychosocial' disease 
model. It appeared that within this umbrella there was considerable variation in how 
staff understood addiction and where the emphasis on treatment was placed. This was 
particularly evident in the in-depth qualitative interviews. Whilst the 
'biopsychosocial' framework is 'holistic', and attempts to avoid reductionist 
formulations, it can also contribute to a lack of focus in the approach to treatment. 
This is in contrast to treatment centres such as 'concept houses' where there is a 
narrow focused or traditional disease model as a basis for treatment. The diversity 
of focus has implications for assessment and outcome measurement. In this and other 
similar services it may be necessary to outline the model, its assumptions and 
treatment objectives before a framework of assessment and outcome measurement is 
introduced. This would also enable individuals from different professions and 
different skills to state explicitly what they do and why they do it. 
A staff participant alluded to this in a context of matching clients to staff, according 
to the skills the staff member possesses. This happens in services by default or by 
internal referral. The internal referral process may happen between different 
professions, but is rare within professions. 
If the underlying model adopted by either a professional group or individual staff is 
made explicit, then the assessment process can take this on board. Under such 
circumstances outcome measures can be set accordingly. The motto here will be 
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'clarity of model leads to clarity of treatment objectives which leads to clarity of 
expected outcomes. The general ambivalence to outcome measurement that the 
results indicate may stem from the lack of clarity described above. 
It can be recommended as an intervention that a clear statement regarding the 
underlying model of treatment provision (in this service the 'biopsychosocial' disease 
model) is made available to all staff and is introduced as an essential element in the 
induction of new staff. Staff placing different emphasis in their work within this 
framework for example physical health, relationship issues, psychological problems 
etc, should be encouraged to explicitly state their rationale for working in such a way 
and communicate this to other staff and clients. They may be even encouraged to 
defend their way of working. Similarly, if there are members of staff who subscribe 
to an entirely different model to the broad medical model then they should be asked 
to defend their approach. This is particularly relevant when recruiting new staff. If 
the model that underpins the service provision is made explicit, this can be stated 
when interviewing new staff and if a candidate has a different approach, questions can 
be asked as to how their approach may complement or conflict with treatment 
objectives of the service. 
5.2.2 Goals of treatment 
Following on from the points made above, the next level down from the overall 
theory or model of treatment is the issue of goals of treatment. Within a model of 
treatment there is a possibility of a number of goals of treatment. These could be 
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categorical goals (abstinence vs harm reduction or abstinence vs reduction of use) 
temporal goals (short term, medium term and long term outcomes) or a combination 
of both. The importance of goals of treatment to outcome measurement was 
discussed in Chapter 1 and needs to be reiterated here. This is a fundamental factor 
in outcome measurement and although this is obvious, this fact is rarely made explicit 
in the outcome literature. Unless there is clarity as to the expected outcomes of 
treatment in relation to the goals of treatment, the criteria for measuring outcome 
cannot be set. The heterogeneity of outcome criteria reported in reviews 
(Charuvastra, et al., 1992; Ziebland and Rogers, 1994), can be attributed to lack of 
clarity on the goals of treatment. In the field of addictions, particularly in the 
treatment of opiate addiction, goals of treatment take a temporal perspective: 
treatment goals become short term, medium term and long term. If outcome 
measurement is to be relevant, then outcome criteria needs to be set according to 
these goals. The phases of care approach to the treatment of opiate addiction 
(Moolchan and Hoffman, 1994) is an example of temporal treatment goal approach. 
Nevertheless, outcome criteria for each phase of this approach are not clearly defined. 
The results of the staff feed-back aspects of the studies clearly indicate that there is 
a great deal of confusion about the goals of treatment as well as the aims of service 
provision which will be discussed in the next section. Both direct and indirect 
statements refers to the lack of clarity surrounding the goals of treatment. It can be 
argued that reluctance of or resistance by staff with regard to measuring outcome is 
based on this fundamental issue. In the absence of a coherent explicit treatment goal 
statement from the service, individual members of staff are free to follow their own 
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goals for the treatment they provide. It can be argued that clients set the goals for 
their treatment and not the staff or the service. There is some strength in this 
argument, but on the other hand it can be pointed out that exactly the opposite is true. 
Following assessment of clients it is staff who decide (according to the prevalent 
wisdom on levels of methadone prescription) how much substitute methadone a client 
should have: the client has little or no say in the matter. Clients often try to influence 
this situation by exaggerating the amount of street drugs they are using. Different 
members of staff with different emphasis on goals of treatment in the continuum 
between abstinence and harm reduction, would look for different outcomes. The 
results of the study shows that this is indeed the case. The results show that the 
majority of staff favour harm reduction as a treatment goal. The positive outcomes 
measured in the PDOQ with an increase in composite scores were largely made of 
indices of reducing drug related harm. The reduction of illicit drug use as measured 
by urine test results showed no change. At the same time the overall levels of 
prescribed methadone were reduced. This paradoxical situation sums up the 
confusion regarding treatment goals that prevails in the service. The progressive 
reduction in levels of prescribed methadone is the basis of detoxification which is the 
hallmark of abstinence orientated treatment. Increase in the levels of methadone until 
a level of stability is achieved and subsequently maintaining that level of prescription 
is the basis of methadone maintenance which is the hallmark of treatment aimed at 
harm reduction. It appears that the service policy or preset treatment programmes 
are implemented as if they were abstinence-oriented, whilst the majority of the staff 
feel their work is aimed at harm reduction. It is not surprising that the staff are 
reluctant to look at outcome in a systematic and objective way as this may require 
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them to confront a fundamental conflict in their work. A further study should survey 
staff in the service to find out what their preferred treatment goals are and their 
preferred way of working with their clients to achieve these goals. Clear statements 
on short term, medium term and long term goals, clear statements on each temporal 
band and expected outcome for each temporal band are recommended as an 
intervention following from the results of the study. 
5.2.3 Aims of service provision 
This is the third factor effecting assessment and outcome. In Britain broad guidelines 
for treatment provision are laid out by Advisory Council on the Misuse of Drugs 
(ACMD) and the Department of Health (DoH) periodically. Overall national health 
targets set out by the DoH also encapsulate opiate users, for example reduction in 
sharing needles. Individual services make decisions within a national context as to 
what services or treatment hey will provide. There has been some flexibility around 
what treatments, services would provide for drug users dependent on the 
demographical features of drug users in the area, the epidemiological picture, 
traditions of the particular service and the skills and expertise of the clinicians. In 
many services treatments provided for opiate users were a result of the pioneering 
zeal or vision of lead clinicians, usually a consultant psychiatrist. The internal market 
in the health service has in effect introduced restrictions to the flexibility of service 
provision to opiate users. The development of purchasing guidelines involved the 
purchaser (Health Authority) specifying what treatment for how many it is prepared 
to fund. Service development and the provision of a range of services have to take 
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place within the funds secured to provide services for drug users in the area. In some 
areas different services secure funding to provide different treatments to drug users. 
Each service has to decide on the range of treatments or services it provides for 
opiate users. Initial assessments are influenced by what treatments are available in 
the service, because information gathered is used to make clinical decisions regarding 
matching patients to the available treatment. This necessitates service specific 
assessments. Hence, general or national assessment instruments such as MAP 
(Gossop, 1996) may have limited utility. It was discussed in Chapter 1 that outcome 
measures have to be linked to assessment. If there is to be sensitive and relevant 
outcome measurement then it not only has to relate to treatment provided, but also 
to the approach to treatment of that particular service. The results of the studies have 
a number of implications for the issues covered in this section. 
The nature of the service, its complexity and the stability of certain programmes of 
treatment indicated that the use of the OTI, although by far the more sensitive and 
comprehensive instrument, was still not feasible. The pressure from purchasers to 
see more patients limits the time available to carry out detailed outcome 
measurement. Staff who feel under pressure already invariably saw outcome 
measurement as an extra demand. The results indicate that in busy services like that 
where these studies were carried out, the use of the OTI or similar instrument in 
routine clinical work will not be appropriate. It may however, have a place in the 
evaluation of specific interventions if the outcome measurement is carried out by 
dedicated researchers. 
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The range of services provided and the perception of a general lack of clarity about 
the philosophy of treatment made staff feel that general outcome measurement was 
irrelevant and the most appropriate measure of outcome was individual case reviews. 
There was an ethos in the service of tailoring treatment to the individual patient; 
whilst this basic philosophy is not challenged, the resulting confusion or lack of focus 
as to what treatment an individual is receiving is questioned. The observed resistance 
to generic outcome measurement may be in part attributable to this factor. Finding 
standardised treatment or programme specific outcome measures is a possible solution 
to this problem. 
5.2.4 The framework of assessment and outcome measurement 
The evaluation of the OTI and the PDOQ was carried out by utilising the framework 
for outcome measurement suggested by Moos and Finney (1983), which was 
discussed in Chapter 1. Information is gathered in a preplanned manner from 
assessment o discharge, with periodic and systematic reviews or remeasurements. 
It was clear from the analysis of case reports that such a framework did not exist in 
the service. Aspects of such a framework did exist, which was the assessment 
component. This aspect was well developed and was functioning to fulfill 
requirements of clinical decision-making and other external information (Chapter 3). 
Components to measure outcome or review clients was clearly lacking. The 
validation of the PDOQ by corroborating the reported changes with case note entries 
was clearly not possible. In the absence of an infrastructure or framework, staff only 
record major changes or incidents and not subtle changes in the various outcome 
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domains. If the outcome domains were specified, say in case note sheets, this might 
prompt staff to comment on patients' performance in these areas. Comments by staff 
on both the OTI and PDOQ studies indicated that they found the specificity of the 
domains helpful. The staff also found the framework helpful in 'tracking progress'. 
The findings do indicate that an installation of such a framework will be acceptable 
to staff and will be used by staff. The installation of a framework and its assimilation 
into the daily routine of the service will of course be enormously enhanced by the 
adoption of a computerised clinical information system. This issue will be dealt with 
in the next section. 
If a formal assessment outcome measurement framework is set up and it becomes 
integrated into the routine of the service, specific 'modules' relating to prediction of 
outcome (i. e. predictive measures) and programme or intervention-specific outcome 
measures could be added on where appropriate. This will give assessment and 
outcome measurement the flexibility that existing standard measures lack. This is 
clearly an avenue that measures for national use that are being developed (MAP) 
should explore. 
5.3 Sensitivity of measures 
The sensitivity of outcome measures emerged as an important issue in the study. If 
outcome measures are to become part of a framework where the measures will be 
repeated at regular intervals, then the sensitivity of the measure becomes a major 
issue. The lack of sensitivity emerged as a major limitation of the PDOQ. Most 
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staff felt that the categorical (0 or 1) responses required by the PDOQ meant that 
reductions in target behaviours or small but significant improvements could not be 
taken into consideration. On the one hand, the simplicity, ease of use and practical 
nature of the PDOQ makes it immensely suitable for use as a repeated measure in an 
assessment and outcome measurement framework; whilst its lack of sensitivity 
essentially makes it unsuitable. This problem has to be resolved if the PDOQ is to 
be used routinely, and further work is required to increase its sensitivity. If this 
cannot be achieved clinicians may have to consider using a combination of measures 
for example selected scales of the OTI and PDOQ routinely. This may not be such 
a difficult task if the measures are incorporated into an information system. 
5.4 Clinical information systems 
The results of the studies clearly indicate that one of the reasons why systematic 
assessment linked to outcome measurement is not common in clinical settings (despite 
demands from health care purchasers and other government organizations) is the 
demand on resources such a process creates. Extra time spent on interviewing 
clients, time required to fill out and process detailed forms (scoring questionnaires) 
and the need to repeat the process at regular intervals are some of the extra demands 
that may be placed on resources. Clinicians clearly indicated their concerns regarding 
this. Rigorous, realistic and routine assessment and outcome measurement in clinical 
settings will only be possible if the modern technology we have at our disposal in the 
form of information systems is exploited for this purpose. Development of 
assessment and outcome measurement systems, if they are to be of clinical utility, 
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must go hand in hand with the development of information systems and integrating 
them to clinical settings. 
It is possible to speculate that many of the problems regarding routine outcome 
measurement hat have emerged from the two studies can be resolved if appropriate 
information systems are developed. Currently there are only a few information 
systems available that are specifically developed for substance misuse services and the 
outcome measurement modules within these systems are not well developed. In the 
literature, there is only one report of a service using a computerised information 
system to measure outcome routinely in Britain (Namgauds, 1995). The development 
of the system and its acceptance by staff leaves room for optimism. This is an area 
where more research is needed and more resources allocated for developmental work. 
The development of new measures should go hand-in-hand with development of 
information systems. Instant and regular feed-back on how a patient is doing (that 
could be provided to clinicians) would not only act as a reinforcer, but has the 
potential of directly improving care, by encouraging more rigid implementation of 
interventions. 
5.5 Staff perspective 
The studies reported in Chapters 3 and 4 placed a great emphasis on the staff 
perspective in outcome measurement. This perspective is largely ignored in the 
literature on outcome measurement in the area (for example, Charuvastra, et al., 
1992; Harrison, et al., 1991; Ziebland and Rogers, 1994). Hassard (1995) is one of 
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the few researchers in this area who has looked at outcome measurement from a staff 
perspective. The 'bottom up' approach that was taken in the development of the 
PDOQ, meant that it was driven from a staff perspective. This is a rare example in 
this area. It can be argued that this is a serious oversight by researchers in this field. 
The general lack of outcome measurement in addictions treatment may be attributed 
to this factor alone. Unless clinicians can be persuaded that there can be benefits to 
their work from outcome measurement, it is unlikely that a system of outcome 
measurement, however sophisticated it may be, will be adopted and complied with. 
A number of variations of a theme of alienation of clinicians from the process of 
outcome measurement emerged from the qualitative aspects of the studies. 
"Outcome measurement is more relevant for research, not for routine clinical work"; 
"it is to do with financial considerations in the present climate 
- 
not about patient 
care"; "Outcome measurement is useful but it depends who we are measuring 
outcome for, is it for the clients or the purchasers? ", are some examples of the theme 
of alienation. The perception that outcome measurement is purely a product of the 
internal market, where the pressure is generated by purchasers, was very much in 
evidence. 
More research is needed on the staff perspective on outcome measurement. The 
findings of such research should contribute to the development of interventions to 
change attitudes and perception of staff regards outcome measurement. This work 
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needs to be done prior to implementation of outcome measurement frameworks to 
services. 
5.6 Limitations of the studies 
The studies reported in this thesis are examples of applied clinical research. There 
are inherent difficulties and drawbacks in doing research in clinical settings. It is 
inevitable that numerous obstacles emerge in the way of progress of such work. 
This itself can be looked upon as enriching as well as contributing to the research, 
rather than a negative feature. Scientific research must eventually lead to practical 
utility. Findings from pure research often encounter limitations when it comes to 
application in clinical settings. In the in the three studies reported here, conflicts 
between research objectives or the "research agenda" and priorities driven by service 
need emerged and influenced the process of research. The best example of this was 
the service need to find a expedient solution to the problem of outcome measurement. 
Despite its comprehensive nature and the published reports of its psychometric 
properties (Darke, et al., 1992), pursuing the original objective of fully evaluating the 
OTI was not possible because of the constraints put on the project by conflicting 
service priorities. The priority from a research perspective would have been allocate 
resources to pursue the research objectives. The need in the service to find an 
expedient method of measuring treatment outcome, influenced the researcher to seek 
a and evaluate a measure that was a complete contrast to the OTI. The PDOQ can 
be placed at the opposite end of a spectrum of outcome measures in comparison to 
the OTI. The choice of the PDOQ was largely based on the claims of the relatively 
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short time it takes to be administered and the expedience of interviewing staff 
compared to interviewing patients. From a research point of view this can be seen 
as a major limitation in the study. 
The tension between research and clinical practice agendas in it self is a subject of 
interest from a qualitative research perspective. The process of discovery and the 
factors that influence that process is largely ignored in a quantitative or positivist 
research perspective. Since the studies reported here intended to use pluralistic 
methodology, the failure of the researcher to keep a log of the research process can 
been seen as a major limitation of the studies. Researcher reflexivity suggested by 
Stevenson and Cooper (1997) as a means of bridging the gap or exploring the middle 
ground between quantitative and qualitative research could have been used here to 
describe the tension between research and practice agendas. If the researcher kept 
a log or a reflexive journal (Lincoln and Guba, 1985), it would have provided a 
narrative on the process of conducting the studies and how the conflicting priorities 
and tensions were resolved or accommodated, and would lend it self to external 
scrutiny. This would have helped to place the studies in context. 
A number of alternative approaches could have been adopted in carrying out this 
research. One approach of resolving the service need vs research tension would have 
been to develop a service relevant outcome measurement instrument, taking into 
consideration recent development in the field. This alternative would have had 
greater resource implications and would have produced another measure into the field 
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with limitations of generalisability. Such a measure would also have limited utility 
in comparative outcome evaluation. 
Another approach that could have been adopted was to use a parallel measure. This 
approach would have particularly enhanced the validation of the PDOQ. The ASI 
was used to cross-validate the OTI (Darke, et al., 1992). The choice of hard 
outcome measures selected for the study (Urinanalysis and level of methadone) and 
case note analysis failed to unequivocally validate the PDOQ. Not using a parallel 
outcome measure in the validation process can be seen as a major limitation in the 
PDOQ study. Future validation of the PDOQ should take this into consideration. 
Other limitations in each study are outlined below. 
A) Expectations measure 
The items of the expectations measure was developed from a qualitative study of 
expectations of methadone treatment (Dale, Jones and Power, 1992). The rationale 
used was to develop measures from client descriptions that would have salience with 
a clinical population. This method was preferred to a method whereby questionnaires 
are developed by generating a large number of items and then scaling the measure 
down by item analysis. The development of the measure may have benefited from 
using both approaches. There was confusion with regards to expectations of 
treatment and expectations of methadone. This is an unique problem dealing with 
opiate users where treatment may to some mean methadone. It may be necessary to 
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clearly differentiate between methadone and other aspects of treatment by clearly 
defining what is meant by treatment. This may explain the failure to find predictive 
validity of the instrument. Defining treatment in a service such as the one in which 
the study was carried out may not be an easy task. A client may receive a number 
of inputs from the service that may be seen as "treatment". These may include both 
chemical and psychological interventions. An input may not be discrete and clearly 
definable. For example, the milieu in which the treatment is carried out including the 
"atmosphere" in the waiting room can be seen as a treatment input that the client 
receives. Treatment that a client receives may not be stable or fixed and may have 
a dynamic quality dependant on the clients behaviour. A possible solution would be 
to give broad descriptions or vignettes of treatments such as counselling, group work 
and variable prescription of substitute drugs for the purpose of measuring expectations 
prior to such measures are taken. The number of participants used in testing the 
psychometric properties of the scale and the outcome study can also be seen as 
limitations. Future research on the measure should be carried out on larger samples. 
The validation of the expectations measure in terms of outcome is also limited by the 
fact that outcome was only looked at in a three month period. Longer-term follow 
up studies are needed to test predictive validity of such a measure. Further research 
into the construct of expectations as a predictor of outcome in addictions should look 
at different addictions. Comparative studies with the same measure may establish 
whether expectations of treatment of opiate addicts are different from treatment 
expectations of addiction to other drugs or problem drinkers. 
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B) Validation of the OTI 
The study involving the validation of the OTI was greatly limited by the small 
number of participants recruited for phase II of the study. The organisational changes 
within the service and the resulting de-stability of the treatment programmes meant 
that not only was intended evaluation of the two interim methadone programmes not 
possible, but sufficient number of participants could not be recruited to the study in 
general. This may be taken as a typical example of problems encountered in action 
research. The small numbers meant that it was not possible to validate the sensitivity 
to change of the OTI measures and carry out the intended validation of the predictor 
measures. The lack of British norms for the OTI is still an issue. The modification 
to the OTI that were made as a result of phase I of the study needs to be looked at 
to establish whether it has resulted in any changes to the psychometric properties of 
the OTI. This can only be done with a sufficiently large number of participants. The 
results of phases I and III of the study clearly indicated that the OTI was not suitable 
for use with a British population without modification. The failure of the present 
study to validate the measure with the changes means that this work needs to be done 
before it can be recommended for use with a British population. Given the practical 
difficulties of carrying out a validation of this measure in a single service, it is 
suggested that a consensus is reached by clinicians interested in using the OTI in 
Britain (Wilkes and Armstrong, 1996) with regard to the modifications, in 
consultation with the developers of the measure (Darke et al., 1991) and then carrying 
out a multi-centre small scale validation of the instrument so as to pool the data 
collected. 
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C) The PDOQ study 
This study too was limited by organisational difficulties within the service, although 
the intended number of participants were recruited to the study. The difficulties in 
the service meant that the recruitment phase took longer than intended and the follow- 
up period of the study had to be reduced from six to three months. A six month 
follow-up period may have clarified the sensitivity problem of the PDOQ and this 
enabled more firmer conclusions about the validity of the predictor measures. 
Further validation work on the PDOQ should involve larger numbers and a longer 
follow-up period, ideally a year to 18 months. 
The staff feed-back aspects of the study could be criticised on the grounds that staff 
may have shown reticence to express their views as the researcher was a senior 
member of staff working in the service. The results do not indicate a reticence on 
the part of the staff to express their feelings about outcome measurement. There are 
clearly no indications of socially desirable answers. Further investigation of staff 
views by using in-depth qualitative interviews carried out by an independent 
researcher can be taken as a step to address this limitation. There was no discordance 
between the views obtained by the two methods. Carrying out only three in-depth 
interviews can be criticised as resulting in a biased picture. Again the themes that 
emerged are consistent with those expressed in testing larger samples of staff. A 
larger study using this methodology with staff from different units is recommended 
to further investigate the staff perspective on outcome measurement. 
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5.7 Conclusions 
The results of the studies indicate that outcome measurement in the treatment of 
opiate addiction is a field that is in an early stage of development. The studies 
reported have identified a number of issues and areas that need further investigation. 
It has also in a limited way contributed to the extension of knowledge regarding the 
two measures investigated and factors relating to outcome measurement and 
prediction. It is hoped that this would contribute to larger projects that are being 
carried out nationally for example the NTORS study (Gossop, 1996), particularly in 
the areas of sensitivity of measures and staff perspectives. It is clear that success of 
the introduction of any national measures, will largely be dependent on the 
compliance of clinicians. Much work is needed to prepare the ground for such 
implementations within services. This has to be an urgent priority. The predictor 
measures, although of limited utility in predicting outcome, revealed a number of 
interesting interrelationships that need to be investigated more closely. Further 
development of these measures and further investigation into how they operate has the 
potential of illuminating the 'process' of treatment and 'behaviour change'. 
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CASE STUDY 
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Chapter 6 Development and evaluation of a new model of psychology service 
provision for drug users 
6.1 Background 
During the last two decades psychology, as a discipline, has undoubtedly made the 
greatest single contribution to the field of addiction and substance misuse (Orford, 
1992). It has led the move towards changing the key conceptualisation within the 
field from a disease-orientated approach to a global 'biopsychosocial' approach. The 
contributions made by psychologists have not only had a major influence in the 
conceptual sphere (for example, Gossop, 1989; Orford, 1985; Heather and Robertson, 
1985; Prochaska and DiClemente, 1983) but also span the areas of prevention, 
treatment, training and research. Key examples of this include, assessment of 
severity (Gossop, et al., 1995; McLellan, et al., 1980; Sutherland, et al., 1987), 
motivational interviewing (Miller, 1983), relapse prevention (Annis, 1986; Marlat and 
Gordon, 1985) and controlled drinking (Booth, 1990; Heather and Robertson, 1985; 
Sobel and Sobel, 1976). 
Considering the impact psychology has had in the field at large, in the United 
Kingdom at least, relatively few clinical psychologists appear to make the choice of 
working in the field (Sutherland, et al., 1992). This is despite two seminal reports 
from the British Psychological Society (BPS) outlining the potential contribution and 
roles psychologists can play in the area (BPS, 1984,1989). 
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A recent survey in the West Midlands showed that out of a total of 188 qualified 
psychologists only 3.9 WTE (2%) worked in area of substance misuse (Sutherland, 
et al., 1992). A number of hypotheses might be put forward to explain this. The 
general negativism that exists about individual's with addiction problems as a result 
of mass media reports of addictions emerging from the skewed portrayal of addictive 
behaviours in the media colouring public attitude towards the field, could influence 
decisions of individuals from various professions to enter the field. Recruitment 
problems are similar for other professional groups including nursing, medical, social 
work and occupational therapy professions as well as for psychology. Higher 
grading, faster promotion and specialist status are some of the strategies that have 
been used by the professions to attract staff to work in this area. 
Another factor that has undoubtedly deterred psychologists making the choice of 
working in the field is what might be called the 'generic worker' problem. 
Multidisciplinary teams developed an ethos of equality and a flattened hierarchy in 
the early 1980's. The introduction of multidisciplinary teams was a result of the 
acceptance of holistic care or the concept of treating the patient as a 'whole person', 
the application of a 'biopsychosocial' framework to patient care. In many areas, 
addictions being a good example, this was a move away from the disease or medical 
model of working. Nevertheless, the teams were largely led by the medical 
profession, usually a medical consultant. The vestiges of the old medical hierarchy 
undoubtedly prevailed resulting in a backlash (particularly by the nursing profession) 
aimed at flattening the hierarchy and shifting power. Perhaps some held the ideals 
of a democratic socialist model for running of the multidisciplinary teams. In 
Substance Misuse Services a strong culture of flattened hierarchy and generic 'drugs 
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worker' or 'alcohol worker' emerged: the power structure in some teams had 
changed. The focus of power had shifted from the medical to the nursing profession, 
the fact that the latter were the largest group in teams some times contributing to this. 
In non- NHS voluntary sector teams, inclusion of non-professionals in teams as drugs 
or alcohol workers also contributed to the consolidation of the generic worker culture. 
A paradoxical situation emerged where multidisciplinary teams (by definition offering 
different specialist skilled professional input to the patients) were unable to function 
as such, because of the demand to fulfill the generic function first. A relatively new 
and small professional group such as psychology with very specific skills found it 
particularly hard to make appropriate contributions to patient care and to develop 
within such an environment. Whilst other fields where psychologists skills were 
valued and sought after were opening up rapidly, and with no shortage of jobs, 
addiction services were less than attractive for psychologists to enter. 
The third factor that may have contributed to clinical psychologists not choosing to 
work in addictions is the failure of the profession to promote this area in 
undergraduate psychology courses and postgraduate training courses. Psychologists 
who were working in the area are partially responsible for this. Despite the 
enormous contribution that was mentioned earlier made by psychologists in the field, 
the real potential for the application of the science of psychology in this area remains 
untapped. Unless this is communicated to students of psychology at undergraduate 
and postgraduate level by psychologists in this area who possess strategic thinking, 
this potential will be long time in being realised. 
264 
Clinical psychologists who worked in Substance Misuse Services have tended to work 
in isolation from each other and from other clinical psychologists. This appears to 
reflect the invisibility of the client group they were working with. Apart from small 
informal networks, attempts to form a stronger national network were not successful 
until 1993. Poor networking and organisation among clinical psychologists working 
in addictions can be suggested as another factor that has contributed to the failure of 
recruitment and development of the speciality within the profession in the United 
Kingdom. The Society for the Study of Addiction, the foremost grouping of 
professionals in the area, has a membership largely comprising of psychiatrists and 
physicians with a few notable academic psychologists as active members. The 
nursing profession formed the Association of Nurses in Substance Abuse (ANSA) 
which has been thriving for the past ten years. The latter has undoubtedly contributed 
to making the speciality more attractive to nurses and the development of skills and 
a knowledge base in addiction within the nursing profession. 
6.1.2 The BPS Special Interest Group in Addictions (PSIGA) 
The future for clinical psychology in the area of addictions now looks more 
promising. A critical ºnass of enthusiastic clinical psychologists managed to form an 
informal network and work towards the formation of a special interest group within 
the Division of Clinical Psychology of BPS in 1994. It is encouraging that the newly 
formed Special Interest Group in Addictions (PSIGA) has, within a very short period 
of time acquired a membership of over 60 and has had a very successful first 
conference. This buoyancy of clinical psychologists in addictions has to be 
capitalised. 
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This group has its work cut out. There is a tremendous amount of work that can be 
done to address the gaps in the three areas mentioned above. Having a group of 
expert clinicians from the BPS to direct its media inquiries (particularly when there 
are sensationalised negative media reports) more pro-active promotion of the scope 
of the real nature of addictions and ways of getting the message across for example 
consultation to drama programmes and emphasising the scope of psychological input 
in this area. 
The nature of multidisciplinary teams is changing at present to a more skills-based 
approach. In this period of transition the Special Interest Group can act as a resource 
body and a focus of support for those clinicians who are in the process of negotiating 
their roles in teams. This it-self is a critical function and the present paper provides 
a model for service provision that was developed in one of the foremost drug 
treatment centres in the country. 
In the area of training the special interest group can provide a forum for educators 
or create a sub-committee that would advise the BPS and the universities in the 
development of curricula for undergraduate psychology courses and postgraduate 
training courses in clinical and counselling psychology. It can also advise the BPS 
Division of Clinical Psychology on Continuing Professional Development (CPD) 
needs in this area for qualified clinical psychologists. 
In addition to filling the gaps in the areas mentioned above, having a Special Interest 
Group for psychologists in this area provides the opportunity to give co-ordinated 
responses to important government documents such as the recent "Tackling Drugs 
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Together" (1995) and also permits response to changes and new developments in the 
NHS. It can provide the forum for wide-ranging consultation on changes in the NHS 
and provide guidelines to its members and to relevant bodies within the NHS. 
Guidelines for Purchasing Clinical Psychology Services in Addictions (BPS, 1997) 
is an example of such a document, being prepared by the group and is expected to 
have a significant impact on shaping psychology service provision in this area. 
There is a need for similar documents to be developed in the areas of clinical audit, 
clinical effectiveness, developments in conceptual models, directions for research and 
relationships with other disciplines. The present paper attempts to sketch an outline 
for future direction for work in the above areas. 
6.1.3 The BPS and the Division of Clinical Psychology 
The British Psychological Society (BPS) is the professional body and umbrella 
organisation for psychologists in the UK. Its present structure consists of Divisions 
for professional groupings, for example Clinical, Occupational, and Educational, and 
the various functional demands on the organisation are carried out by groupings of 
voluntary elected officials, for example the professional affairs board and the 
scientific affairs board. There are few full time paid officials in the organisation. 
The special interest groups are linked to the various Divisions. The BPS has a part 
time advisor to the department of health. 
In the field of addictions, professional bodies have produced excellent reports that 
have had considerable influence in the area. The report by the Royal College of 
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Psychiatrists on alcohol (Alcohol Our Favourite Drug, 1986), the report on drug use 
('Drug Scenes', 1987) and the report by the Royal College of Physicians on alcohol 
use ('A Great and Growing Evil: the medical consequensces of alcohol abuse, 1987). 
The BPS, although less influential, also produced two excellent reports entitled 
Alcohol Use (BPS, 1984) and Substance Misuse (BPS, 1989). These reports are now 
rather dated and it is perhaps time for the BPS to commission new reports in the area 
with the help of the special interest group. In this they may also have to look at its 
sister organisations in the USA the American Psychological Association (APA) and 
in Europe for guidance. It must also be stated that psychologists on the whole have 
been slow at adopting the recommendations of these reports, particularly the report 
on substance misuse. 
The Management Advisory Service report (MAS, 1989) on clinical psychology was 
an important milestone for the profession and has to be mentioned in the context of 
BPS and DCP. This was a critical evaluation of the profession by independent 
management consultants commissioned by the Department of Health. This report not 
only gave a glowing endorsement of the profession and the contribution it has to 
make in the area of health care, it also provided a structure for clinical psychology 
input in health care settings by outlining levels of skills in psychological work. The 
model for psychology service provision in addictions presented in this paper is based 
on the MAS model of psychology service provision. 
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6.1.4 The NHS context 
It is difficult to present a developmental model of psychology service provision 
without a brief sketch of the changes that have taken place in the NHS during the past 
17 years. The NHS reforms and the numerous organisational changes have had a 
considerable impact on how each profession provides patient care and particularly 
how professions relate to each other. Some of the problems of multidisciplinary 
teams and its effect on psychology service provision in the 80's were alluded to 
earlier on in this chapter. 
Reorganisations continuing apace in many Trusts up and down the country, the 
relationships between the professions continue to be a critical factor in defining 
service provision or the role of a particular profession such as clinical psychology 
within a treatment setting. The internal market was introduced in 1989 and even the 
most fierce critic of the purchaser / provider split will acknowledge some positive 
aspects to it. Indeed the new Labour government have indicated that they will 
maintain aspects of the purchaser provider split. The contracting process can be 
argued to have many positive aspects to it and it has provided professions such as 
psychology with an opportunity to deliver its services more effectively. Service level 
agreements (SLA's) provided an excellent opportunity to specify what psychologists 
can do in a particular service and the volume of work it intends to carry out for 
example the number of patients to be seen (Ovretveit, 1992). In the case of 
Substances Misuse Services and other services where psychologists were immersed 
in the generic worker debate this provided an excellent opportunity to specify `skills' 
and `roles' within teams. The 'Quality' aspects of the contracting process also 
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offered a number of positive 'spin-offs' for psychology. Services needed to carry out 
systematic and regular service evaluations, audits and patient satisfaction surveys as 
part of standards demanded by purchasers. Psychologists acquire the skills and 
expertise to carry out these activities as part of their core training. In many services 
and teams these skills that psychologists possessed became much valued and sought 
after. Despite fears of the potential danger of purchasers deciding not to purchase 
psychology (for reasons for example of high cost), so far it appears to have had the 
opposite effect. The principle of multidisciplinary input appears to be carried out to 
the letter and so far it has had the effect of consolidating, and in some services 
expanding, psychology services. The contracting process with service level 
agreements also enables psychology to be provided as an independent service both 
within and without services and teams. The internal market also demanded that 
multidisciplinary teams were truly multidisciplinary, if one service was and another 
service competing for the contract was not, then the latter is less likely to get the 
contract. 
6.2 The model developed at the Camden & Islington Drugs Service 
The Camden & Islington Drugs Service was opened in 1968 and was one of the first 
services of its kind in the country. It has pioneered many developments in service 
provision in the U. K. and its history parallels the history of treatment of drug users 
in the country. Situated in an inner city area in London it is also one of the largest 
services for substance users in the U. K. The current structure of the Drugs Service 
has four distinct sections to it: 
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i) The Hampstead Road Centre (HRC) the main outpatient service which was 
previously the Drug Dependency Unit (DDU). 
ii) The Community Health and Drugs Service (CHADS) which is a community 
service concentrating mainly on shared care with G. P. 's, 
iii) The Primary Care Unit (PCU) which provides a G. P. facilities for drug users. 
iv) The Needle Exchange which focus mainly on reducing harm from intra-venous 
drug use. 
The present chapter describes the development of a psychology service in the above 
service. It describes the principles, the theoretical underpinnings, the process of 
negotiation involved, and the evaluation of the service. It is presented in an 
generalised form and it is hoped that it would be useful for other Substance Misuse 
Services in the UK trying to develop or purchase clinical psychology services. The 
outline of the specification developed here for the purpose of service level agreements 
forms the basis of the specifications included in the Guidelines for Purchases 
Developed by the BPS Special Interest Group in Addictions (BPS, 1997). 
6.2.1 Theoretical underpinnings 
In the field of addictions aetiological conceptualisations and much of treatment 
rationales are psychological. In the area of substance misuse, medical and chemical 
treatment such as detoxification, substitute prescription (with the exception of 
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maintenance treatment), antagonist treatment (for example, Antabuse, Naltraxone) and 
anti-depressant treatment are seen as a prelude to psychological interventions. 
Psychological interventions or therapies are seen as the mainstay of substance misuse 
treatment. This factor will be taken as the main tenet of the argument for clinical 
psychologists to play a more central role in substance misuse and addiction treatment 
services in this chapter. In the UK the goals of treatment for substance misuse have 
become much broader over the last decade or so compared to the traditional 
abstinence-only approach which appears to be still dominant in the USA. Alcohol 
treatment services have accommodated controlled drinking (Heather and Robertson, 
1985; Sobel and Sobel, 1976). Drug treatment centres in varying degrees have 
accommodated the 'harm reduction' directive (ACMD, 1988,1989) in the wake of 
the HIV epidemic. The Twelve Step movement (Wells, 1991) with its abstinence 
philosophy continues as a parallel and complementary service offering psychosocial 
help (while subscribing to a disease model) to the statutory and voluntary sector 
treatment centres. The move away from abstinence as the only goal has not reduced 
the emphasis on psychological treatments, on the contrary it has increased its scope. 
A recent report by the Task Force set up by the Department of Health to review 
treatment of drug users emphasised the importance of psychological factors in drug 
dependence and the need for structured counselling approaches....... (Task Force to 
Review Services for Drug Misusers, 1996). 
6.2.3 The Management Advisory Service (MAS) report 
In the health service psychological work forms the main part of treatment offered to 
patients. A number of professionals, psychiatrists, physicians, general practitioners, 
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general nurses, psychiatric nurses, occupational therapists, psychotherapists, 
counsellors and psychologists to name a few carry out this work. The Man Power 
Advisory Group (MPAG) of the Department of Health which carried out an 
evaluation of psychological work in the health service, identified three levels at which 
psychological work was carried out. 
Level 1: basic skills in establishing and maintaining relationships, simple and 
often intuitive techniques of counselling and stress management. 
Level 2: undertaking circumscribed psychological activities e. g. behaviour 
modification 
- 
may be defined by protocol. 
Level 3: a thorough understanding of varied and complex psychological 
theories and the ability to apply these to new problems to generate 
interventions. 
The review concluded that almost all healthcare workers use level 1 and level 2 
skills. Only psychologists as a professional group have level 3 skills as a result of 
their core training, compared to other professional groups in the NHS (MAS 
report on Clinical Psychology, 1989). It must be added here that individuals from 
other professional groups can develop level 3 skills by further training for example 
psychotherapy training, advanced training in counselling such as Diploma courses 
and Masters courses. 
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The MPAG review (MAS Report, 1989) describes psychologists working at three 
levels. 
i) Individual 
ii) Family 
iii) Organisational levels 
The work would involve direct and indirect clinical work, consultation, supervision, 
input to multidisciplinary meetings, teaching and research. This forms the basis of 
any Job Description in a psychology department. Depending on the speciality, area 
of work or setting this can be elaborated to describe what psychologists can do 
(Harris and Wanigaratne, 1995). 
6.2.4 Models for interventions in addictions 
New conceptualisations and models with interventions for addiction problems have 
emerged in recent years. The step care approach (Sobel and Sobel, 1995) and 
matching hypothesis (Marlatt, 1995) have been particularly utilised in developing 
the model of intervention that underpins the service provision specification 
developed. The matching hypothesis is schematically presented as a spectrum of 
intervention responses in figure 6.1. 
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A stepped care model for treatment of substance misuse problems are 
schematically presented in figure 6.2. The steps in the above model could also 
overlap with the Stages of Change described by Prochaska and DiClemente 
(1983). However targeting treatment approaches in the above fashion (although 
appears to be obvious, simple and logical) is far from common practice in 
addiction treatment settings. 
The tradition in many treatment settings for psychological interventions are 
underpinned by assumptions based on psychodynamic approaches. Abstinence or 
`cure' from substance dependence was achieved through the therapeutic 
`relationship' with the substance misuse worker or counsellor. Psychodynamic 
work, from this perspective was attempted from the entry point to a service 
(bottom of the gradient in figure 6.2). A critique of this approach will be 
presented later in this paper. It is sufficient to state here that the flexibility and 
targeting of interventions that the model presents above (figure 6.2) is not allowed 
for within the traditional approach. 
6.2.5 The Advisory Council on the Misuse of Drugs (ACMD) reports 
(1988,1989) 
After the publication of the 1988 ACMD report, huge demands were placed on 
Drugs Services in Britain to increase the numbers receiving interventions. The 
threshold for entry into treatment had to be lowered and more flexible approaches 
had to be developed. The increasing awareness of the extent and consequences 
of alcohol problems has placed similar demands on Alcohol Services. The model 
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described above (figure 6.2) was developed and has evolved as a response to new 
demands, assimilating new theoretical developments in the field of addictions. 
The scope of this approach is immense. It can provide a framework for evaluation 
of interventions with desecrate parameters for outcome measurement; it can 
provide the basis for effective utilisation of human resources within a treatment 
setting by using appropriate skills for appropriate levels of interventions; it can 
help set targets for professional skills development; it enables the provision of 
treatment choice and options for patients; it can set out clear parameters for 
assessment process; it cangives clarity to multidisciplinary input to the service; it 
has major implication for research and audit. 
The development and evaluation of a clinical psychology service in a busy London 
inner city Drugs Service based on the above models and the reports described 
above is presented below as a case study. 
6.3 Development of the new model 
6.3.1 The process 
Initially a skeleton structure for ideal psychology service provision based on the 
models and reports described above and the perceived needs of the Drugs Service 
was developed. The psychology team had a number of brainstorming sessions to 
decide the content of the service specification. This was then translated into a 
draft specification that was worked upon by the psychology team and the head of 
mental health psychology who was the next line manager. The psychology team 
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met on a number of occasions to discuss the drafts and a final version of the 
service specification was agreed. 
The head of the psychology team presented the final draft of the specification to 
the manager of the Drugs Service. The manager of the Drugs Service discussed 
the specification with the director of the Trust responsible for the Drugs Service 
and accepted the specification with few modifications. Both the manager and the 
director indicated that they would like the Service Specification translated to a 
Service Level Agreement (SLA). The philosophy of the new psychology service, 
the specifications for the services (appendix C) and a SLA was presented to the 
Drugs Service management team, comprising of consultant psychiatrists, a senior 
nurse, co-ordinators of the various parts of the service and the head of 
psychology. The management team accepted the specifications on the basis that it 
would be reviewed after a year. 
The members of the psychology team presented the philosophy of the service, the 
specifications and the outline of the SLA to the different teams within which they 
worked. 
The psychology service was then delivered to the Drugs Services on the basis of 
the specification and the service level agreement for a period of a year prior to 
evaluation and review. 
279 
6.3.2 The philosophy of the new psychology service 
The philosophy of the new psychology service was outlined as follows: 
i) To provide a high quality clinical psychology service based on a broad 
theoretical perspective to both clients & staff of the Drugs Service. 
ii) To provide a service as an independent team within the Drugs Service. 
iii) The fundamental principle (and the basis of the specification) was 
psychologists moving away from doing generic work towards specialised 
work by providing an input to the service based on the unique core skills of 
psychologists. 
iv) Direct clinical work will be the major priority of this service and will 
include both assessment and treatment. 
v) The clients having the "choice" to receive psychological treatment is the 
fundamental basis of receiving interventions. This means that clients with 
a `key-worker' and on substitute prescription provided by the service or a 
G. P. will decide to have psychological treatment with the full 
understanding that if he/she decides not to continue with the treatment, this 
will not jeopardise the prescription or the key-worker relationship. 
Similarly when treatment is terminated at the end of a contract with the 
psychologist, the client will continue with other inputs from the service. 
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vi) This model of working means that only under exceptional circumstances 
would a psychologist `key-work' and provide prescriptions for patients. 
vii) Psychological work should be clerly defined and separated from other 
inputs a client receives from the service. 
6.3.3 The service specifications 
The structure and an outline of the service specifications are presented below, a 
more detailed description of specified activities in each category can be found in 
Appendix (C). 
A) Clinical service provision 
i) Assessment 
ii) Treatment 
iii) Supervision 
iv) Consultation 
B) Service development 
C) Research and evaluation 
D) Teaching 
E) Staffing levels 
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F) Quality of the service 
6.3.4 Service level agreement 
The service level agreement based on the above specification is outlined in Table 
6.1. 
Table 6.1 The level of clinical psychology service provision for Camden 
and Islington Drugs Service 
Type of Activity No. of Sessions Description 
Assessment 3 Multidisciplinary meetings 
2 Assessment for psychological 
2 Treatment 10 Specific psychological 
interventions 
3 Supervision 3 Clinical supervision 
4 Consultation 1 
5 Service Development 1 General management 
1 Development of assessment 
systems 
2 Service for Stimulant users 
Researc Service esearc i
Evaluation 1 Audit 
7 Teaching 1 
8 Continuing Profession 
Development 
3 
Total 30 Sessions per week 
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6.4 Evaluation of the service 
The service was evaluated in the following six ways at the end of the review 
period of one year. 
i) Delivery of each aspect of the specification. 
ii) The quantity of referrals and the analysis of the types of referral. 
iii) Audit of waiting times and number of sessions for an assessment or episode of 
care. 
iv) Informal and formal feed-back from the co-ordinators of each part of the 
Drugs Service and management team. 
v) Feed-back from clients. 
vi) Job satisfaction of the psychologists. 
6.4.1 Delivery of each aspect of the specification 
A) Method 
This was carried out by an audit of the work done during the year and a review 
meeting of the psychology team. 
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B) Results 
The audit and the review of the work done revealed that the team had delivered on 
every aspect of the specification and exceeded the specification in many areas. 
The only service not delivered was the input in the area of psychotherapy. This 
was due to the psychotherapist, who was part of the psychology team and provided 
3 sessions, leaving the team. The number of referrals to psychology increased by 
92%. The expansion of the psychology team during the year was also an outcome 
of the new service and also contributed to the increase in the referral rate. 
Indirect clinical work in the form of consultations and supervision also had 
increased substantially the review process identified the need for careful audit of 
this work. Unlike referrals, this input was not clearly documented. 
6.4.2 The quantity of referrals and the analysis of the types of referral 
A) Method 
An audit was carried out on the referrals by analysing the referral forms and the 
referral book kept by the psychologists. 
B) Results 
The number of referrals to the psychology team had increased from 69 referrals 
in the previous year to 129 referrals. 
The analysis of the referral according to the type of problem stated in the referral 
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form or letter is shown in Table 6.2. below. 
Table 6.2 Referral to the psychology service 
Type of problem Percentage 
Adjustment to HIV 2 % 
Aggression 10 % 
Anxiety 7 % 
Anxiety/Depression 6 % 
Behavioural difficulties 1 % 
Bulimia 1 % 
Depression 21 % 
Munchousen Syndrome 1 % 
Neurological Assessment 2 % 
Obsessive Compulsive Disorder 1 % 
Pain Management 1 % 
Paranoia 2 % 
Post Traumatic Stress Disorder 2 % 
Rape 2 % 
Relapse Prevention 20 % 
Self Harm 4 % 
Sexual Abuse 1 % 
Stimulant use 13 o 
The problem categories reveal the appropriateness of the referrals for 
psychological intervention and the utilisation of the skills of the psychologists. 
6.4.3 Audit of waiting times and number of sessions for an assessment 
or episode of care 
A) Method 
The audit was carried out by devising a template (appendix C) and analysing the 
psychologists referral book and case notes according to the template. 
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B) Results 
i) Waiting times (referral date to first appointment) = 14.6 days (range 1- 
28). 
ii) Number of sessions for assessments = 3.6 sessions (range 1- 7). 
iii) Number of sessions for discrete interventions = 8.3 sessions (range 4- 
20). 
6.4.4 Informal and formal feed-back from the co-ordinators of each 
part of the Drugs Service and management team 
A) Method 
A simple questionnaire was devised to obtain qualitative responses and sent to the 
co-ordinators of each part of the service and the head of the psychology service 
met with each of them to discuss the service (appendix C). 
B) Results 
The feed-back from the meetings is summarised as follows: 
Very high satisfaction with service received from psychology in general. 
Two out of the three parts of the service wanted more input from 
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psychology. In these parts of the service it was felt that the demands of the 
service was not met. 
Co-ordinators of two parts of the service felt that there were tensions 
among other members of the multidisciplinary team about psychologists not 
doing generic work. This was not felt to be wholly unhealthy and it 
brought out issues in the service that needed to be addressed. It was 
clearly felt that there was a better use of psychology than in the old model. 
The model of separation of psychological work from substitute prescribing 
work was having a positive knock-on effect on the service provision in the 
clinic as a whole. More key-workers were beginning to work 
behaviourally and were having brief monitoring sessions with patients, 
rather than longer `counselling sessions', with patients who were thought to 
be not ready for psychological work. 
In terms of changes to the psychology provision, the co-ordinators wanted 
psychologists to be based more within the different services rather than 
operate in a central manner across the services. This view was also 
combined with a call for more psychology sessions. The community arm 
of the service (CHADS) wanted psychologists to move away from the 
central site and provide a service from community settings (for example 
G. P. practices) and also take a lead in evaluating developments in the 
community for example `G. P. shared care'. 
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Other comments from the co-ordinators included an appreciation of the 
feed-back received from the psychologists following assessments and about 
on going work. There was much positive feed-back about the usefulness of 
consultation with psychologists and the clinical supervision received from 
psychologists. 
6.4.5 Feed-back from clients 
A) Method 
A patient satisfaction survey was carried out in the service and was led by 
members of the psychology team but did not include a specific question about the 
psychology service. Instead there was a general question about satisfaction with 
counselling received at the service. 
The patient satisfaction information was obtained from clinical supervision, peer 
review meetings and from psychology team meetings. 
B) Results 
The single item in the general satisfaction survey carried out across the service 
showed a 73% satisfaction level (clients rating the service fair & excellent) with 
counselling. Not all clients participating in the survey would have been referred 
to a psychologist. 
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The anecdotal feed-back from clients directly to the psychologists and to their key 
workers indicated a high level of satisfaction with the sessions with psychologists. 
Clients appear to exercise choice to have sessions with psychologists by indicating 
that they wish not to continue with sessions or by dropping out. Some clients re- 
referred them selves after dropping out of treatment. The feed-back also indicated 
that, although it was very clearly explained to them that their Methadone 
prescription was not conditional upon continued attendance to see a psychologist, 
there was much anxiety about jeopardising their prescription. This indicated that 
old expectations of treatment may take some time to change. 
6.4.6 Job satisfaction of the psychologists 
A) Method 
This information was obtained from clinical supervision sessions, peer review 
meetings and psychology team meetings. 
B) Results 
Qualitative information obtained revealed an increasing sense of job satisfaction 
among the psychology team. This centred around a number of factors: 
i) Clarity of role. 
ii) Ability to use core skills of a psychologist. 
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iii) Not getting caught up in the trap of patients anxiety around prescriptions 
and working with patients motivated to work. 
iv) Freedom to use psychological skills at an appropriate level. 
v) Scope to take the lead or be involved in innovative developments. 
vi) Scope to carry out research and support research. 
vii) Increase in the consultation role. 
viii) Increase in the demand for supervision from different professions in the 
multidisciplinary teams. 
ix) Being valued for their input. 
6.4.7 Comments on the evaluation 
A wealth of qualitative and quantitative information was obtained from the 
evaluation that would clearly contribute to the further development of the service. 
Nevertheless a number of limitations and areas for improvement of the evaluation 
process were identified. Examples of these are: 
Inclusion of questions on the psychology service in the patient satisfaction 
survey. 
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The audit work carried out can be seen as `pre 
- 
audit' enabling the setting 
up of templates and standards for audit work in the future. 
Anonymous survey of all staff about the psychology service may yield 
more accurate feed-back. 
Patient feed-back could be obtained by methods such as a `focus group' of 
patients seen by the psychologist run by an external facilitator. 
6.4.8 The annual report 
An annual report was produced with a summary of the evaluation of the service 
covering most of the above areas. This report covered details of the delivery of 
each item in the service specification. Copies of the report was distributed to 
members of the management team and staff of the Drugs Service. 
6.5 Discussion 
Changing ways that services are provided in treatment settings that have a history 
or a strong tradition is challenging. Approaching such a problem armed with 
conceptual models and clarity of priorities dictated by contemporary demands may 
prove to be advantages. The new model for clinical psychology service provision 
for the Drugs Service was developed by synthesising recent theoretical 
developments in psychology, professional developments in clinical psychology, 
National developments in health care provision and perceived demands of the 
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Drugs Service in particular. The approach was a `holistic' or a `systemic' one 
with the drug user and his/her family at the centre and with the Drugs Service as 
an organisation, the national context of substance misuse and service provision and 
the international context nested around them. If a `systems' view is taken, then 
any change to part of the system has implications for the whole system (Bateson, 
1979, Bor, et al., 1988). The model of service provision will be discussed here 
looking at its implications in a wider context. 
The evaluation of the new model of service provision discussed above clearly 
indicated that it was an outstanding success in all of the parameters set for its 
evaluation. The immediate objectives for its development and the objectives of the 
service it was developed for appears to have been clearly met. It is perhaps more 
important to go beyond the immediate objectives to look at the wider context or 
the `ripple effects'. Taking the view that services are co-evolutionary, the 
evolution of the psychology service should have knock on effects on the rest of 
the service. The feed-back from the evaluation process is crucial to analyse the 
impact in the wider context. Unfortunately getting a full picture necessitates 
going into the evaluation in great detail for which there is no scope here. 
Therefore a few areas are selected for discussion that are considered to be 
particularly significant. These are: 
i) the impact of the integrated step model for psychological interventions 
ii) development of interventions for stimulant users 
iii) development of the consultation role 
iv) the scope for research and evaluation 
292 
6.5.1 Impact of the step model for psychological interventions 
This model (figure 6.2) integrates recent theoretical developments in psychology 
and contemporary thinking in service provision for drug users. This model was 
used to underpin the direct and indirect clinical work in the service specification. 
This also provided the framework for assessment for psychological interventions. 
The 92% increase in referrals to psychology can be seen as the most salient 
endorsement of this model. The significant increase in consultations with 
psychologists regarding psychological work by other members of the 
multidisciplinary team is another indication of the impact of the model. The 
model appears to have given clarity to the service on targeting interventions and 
psychologists with their `level 3' skills were taking a lead in the decision making 
process of providing psychological interventions within the service. The model 
suggests behavioural interventions for chaotic and unstable drug users and insight 
oriented work for abstinent or stable users. It is not uncommon to observe that in 
many treatment settings, insight and relationship based psychological interventions 
are attempted with this chaotic client group. This may account for many wasted 
therapy hours or loss of valuable service time. Traditionally 
, 
the model that 
underpinned psychological work with drug users was a psychodynamic one. 
Vestiges of this are still operational in services. The new model (figure 6.2) 
gives scope for strategic use of different psychological models. Apart from the 
two indicators discussed above, the evaluation of the psychology service revealed a 
number of other indicators for the knock-on effect that the introduction of this 
model has had in the wider service. Greater increase in behavioural work and 
group work around behavioural change objectives, increase in the practice of 
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`minimal key-working' with chaotic clients by other members of the 
multidisciplinary team, an increase in uptake of supervision workshops on `relapse 
prevention' and `motivational interviewing', identification of training needs in the 
area of counselling by members of the multidisciplinary teams and enroling in 
courses and overt expressions of possession or lack of skills in counselling are 
only some examples of this process. There is a clear indication that the 
introduction of the new model of psychology service provision has had the effect 
of moving the whole service to be more focussed on the psychological work they 
that they carry out. The adoption of this approach by other services in the country 
and its evaluation will confirm its generalisability and wider adoption as a model 
of service provision for Substance Misuse Services as a whole. 
6.5.2 Development of intervention for stimulant users 
The pattern of referrals to the psychology service indicated that assessment and 
treatment of stimulant users made up the third largest category. This is a 
development that has a number of implications. Stimulant use in the U. K. is 
increasing with alarming trends (The National Audit of Drug Misuse in Britain: 
ISDD, 1992), creating an urgent need to develop services to meet this demand. 
The existing Drug Services are predominantly geared towards providing services 
for opiate users, with the focus on substitute prescribing. Despite the fact that a 
large proportion of patients treated are polydrug users, abusing benzodiazepines, 
stimulants and alcohol, the treatment focus centres around opiate use. Substitute 
prescription is not an accepted treatment option for stimulant use, although some 
services do prescribe amphetamines. Psychological interventions are the only 
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acceptable treatment for stimulant users. The service looked towards the 
psychologists to take a lead in developing services for stimulant users. In the 
specification this was made a major service development priority. A new 
programme was developed and evaluated during the period under review. This 
was followed by an eight session training programme for all staff in the service, 
run by psychologists. Assessment, treatment, consultation and supervision around 
the management of stimulant users has become a major area of activity for the 
psychology team. In the U. K. the demand to develop and provide services for 
stimulant users will be increasing rapidly and is an area where psychology has 
much to offer. Psychologists in substance misuse teams should capitalise on this 
in negotiating their roles. This should be an area which should be particularly 
highlighted in issuing guidelines for purchasers. 
6.5.3 Development of the consultation role 
One of the most significant developments following the introduction of the new 
specification for the psychology service was the increase in the consultancy role of 
the psychologists. Areas where there were marked increases included: seeking 
advice and supervision on clinical matters; discussion of cases; consultations on 
research; evaluation and audit matters; consultations on professional and ethical 
issues; and management and service development issues. The clarity of role and 
explicit expressions of psychologists' skills may have contributed to the increased 
utilisation of psychologists skills in this manner. It has been suggested that the 
development of the `consultants' role is of considerable importance for the future 
of the profession (Brunning et al., 1989; Campbell, et al., 1989). Taking into 
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consideration the number of psychologists working in the area of substance 
misuse, development of this role is crucial to maximise the impact of 
psychological interventions to the patient population. Being consulted about a 
patient, as in the case of clinical supervision, has implications in the areas of 
clinical and legal responsibility. Clarification of these issues are needed in a 
national context for further enhancement of this role. 
6.6 Scope for research and evaluation 
During the period under review the psychologist's involvement in research activity 
in the service showed an enormous increase. Not only did other staff value 
psychologists' skills and expertise in this area, they appeared to utilise these skills 
very well. Psychologists in turn were able to stimulate research and audit activity 
in the service by providing back-up and support to other staff as well as taking the 
lead in a number of research areas. Within multidisciplinary teams psychologists 
are the only profession that have expertise in research and evaluation as part of 
their core skills. In the current climate these skills are much in demand and this 
provides another area where psychologists can obtain a clear role for themselves in 
teams. The research potential in the field of substance misuse is immense. 
Psychologists working in the area are in an unique position to exploit this and take 
a lead. The key areas of research in which psychologists have taken the lead in 
Camden & Islington can be taken as good examples these include: development of 
outcome measures, development of assessment instruments, compliance with 
treatment, evaluation of health promotion initiatives, evaluation of new treatment 
packages for example stimulant use, development and evaluation of information 
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systems, evaluation of new service developments, study of overlap between 
substance misuse problems and mental illness and gender differences in 
dependence. 
In terms of future research, areas such as; neuropsychological assessment of 
substance misusers, cognitive behavioural treatments of borderline personality 
disorder (Linehan, 1993) and post traumatic stress disorder (Resick and Schnicke, 
1993), study of early attachment patterns in substance misusers and application of 
new cognitive behavioral techniques for example Eye Movement Desensitisation 
and Reprocessing (Shapiro, 1995) offer much scope for psychologists to do 
applied clinical research. 
6.7 Conclusions 
The model for the provision of a psychology service developed by integrating 
recent theoretical developments in psychology, national developments and service 
demands was shown to be effective in terms of overall better utilisation of 
psychology within the service, the general satisfaction with the psychology service 
and the job satisfaction of psychologists. Within an organisational context this has 
knock on effects in changing the clinical work and the relationships between the 
various professions and the general attitude towards research and the level of 
research activity. The positive evaluation of this model may suggest that it 
provides a good template to plan and develop psychology services in substance 
misuse settings. 
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SECTION D 
LITERATURE REVIEW 
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Chapter 7 The relationship between post traumatic stress disorder, 
borderline personality disorder and substance misuse 
7.1 Introduction 
This chapter aims to examine the definitions and diagnostic classifications of Post 
Traumatic Stress Disorder (PTSD), Borderline Personality Disorder (BPD) and 
substance misuse, and review the literature that describes a relationship between 
the three disorders. The central tenet of the argument presented in this chapter is 
that traumatic experience is the common aetiological factor in the three diagnostic 
categories discusses. The main moot point is whether they share a common 
pathological pathway or are they aspects of the same syndrome, 'a post traumatic 
syndrome'? Examining the literature as to how the diagnostic criteria for PTSD 
have evolved, is an essential first step. Hypothetical models that attempt to 
explain the links are presented. The implications of these models for treatment are 
also examined. 
7.1.1 Definitions 
Diagnostic or classification systems are not perfect and in general, they are 
dynamic and are in a state of evolution. This process is particularly salient in 
psychiatry. There are two major systems of classification in the world today: the 
World Health Organisation (WHO) International Classification of Diseases (ICD- 
10,1992) of mental and behavioural disorders; and the American Diagnostic and 
Statistical Manual (DSM-IV, 1994). Whilst these two systems are becoming 
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closer to each other there are still important differences. The position of a 
particular disease or a syndrome in a classification system, could be as much to do 
with its natural history and the phenomenology as politics and majority opinions of 
committees that are appointed to decide on them. This gives rise to equivocal and 
controversial classifications and definitions. The three areas under consideration 
in this chapter particularly fall in the debatable fringe area. It is therefore 
necessary to outline the current definitions in both classification systems and also 
briefly sketch the evolution of the concepts within each system. 
7.2 Post traumatic stress disorder (PTSD) 
7.2.1 ICD-10 (1992) definition 
PTSD is defined as a delayed and/or protracted response to a stressful event or 
situation (either short- or long-lasting) of an exceptionally threatening or 
catastrophic nature, which is likely to cause pervasive distress in almost anyone 
(e. g. natural or man-made disaster, combat, serious accident, witnessing the 
violent death of others, or being the victim of torture, terrorism, rape, or other 
crime). 
Typical symptoms include episodes of repeated reliving of the trauma in intrusive 
memories ("flashbacks") or dreams, occurring against the persisting background of 
a sense of "numbness" and emotional blunting, detachment from other people, 
unresponsiveness to surroundings, anhedonia, and avoidance of activities and 
situations reminiscent of the trauma. Commonly there is fear and avoidance of 
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cues that remind the sufferer of the original trauma. Rarely, there may be 
dramatic acute bursts of fear, panic or aggression triggered by stimuli arousing a 
sudden recollection and/or re-enactment of the trauma or of the original reaction to 
it. 
There is usually a state of autonomic hyperarousal with hypervigilance, an 
enhanced startle reaction, and insomnia. Anxiety and depression are commonly 
associated with the above symptoms and signs, and suicidal ideation is not 
infrequent. Excessive use of alcohol or drugs may be a complicating factor. 
The onset follows the trauma with a latency period which may range from a few 
weeks to months (but rarely exceeds 6 months). The course is fluctuating but 
recovery can be expected in the majority of cases. In a small proportion of 
patients the condition may show a chronic course over many years and a transition 
to an enduring personality change. 
7.2.2 DSM-IV (1994) definition 
The DSM-IV definition of PTSD is contained in axis II within anxiety disorders. 
The definition is similar to that of ICD-10. To receive a diagnosis of PTSD an 
individual must have been exposed to a traumatic event and have at least six 
symptoms from seventeen symptom list, categorised in the following three 
clusters: 
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a) persistent re-experiencing the traumatic event, b) persistent avoidance of stimuli 
associated with the trauma and numbing of general responsiveness (avoidance and 
numbing reactions), and c) persistent symptoms of increased physiological arousal. 
In addition, the symptoms also must be present for at least a month for an 
individual to receive a diagnosis of PTSD. A detailed DSM-IV definition is 
included in Appendix (D). 
7.2.3 PTSD, the evolution of the definitions and the concepts 
In the last 25 years there has been a proliferation of interest in traumatic stress 
syndromes, particularly in PTSD as a diagnostic category (Wilson, 1994). The 
recent history of the diagnostic category of PTSD in psychiatric literature can be 
traced back to the appearance of Gross Stress Reaction (GSR) in DSM-I (1952). 
GSR was under a classification of Transient Situational Personality Disorders: 
"under conditions of great or unusual stress, a normal personality may 
utilize established patterns of reaction to deal with overwhelming fear. The 
patterns of such reactions differ from those of neurosis or psychosis chiefly 
with respect to clinical history, reversibility of reaction, and its transient 
character...... When promptly and adequately treated, the condition may 
clear rapidly. It is also possible that the condition may progress to one of 
the neurotic reactions, 
The criteria goes on to state that: 
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This diagnosis is justified only in situations in which the individual has 
been exposed to severe physical demands or extreme emotional stress, such 
as in combat or in civilian catastrophe. " 
Wilson (1994) notes that there are several criteria implied by the narrative 
description of DSM-I. These are: a) the condition is an acute reaction to unusual 
stress that resolves quickly, b) if there are prolonged or persistent reactions, an 
alternative diagnosis was to be considered that includes psychosis, neurosis or 
character disorders, and c) the belief that rapid intervention facilitates recovery. 
The implication of prolonged disorder that may lead to neurosis and more 
importantly to character disorder (personality disorder) is of particular relevance to 
this chapter and will be discussed later. 
The PTSD equivalent diagnostic category in DSM-II (1968) was Adjustment 
Reaction of Adult Life. The interest, reflected in the development of the criteria 
appears to have suffered a retrograde phase during the sixteen year period between 
DSM-I and DSM-II. The criteria just had three examples, a) an unwanted 
pregnancy accompanied by depression and hostility, b) a frightened solder in 
combat and c) a prisoner facing execution in a death penalty case. 
It is difficult to explain the retrograde phase of academic and clinical interest in 
trauma and its psychological sequelae during this period. It was not that this 
period in history was devoid of traumatic events. Commenting on the paucity of 
the diagnostic criteria in DSM-II Wilson (1994) states that 
.... 
"what makes this so 
peculiar is that by 1968 the cumulative historical events involving war, civil 
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violence, nuclear warfare, etc. produced more trauma, killing, mass destruction 
and death in a delimited time frame than at any prior time in recorded history". 
DSM-III (1980) marked a dramatic development phase in the field. PTSD 
emerged as a separate diagnostic category, placed among the anxiety disorders. 
The rationale for this being that anxiety, emotional distress and physical 
disequilibrium are the primary affective reactions associated with traumatisation. 
DSM-III, whilst seeming to rediscover the DSM-I criteria, progressed from a 
narrative description to a distinct diagnosis system. To receive a diagnosis an 
individual has to manifest at least four symptoms from a cluster of twelve. 
DSM-III made a number of advances on previous diagnostic descriptions. These 
include, a) clarifying the role of dissociative processes (for example, flashbacks, 
forms of enactment), b) magnitude of the stressor can generate traumatic reactions 
in almost everyone, c) the concept of a continuum of symptom severity and a 
continuum of pathological impact. The formal official recognition of PTSD as a 
mental disorder had a tremendous impact on the medical-legal sphere and most 
importantly caused a rapid proliferation research studies with different populations 
of trauma victims. 
DSM-III-R (1987) revised the diagnostic criteria for PTSD, taking on board 
findings emerging from research and clinical work. The number of diagnostic 
symptoms were increased to seventeen and six symptoms from three major clusters 
were necessary to receive a diagnosis of PTSD. The clusters included, a) forms 
of re-experiencing the traumatic event, b) avoidance and numbing reactions, and c) 
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symptoms of increased physiological arousal. In addition the symptoms also 
required to be present for at least a month. 
DSM-IV (1994) contained minor revisions to the above criteria and is presented 
above. DSM-IV also introduced a new category of Acute Stress Reaction to 
describe abnormal immediate reactions to trauma. 
The future place of PTSD in the diagnostic system is the subject of intense debate. 
There are suggestions that PTSD be moved from the umbrella of anxiety disorders 
and placed in an axis of its own, as an environmentally caused disorder. New 
subtypes of PTSD are also beginning to be reported in the literature and it may 
no longer be possible to consider it to be a single condition (Daien and Witztum, 
1994; Neal, 1994; Rosser, 1995; Thrasher et al., 1994). 
7.3 Type I and type II trauma 
The concept of type I and II trauma that has emerged from the intense research 
activity in the area of PTSD during the last decade, is of particular relevance to 
the arguments presented in this chapter. Studies on traumatised children have 
revealed that single event trauma (type I) and traumatic events that were 
experienced over a period of time eg. sexual and physical abuse (Type II) have 
differential consequences for PTSD manifestation and character changes (Cole and 
Putnam, 1992; Finkelhor, 1990; Terr, 1991). There is a vast literature emerging, 
that makes causal attributions to Type II trauma and a range of mental health 
disorders including, dissociative disorders, personality disorders and substance 
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misuse (Evans and Sullivan, 1995; Shapiro, 1995; Van der Kolk, et al., 1996; 
Wilson and Keane, 1997). The association of type II trauma in particular, with 
borderline personality disorder and substance dependence is explored later in this 
chapter. 
7.4 Personality Disorders 
The definition and diagnosis of personality disorders are relatively problematic and 
have undergone many changes in the evolution of diagnostic systems. This 
situation is summarised in the introduction to the section on personality disorders 
in ICD-10 as follows: 
"In all current psychiatric classifications, disorders of adult personality 
include a variety of severe problems, whose solution requires information 
that can come only from extensive and time-consuming investigations. The 
difference between observations and interpretation becomes particularly 
troublesome when attempts are made to write detailed guidelines or 
diagnostic criteria for these disorders; and the number of criteria that must 
be fulfilled before a diagnosis is regarded as confirmed remains an 
unsolved problem in the light of present knowledge. Nevertheless, the 
attempts that have been made to specify guidelines and criteria for this 
category may help to demonstrate that a new approach to the description of 
personality disorders is required. " 
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DSM-IV (1994) defines a Personality Disorder is an enduring pattern of inner 
experience and behaviour that deviates markedly from the expectations of the 
individual's culture, is pervasive and inflexible, has an onset in adolescence or 
early adulthood, is stable over time, and leads to distress or impairment. 
7.5 Borderline Personality Disorder (BPD) 
The current ICD and DSM diagnostic systems differ in how they deal with BPD. 
Whilst DSM-IV (1994) provides a very clear definition and diagnostic guidelines 
on BPD, ICD-10 gives it a brief mention. ICD-10 places BPD as a sub category 
of 'emotionally unstable personality disorders'. It appears that scientific 
committees that decide on diagnostic classifications outside the USA have had 
doubts about existing evidence for BPD. The following quote from the 
introduction to ICD-10 sums up this position: 
"After initial hesitation, a brief description of borderline personality 
disorder was finally included as a sub category of emotionally unstable 
personality disorder, again in the hope of stimulating investigations. " 
This situation has resulted in increased research activity and this trend is 
continuing. Some aspects of new research emerging in this area are reviewed in 
this chapter. 
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7.5.1 ICD-10 (1992) definition 
A) Borderline type 
Several of the characteristics of emotional instability are present; in addition, the 
patient's own self-image, aims, and internal preferences (including sexual) are 
often unclear or disturbed. There are usually chronic feelings of emptiness. A 
liability to become involved in intense and unstable relationships may cause 
repeated emotional crises and may be associated with excessive efforts to avoid 
abandonment and a series of suicidal threats or acts of self-harm (although these 
may occur without obvious precipitant). 
B) Emotionally unstable personality disorder 
In order to place the definition of borderline type in context it is necessary to 
give a brief outline of the definition of Emotionally unstable personality disorder. 
A detailed definition is included in appendix (D). 
A personality disorder in which there is a marked tendency to act impulsively 
without consideration of the consequences, together with affective instability. The 
ability to plan ahead may be minimal, and outbursts of intense anger may often 
lead to violence or "behavioural explosions"; these are easily precipitated when 
impulsive acts are criticised or thwarted by others. 
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7.5.2 DSM-IV (1994) definitions 
The essential feature of Borderline Personality Disorder is a pervasive pattern of 
instability of interpersonal relationships, self-image, and affects, and marked 
impulsivity that begins by early adulthood and is present in a variety of contexts. 
The diagnostic criteria in DSM-IV requires the individual to have five or more 
symptoms from nine clusters of characteristics. These include: 
i) Efforts to avoid real or imagined abandonment, 
ii) A pattern of unstable and intense interpersonal relationships characterised 
by alternating between extremes of idealisation and devaluation, 
iii) Identity disturbance, 
iv) Impulsivity in at least two areas that are potentially self-damaging (e. g., 
spending, sex, substance abuse, reckless driving, binge-eating), 
v) Recurrent suicidal behaviour, 
vi) Affective instability due to a marked reactivity of mood, 
vii) Chronic feelings of emptiness, 
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viii) Inappropriate, intense anger or difficulty controlling anger, 
ix) Transient, stress-related paranoid ideation or severe dissociative symptoms. 
A more detailed definition of BPD is given in Appendix (D). 
7.5.3 Evolution of definition of BPD 
The term borderline personality disorder first appeared in the literature in the 
1930's to describe a condition that was between (or on the border of) the 
dichotomous classification of psychosis and neurosis (Glover, 1932; Kernberg, 
1975; Rickman, 1928; Stern, 1938; Schmideberg, 1947). The term initially 
referred to patients whose neurotic condition was thought to mask a psychosis and 
those with a tendency to react negatively to analytical therapy and become 
dramatically regressed or suicidal. Essentially it was seen as a transitory state. 
The current descriptions of the borderline personality disorder moves away from 
the `transitory' to one of `persistent instability' or `stably unstable' (DSM-IV, 
1994, DSM-III-R, 1987, Schmideberg, 1959). It is observed that under highly- 
structured and supportive conditions the BPD may not manifest it-self but when 
the individual is stressed they regress and demonstrate clear disturbances in their 
capacity to contain and manage feelings and impulses (Sederer and Thorbeck, 
1990). 
Three sub-categories of borderline patients are identified by Andrulonis, et at., 
(1982). 
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Group 1 History of acting out behaviour, drug and alcohol abuse, depression, 
family history of affective disorder, mainly female with onset in 
early adolescence. 
Group 2 Significant head trauma, epilepsy or encephalitis. 
Group 3 Severe hyperactivity, distractibility and learning difficulties. 
Mainly male. 
This chapter essentially focusses on group 1, of the above categorisation. In this 
group the cluster of behaviour patterns of self harm, parasuicide and substance 
abuse and dependence have been observed by many writers (Greer and Lee, 1967; 
Linehan, 1981; Linehan and Shearin, 1988; Maris, 1981 Paerregaard, 1975; 
Stone, 1980,1989; Widiger and Francis, 1989). 
Linehan (1993) outlines four approaches to understanding the concept of BPD and 
highlights areas of overlap. The overlap of BPD symptomatology with affective 
and other diagnostic categories have led some as in the example of ICD-10 (1992) 
given above, to question the usefulness of the concept. One of the concept's 
strongest critics on the grounds of overlap is Theodore Millon (Millon, 1981, 
1987a; Millon and Davis, 1996). Usefulness of labelling individuals "borderline" 
is questioned by some, who suggest the association of BPD with childhood sexual 
abuse and advance the same argument that is mooted in this chapter, that a label of 
a "post traumatic syndrome" would be more useful (Linehan, 1993). The 
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controversy whether BPD is a useful and valid diagnostic entity is set to continue 
and is a fertile area for future research. 
7.6 Substance misuse 
In the area of substance misuse both diagnostic systems, by means of close 
consultation, have arrived at very similar definitions. They have moved away 
from a predominantly pharmacological model to a multi-factorial 'biopsychosocial' 
model. There are a few differences and they can be outlined as follows. ICD-10 
uses the term psychoactive while DSM-IV does not use the term but specifies 11 
different substance categories. ICD-10 use the term 'harmful use' instead of 
'abuse' in DSM-IV. 
Detailed descriptions of both ICD-10 and DSM-IV definitions of substance related 
disorders are given in Appendix (D). To avoid repetition a brief outline of the 
DSM-IV definitions of substance use disorders are given here. There are two 
substance use disorder categories in DSM-IV, substance abuse (harmful use) and 
substance dependence. 
7.6.1 Substance abuse 
The criteria for the diagnosis of substance abuse are outlined below. A 
maladaptive pattern of substance use leading to clinically significant impairment or 
distress, as manifested by one (or more) of the following, occurring within a 12- 
month period: 
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i) Recurrent substance use resulting in a failure to fulfill major role 
obligations at work, school, or home, 
ii) Recurrent substance use in situations in which it is physically hazardous 
(eg., driving an automobile or operating a machine when impaired by 
substance use), 
iii) Recurrent substance-related legal problems, 
iv) continued substance use despite having persistent or recurrent social or 
interpersonal problems caused or exacerbated by the effects of the 
substance. 
It is also required that the symptoms have never met the criteria for substance 
dependence (described below) for this class of substance. 
7.6.2 Substance dependence 
Substance dependence or dependence syndrome is defined as a maladaptive pattern 
of substance use, leading to clinically significant impairment or distress, as 
manifested by three (or more) of the following, occurring at any time in the same 
12-month period: 
i) Tolerance, a need for markedly increased amounts of the substance to 
achieve intoxication or desired effect; 
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ii) Withdrawal syndrome manifested by either withdrawal from the specific 
substance or a closely related substance that is taken to relieve or avoid 
withdrawal symptoms; 
iii) The substance is often taken in larger amounts or over a longer period than 
was intended; 
iv) A persistent desire or unsuccessful efforts to cut down or control substance 
use; 
v) Spending a great deal of time in activities necessary to obtain the 
substance, or recovering from its effects; 
vi) Important social, occupational, or recreational activities are given up or 
reduced because of substance use; 
vii) The substance use is continued despite knowledge of having a persistent or 
recurrent physical or psychological problem that is likely to have been 
caused or exacerbated by the substance 
. 
The above criteria are based on the description of the dependence syndrome by 
Edwards and Gross (1976) and is used by both systems of classification. 
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7.6.3 Evolution of the definition 
The concept of substance misuse has undergone considerable change over the last 
100 years. It has evolved from a concept of moral failing to that of a complex 
syndrome. It is not within the scope of this chapter to explore the history of its 
evolution. There is a more detailed description in Chapter 1. The central debate 
in this area as to whether substance misuse is a biologically or environmentally 
determined problem is relevant here to this chapter. A causal link between trauma 
and the development of substance misuse problems will be explored in later 
sections. 
7.7 Relationships between PTSD, BPD and substance misuse in the 
definitions 
The definitions of the disease categories outlined above have minimal reference to 
each other. In the ICD-10 definition of PTSD it refers to excessive use of alcohol 
as a complication. In the definitions of PTSD the key symptoms of avoidance 
phenomena and dissociation do not specifically mention substance misuse. The 
ICD-10 definition of PTSD refers to the possibility of transition to enduring 
personality change, with no direct reference to personality disorder. In the DSM- 
IV definition of BPD the fourth criterion of impulsivity refers to substance misuse 
as an example. 
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7.8 Substance misuse and personality disorder 
The evolution of the relationship between substance misuse and personality 
disorders per se in the American classification system is noteworthy. In DSM-I 
(1950's) alcohol use was encapsulated within sociopathic personality disorder, but 
DSM-II separates alcoholism from personality disorder and the multi-axial systems 
of DSM-III and DSM-IV (where personality disorders comprises axis two of the 
system) enables their association with other conditions to be more clearly 
recorded. 
DSM-IV groups personality disorders into three subgroups. The 'Dramatic' 
grouping (cluster B) includes antisocial, borderline, histrionic and narcissistic 
personality disorders. It can be argued that the association between early trauma 
in the aetiology of these conditions and the association with substance misuse in 
the phenomenology of this group is stronger that with other clusters. The 
literature that explores the strengths of these relationships is sparse. 
Millon and Davis (1996) in their review of personality disorders makes a brief 
reference to the association between BPD and substance misuse stating that: 
"There is a strong association in contemporary society between borderline 
personality characteristics and heavy involvement in substance abuse. The 
association does not appear to be an intrinsic element of these two 
disorders, but appear to signify the borderline's desire to experience varied 
forms of reality and an effort to search for an identity that may give 
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structure to divergent impulses and confusions. Hence, borderlines are 
inclined to be abusers of many different substances, including alcohol, 
cocaine, speed and crack. " 
7.9 Psychoanalytic and historical perspectives that link PTSD, BPD 
and substance misuse 
The association of trauma with mental illness has been implied in historical 
writings through the centuries from Homer to Buddhist literature circa 500 BC. In 
modern psychiatry, the first systematic explorations of the relationships between 
trauma and psychiatric illness were conducted by Charcot in 1887 (Van der Kolk, 
Weisaeth and Van der Hart, 1996). Previous to that Briquet in 1859 made 
reference to the link between childhood histories of trauma and symptoms of 
hysteria (Brown et al., 1996) and sexual abuse of children was documented by 
Tardieu in 1878 (Van der Kolk, Weisaeth and Van der Hart, 1996). 
The first conceptual model linking trauma with psychopathology was presented by 
Pierre Janet (1859 
- 
1947) a pupil of Charcot, in papers written in 1894 to 1896. 
His work on dissociative processes has been recently summarised as a three-stage 
model (Van der Hart et al., 1989) includes most of the characteristics of the 
current definition of PTSD. It also provides an environmentally-generated 
developmental model of psychopathology. Janet's contribution to modern 
psychiatry and psychology is described in two scholarly reviews by Ellenberger 
(1970) and by Van der Kolk and Van der Hart (1989). 
323 
The seminal work of Janet was eclipsed by the impact of Sigmund Freud (1856 
- 
1939) who announced his own work on the subject a year after Janet in 1895 with 
the publication of 'Studies on Hysteria' with Joseph Breuer. Freud's original view 
of neuroses was a post-traumatic paradigm known as 'Seduction Theory'. Freud 
stated that during childhood development there was a range of traumatic 
experiences or an emergency type of event that could be profoundly distressing to 
an individual and as a result of the degree of threat experienced to the ego, and 
the subsequent anxiety experienced. The victim typically used repression as an 
ego-defence to remove from awareness unpleasant memories and emotions of the 
traumatic event (Brett, 1993). Freud subsequently shifted his theory away from a 
post-traumatic paradigm to that centred around intra-psychic fantasy. Freud 
returned to the subject of traumatic neurosis in later work 'The Introductory 
Lectures on Psychoanalysis' (Freud, 1917) hinting that traumatic neurosis was 
very different from spontaneous neurosis and went on to clearly describe core 
PTSD symptom clusters listed in DSM-III-R (1987), (Wilson, 1994). Freud further 
elaborated his concepts on trauma in 'Beyond the Pleasure Principle' (Freud, 
1928) referring to 'trauma' as '.... excitations from outside which are powerful 
enough to break through the protective shield of the ego' (Brett and Ostroff, 
1985). He outlined the concept of trauma as involving, a) an external stressor 
which overwhelms the normal ego functioning; b) a change in the steady state of 
the organism (ie., disequilibrium); c) a reduction of ego-defensive and coping 
capacity; and d) the problem of "mastery" in that other stressors can take on 
traumatic proportion. This clearly describes depletion of ego strength that can set 
up the possibility of long term PTSD or other mental illnesses. 
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Wilson (1994) notes that Freud seems to have grasped the essence of PTSD in the 
early part of the 20th Century and describes what happened in the interim period 
as a "kind of intellectual vacuum in which the collective clinical wisdom about 
psychic traumatization seem to have gone "underground" and evaporated by the 
time of DSM-II (1968)". 
7.9.1 Psychoanalysis and substance misuse 
Psychoanalytic literature on substance misuse or addiction is sparse compared to 
literature on personality disorder, including BPD. Some writers have commented 
on the link between, trauma, addiction and BPD. Key contributions in this area 
are outlined below. 
The classical psychoanalytic view is that addiction (largely substance misuse) is a 
perversion, associated with homosexuality and associated with masturbation. 
Limentani (1986) states that addiction is associated with homosexuality in two 
ways; sexualisation of aggression towards female and maternal objects and similar 
process towards male and paternal objects. Based on the dynamics of wish 
fulfilment and the compulsion to repeat unconscious traumatic experience, 
masturbation in connection with taking drugs affords addicts who are non- 
obligatory homosexuals temporary relief from both the psychotic anxieties 
associated with the core complex and the dread of being homosexual (Hopper, 
1995). 
Glover (1932) notes that addiction is associated with very primitive or `psychotic' 
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anxieties and, therefore, is intermediate between the perversions and the 
psychoses. He also notes that it is not uncommon among people with so-called 
`borderline' disorders with paranoid and/or narcissistic colouration. 
Addiction is also seen as associated with, if not actually a form of masturbation, 
by virtue of it being a displacement from or replacement of it. This view 
originates from Freud's comments (Nagera, 1971) that `masturbation is the 
primary addiction and that other addictions 
... 
are 
........ 
a substitute and 
replacement for it' and that both addiction and masturbation is characterised by 
withdrawal into fantasy life. 
Recent formulations 
The link between BPD and PTSD in terms of psychic processes is described with 
rare clarity by Kroll (1993) as follows: 
The PTSD / borderline person suffers first and foremost from a disorder 
of the stream of consciousness. More specifically, the PTSD / borderline 
person suffers from the inability to turn off a stream of consciousness that 
has become its own enemy, comprised of actual memories of traumatic 
events, distorted and fragmented memories, unwelcome somatic sensations, 
negative self-commentaries running like a tickertape through the mind, 
fantasised and feared elaborations from childhood of the abuse experiences, 
and concomitant strongly dysphoric moods of anxiety and anger. Much 
that the adult PTSD / borderline does 
.... 
is a response to, or an attempt to 
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terminate or modify, the intolerable presence of this stream of 
consciousness. " 
This phenomenological description not only captures the link between trauma and 
BPD but also substance misuse in these individuals: "... an attempt to terminate or 
modify, the intolerable presence of this stream of consciousness" 
. 
Recent psychoanalytical theory of addiction syndrome proposed by Hopper (1995) 
suggests that the syndrome is associated with life trajectories that have occurred 
within the context of traumatogenic processes, the phases of which include social, 
cultural and political factors, encapsulation, traumatophilia, and masturbation as a 
form of self-soothing. 
De Zulueta (1993) also states that the addiction syndrome originates within 
traumatogenic processes in which the elements of the traumatic situation are linked 
with early and later consequences of trauma, which in turn, become the 
components of traumatic situations for other people. 
Theories about the traumatic origin of the addiction syndrome from a 
psychodynamic perspective, although a late addition, brings it in line with 
formulations from other perspectives and with the accumulating evidence. This 
appears to be a case of rediscovery. This is a radical departure from the 
traditional aetiological theories and opens the way for a new synthesis or a new 
integration of post traumatic syndromes, personality theories and substance misuse, 
which has exciting implications for interventions. 
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7.10 Review of recent literature linking PTSD, BPD and substance 
misuse 
A computerised search of the literature linking PTSD, BPD and substance misuse, 
using them as key words, yielded 21 papers. These were publications listed in 
Medline and PsychLit between January 1990 and December 1996. There were 9 
articles linking PTSD, BPD and substance misuse. There were 11 articles linking 
PTSD and substance misuse and there was 1 article BPD and substance misuse. 
In addition, recent review articles on each of the diagnostic categories were also 
included in this review. 
The following template was used to analyse the literature: 
i) Relationships in phenomenological descriptions and Co-occurrence 
ii) Relationships in aetiology and aetiological hypothesis 
iii) Relationships in treatment approaches 
7.10.1 Relationships in phenomenological descriptions and co- 
occurrence 
Few studies have linked borderline personality disorder to chronic post traumatic 
stress disorder where there are, as with individuals with substance misuse 
diagnosis, common clinical features. The common features include, affect 
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dysregulation and intolerance, hyperactivity and irritability, chronic dysphoria and 
depression, subjective `deadness and emptiness' risk-taking, impulsive and self- 
destructive behaviours and substance use and abuse (Kardiner, 1941; Van der 
Kolk, 1987). 
Rosser (1995) notes that "if the 'trauma' criterion is removed from the DSM-III-R 
definition of PTSD, the definition becomes almost identical to that of BPD". This 
is the clearest statement on the relationship between the two diagnostic categories 
to be made by a leading figure in British academic psychiatry. 
Sederer and Thorbeck (1990) describes the features of BPD and substance misuse 
as follows: 
"Mood, behaviour, self-image, cognition and interpersonal relationships are 
subject to this instability. The stress may come in the form of 
disappointment, loss, absence of routine and structure, influence of 
substances or a psychotherapeutic transference storm. This inability to 
contain stress is a phenomenon frequently observed in clinical populations 
receiving treatment for substance misuse problems. " 
Sederer and Thorbeck (1990) clearly outlines the questions, what they describe as, 
"rarely asked in the literature" as follows: 
i) Is this is just a phenomenon of co-morbidity a complete overlap in the 
population and a failure to diagnose both conditions simultaneously? 
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ii) Is there a partial overlap and a complex relationship between these 
conditions? 
iii) Are they are very separate phenomena that may have similar features? 
Studies showing co-occurrence of PTSD and substance misuse are accumulating. 
In a screened national sample of women in the USA, Duncan et al., (1996) found 
that women who reported serious physical assault in childhood had significantly 
high prevalence rates and lifetime histories of PTSD and substance misuse. 
Similar associations of PTSD and substance abuse are reported in Vietnam 
veterans; (Bremner, et al., 1996), delinquent boys; (Rigs et al., 1996), peers of 
adolescent suicide victims; (Brent at al., 1995). 
Ellason, et al., (1996) found that in a sample of 106 patients admitted to a 
chemical dependency treatment unit, 66% reported a history of physical or sexual 
abuse during childhood, 26% met diagnostic criteria for PTSD. Brown et al., 
(1995) in a study of treatment seeking substance users found that 25 % had current 
PTSD symptomatology. In both the above studies and in a growing number of 
studies, substance abuse have been linked with childhood sexual and physical 
abuse (for example, Finkhelhor, 1990,1984,1979; Harrison, et al., 1989; 
Hernandez, 1990; Ladwig and Andersen, 1989; Riggs et al., 1990; Swett, et al., 
1991). 
McClellan, et al., (1995) found in a retrospective review of all youth treated over 
a 5-year period in a tertiary care psychiatric hospital that those with histories of 
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sexual abuse had significantly higher rates of PTSD, substance abuse disorders, 
BPD and dissociative symptoms than those with no history of sexual abuse. 
Saxe et al., (1993) in an investigation into the prevalence of dissociative disorders 
in psychiatric inpatients found that patients who met DSM-III criteria for 
dissociative disorder had significantly higher rates of childhood trauma, major 
depression, PTSD, substance abuse and BPD than comparison groups. 
The above examples are no means an exhaustive list of the collection of studies 
showing co-occurrence of PTSD, BPD and substance misuse. These studies can 
be criticised, with the exception of a few, that most of them looked within the 
samples they investigated for specific disease entities and that other conditions that 
may also have been present have been overlooked. This criticism is particularly 
relevant in the development of explanatory models. 
7.10.2 Theoretical models to Describe the link between PTSD, BPD and 
substance misuse 
The aetiology of PTSD compared to the other two diagnostic categories in this 
chapter is fairly clear cut. The mediating factors that causes some individuals to 
develop symptoms is less clear. Whilst single incident traumas (Type 1) leading 
to the syndrome can be mapped to the syndrome, the effects of multiple incident 
traumas (type 2) such as prolonged physical and sexual abuse in children, effects 
of abusive relationships or exposure to combat situations is less straight-forward 
and is open to questioning. The high incidence of violence and abuse in the 
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histories of substance dependence and borderline personality disordered patients 
has led some authors to question whether these diagnostic categories are both 
aspects of a chronic post traumatic stress syndrome (Herman, 1987; Herman, 
Perry & Van der Kolk, 1989). 
This formulation is fairly new; the concept that trauma is at the root of 
psychopathology as was discussed earlier is not new. It appears that in the history 
of abnormal psychology and psychiatry this factor has been rediscovered at regular 
intervals. 
The proponents of the trauma hypothesis argue that early childhood trauma is 
causal in the genesis of borderline pathology as well as chronic PTSD. It can be 
then argued that if they are not closely-elated overlapping conditions, then they are 
aspects of the same condition. In other words, is borderline personality disorder 
an aspect of a post traumatic stress syndrome? Despite it being a recent 
formulation empirical evidence to support the trauma theory is growing (Bryer, et 
al., 1987; Herman, 1987,1981; Herman, Perry and Van der Kolk, 1989; Masson, 
1984). 
The overlap in incidence observes can be schematically represented as shown in 
figure 7.1. Two possibilities, a) all three conditions overlaping in a way that some 
individuals will have all three conditions, two conditions or only having one of the 
conditions; b) All individuals with BPD and substance misuse having PTSD and 
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some having all three. It is possible to include disorders such as dissociative 
disorder, which may also have some overlap in incidence in the second schema, 
assuming that it could also be part of a post-traumatic syndrome. 
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The schematic diagram (figure 7.2) describes two aetiological hypothesis that can 
be generated by examining the literature. A single aetiological hypothesis with 
traumatic experience resulting in PTSD that subsequently gives rise to BPD or 
substance misuse, or both, and a multiple aetiological hypothesis that allows for 
trauma as well as other causes resulting in the development of BPD and substance 
misuse. 
7.11 Implications for treatment 
Aetiological theories dictate treatment approaches. The implications for 
assessment, treatment and prevention work, if a model for a relationship between 
the three conditions is established, are immense. Yet very little work seems to 
have taken place in doing so. This is surprising in that clarification of the 
associations has direct implications for interventions. 
Examination of the literature on treatment also exposes a number of paradoxes. 
Psychodynamic approaches were generally considered to be the treatment of choice 
or the only treatment for personality disorders, particularly borderline personality 
disorder whereas the literature clearly shows a reluctance from a psychodynamic 
perspective to treat substance misuse problems (Hopper, 1995). 
In the area of PTSD most of the available published treatment studies have utilised 
cognitive behavioural therapy (Van der Kolk, et al., 1996). Despite this fact, 
Blake (1993) notes that most clinicians treating traumatized patients continue to 
practice psychodynamic therapy. This is another paradoxical situation in the area. 
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Few studies that have examined the efficacy of psychodynamic therapies, have 
failed to show significant symptom reduction (Lindy, 1987; Van der Kolk, et al., 
1996). 
It can be argued that historically, the differences in approaches to treatment have 
prevented the establishment of links between the conditions. New developments in 
treatment approaches, notably cognitive behavioural approaches, are beginning to 
break down traditional boundaries to reveal the associations and commonalties. 
7.11.1 Treatment approaches to BPD 
Dialectical behaviour Therapy (DBT) developed by Linehan (1993) for BPD is a 
cognitive behavioural approach that also places emphasis on the therapeutic 
relationship. Developed from within a biosocial theoretical framework, DBT 
focusses on the contradictions inherent in the borderline psychopathology. It is 
hypothesised that the patient is stuck with extreme polarities of opposing feelings, 
thoughts and behaviours and is unable to make the move to their synthesis. DBT 
has four categories of treatment strategies: 1) dialectical strategies (therapeutic 
relationship, modelling dialectical responses; 2) core strategies (problem solving, 
validation); 3) stylistic strategies (reciprocal & irreverent communication); and 4) 
case management strategies. This comprehensive approach, with theoretically 
based structures that incorporates firm boundaries and 'acceptance' derived from 
Buddhist philosophy, enables strategic systematic intervention with aspects of BPD 
from emotional dysregulation to behavioural dysregulation that includes substance 
misuse. Aspects of the approach that involves understanding the past enables 
337 
work on traumatic past experiences (eg. sexual abuse) to be undertaken within the 
therapeutic contract. This comprehensive treatment approach has the potential to 
work with trauma-based formulations of BPD and substance dependence. This 
approach, which is relatively new, is yet to be widely used in addiction and other 
treatment settings outside the USA (Williams, 1996). 
A number of cognitive therapy approaches have also emerged recently that have 
expanded the scope of treatment of 'difficult patients', the banner under which 
personality disordered patients are generally described. Schema Focused 
Therapy (SFT) developed by Young (Young, 1983; Young, 1990; Young and 
Klosko, 1993). Young's approach differs from the standard cognitive therapy 
model in that it assumes extremely stable and enduring patterns of thinking that he 
terms 'Early Maladaptive Schemas' (EMS). These schemas, which are said to 
develop in childhood, are assumed to result in maladaptive behaviour patterns, that 
reinforce them. Young (1993) has identified sixteen early maladaptive schemas 
that he places in five categories: a) disconnection and rejection; b) impaired 
autonomy and performance; c) impaired limits; d) other-directedness and e) over- 
vigilance and inhibition. The therapy process involves identification and 
modification of EMS. Young's theory, although not fitting a single trauma 
aetiological theory of BPD, allows for Type II traumas to play a part in the 
process of formation of EMS. 
Beck, Freeman, et al., (1990) have also developed a treatment approach for BPD 
based on the standard model of cognitive therapy. Their approach focusses on 
developing a working relationship, decreasing dichotomous thinking, increasing 
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control over emotions, improving impulse control, strengthening the client's sense 
of identity and addressing assumptions. 
7.11.2 Treatment approaches to substance misuse 
It is beyond the scope of this paper to summarise treatment approaches to 
substance misuse. The focus in general is placed on substance abuse it-self and 
strategies of impulse control. Self-help forms the major psychosocial interventions 
in the area, whilst substitute prescription forms the major pharmacological 
approach. Cognitive behavioural interventions largely focus on initiation and 
maintenance of change in relation to substance misuse for example, Miller and 
Rollnick, 1991, and Marlatt and Gordon, 1985. Traditional psychodynamic 
approaches, as alluded to earlier shows a reluctance to work with substance 
abusers, yet paradoxically much of the psychological work in this area takes place 
under the psychodynamic banner. A more detailed description of treatment 
approaches to substance misuse can be found in Chapter 1. 
7.11.3 Treatment approaches for PTSD 
Despite the history of psychodynamic approaches in the treatment of symptoms 
attributed to be resulting from trauma as referred to above, since the appearance of 
PTSD as a diagnostic category in 1980 all specific interventions developed in this 
area have been based on cognitive behavioural theory. There is only scope here to 
outline key developments in the area. The key elements of the cognitive 
behavioural approach involves evoking the 'fear memory' (traumatic event) and 
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applying principles of exposure therapy in the light of new information. The 
theory behind the approach is that PTSD occurs because of the individual's 
inability to process traumatic experience adequately (Foa, et al., 1989b). 
Prolonged Exposure (PE) therapy (Fairbank et al., 1983; Foa and Riggs, 1993; 
Johnson, et al., 1982; Schindler, 1980); Systematic Desensitization (SD) (Brom 
et al., 1989; Frank and Stewart, 1983; Muse, 1986; Peniston, 1986; Turner, 
1979); Stress Inoculation Training (SIT) (Foa, et al., 1991; Kilpatrick, et al., 
1982; Meichenbaum, 1974; Resick, et al., 1988); Anxiety Management 
Training (AMT) (Frank et al., 1988; Turner and Frank, 1981; Vernon and 
Kilpatrick, 1983); Cognitive Processing Therapy (CPT) which has elements of 
SIT and AMT (Resick and Schnicke, 1993) and Implosion Therapy (Johnson et 
al., 1982; Keane, et al., 1989), have all shown to be effective in reducing PTSD 
symptoms. 
A new technique, Eye Movement Desensitization and Reprocessing (EMDR) 
developed by Shapiro (1989; 1995) can be seen as a further elaboration of 
exposure therapy. The technique involves the patient having to imagine a scene 
from the trauma, at the same time focusing on the accompanying thoughts and 
feelings, and track the therapist's moving finger. The sequence is repeated until 
the client no longer reports anxiety. The client is subsequently instructed to adopt 
more positive (coping) cognitions whilst imagining the traumatic scene. The 
procedure is indeed more elaborate than this simple description and is more an 
integrated therapy approach than a technique. EMDR was initially developed as 
an approach to deal with single event (Type [) traumas; nevertheless its reported 
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use with patients with histories of type II traumas (Shapiro, 1993) and those 
suffering from dissociative disorders, opens up the possibility of using a trauma- 
focussed therapy approach to work with individuals with BPD and substance 
misuse. This would be a new synthesis and example of the utility of a trauma- 
based model for BPD and substance misuse. 
There is a proliferation of studies evaluating the efficacy of EMDR. At present 
the evidence for the efficacy of EMDR is considered to be equivocal (Rothbaum 
and Foa, 1996). 
It should be noted here that the approaches described above (apart from in vivo 
implosion) all involve evoking traumatic memories and reprocessing them 
repeatedly. It has been argued that this is also one of the basic principle of 
psychodynamic therapy, although the techniques and structures differ (Lindy, 
1989,1996; Lindy, et al., 1995). This can be seen as yet another paradox that the 
periodic amnesia for trauma as a root cause of psychopathology has produced in 
the world of therapy. 
7.12 Conclusions 
A review of the literature of PTSD, BPD and substance misuse reveals a picture 
that is yet to come into focus. The old Indian metaphor of the six blind men and 
the elephant, where each person felt different parts of the elephant and arrived at 
different conclusions is an apt one to describe the literature. The complete picture 
is yet to be grasped. The phenomenological and prevalence studies show 
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significant co-occurrence or overlap between these categories. These associations 
have been noted throughout the recent history of psychiatry. Few studies have 
attempted to link these categories or produce models to explain the link. The 
theory that trauma could be at the root of psychopathology, as noted earlier has 
been discovered, forgotten and rediscovered periodically (Van der Kolk et al., 
1996). 
The hypothesis that this review raises ie. that BPD and substance misuse are part 
of a post traumatic syndrome, needs to be tested. If such a model is accepted the 
emphasis on treatment of both substance misuse and BPD could change to from 
that of a covert to trauma focussed one to an overt one. 
This would have obvious implications for assessment and treatment provision. It 
could also help to break down the prevalent barriers in treatment conceptualisation 
and the paradoxes alluded to above. The striking overlap between cognitive 
behavioural therapies and traditional psychodynamic therapies in this area is 
beginning to be noted by clinicians (Williams, 1996). This could indeed lead to a 
new synthesis enabling integration of different treatment modalities used 
strategically to help individuals with BPD and substance misuse problems. 
Further research into applications of trauma-based treatments in these areas, as 
well as aetiological and epidemiological research is needed to obtain the 'full 
picture'. This will be a fertile territory for clinicians working in substance misuse 
areas as well as in mental health settings, to do treatment research. 
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The current knowledge of three diagnostic categories show an undeniable overlap 
between them. The extent of this overlap can only be determined by specific 
research designed to answer this specific question. Large scale epidemiological 
studies are needed establish this. Researchers also need to ask the question as to 
what other diagnostic categories overlap with PTSD, BPD and substance misuse, 
for example, dissociative disorders. The knowledge of the extent of overlap 
between associated diagnostic categories will contribute to the development of 
more precise models to explain the relationship. Such models will be of 
considerable help in developing interventions. 
Further research is needed to firmly establish the trauma-based aetiological theory 
for the diagnostic categories discussed in this chapter, although this evidence is 
growing. If an alternative 'multiple aetiology' theory is to be established, then 
these factors must be clearly identified. Factors such as 'patterns of attachment' 
have been implicated in the aetiology of BPD and substance misuse (Fonagy, 
1996). If these factors singularly lead to the development of the disorders or they 
act cumulatively with traumatic experiences needs to be determined. Models need 
to be developed that could predict the severity of the resulting disorders, according 
to the extent of the contributory factors. This provides fertile ground for future 
research. 
Natural and man-made disasters and catastrophes, and the current state of 
knowledge on PTSD have led to the establishment of 'Trauma Centres' in many 
parts of the world to treat victims of trauma. These centres also provide the 
opportunity to extend our knowledge of the psychological sequelae of trauma. 
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These centres enable longitudinal research to be carried out trauma victims, both 
children and adults. Longitudinal research could not only answer the questions 
raised above, but more importantly, inform us of the mediating factors that may 
prevent the development of PTSD and other disorders. Knowledge that can lead 
to preventive intervention could have implications to the whole field of mental 
health. 
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Appendix A (i) 
EXPECTATIONS QUESTIONNAIRE 
Below are a number of expectations that people have had about drug treatment 
programmes. Please indicate how likely you think they are to happen to you. 
1. The treatment programme will help me to reduce my drug use. 
Not at all likely Very likely 
12345 
2. The treatment programme will help me feel more in control. 
Not at all likely Very likely 
12345 
3. The treatment programme will help me avoid feeling sick. 
Not at all likely Very likely 
12345 
4. The treatment programme will keep me straight and functioning. 
Not at all likely Very likely 
12345 
S. The treatment programme will help me to be safer and healthier. 
Not at all likely 
123 
Vcry likely 
4j 
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6. The treatment programme will help me to have less legal problems. 
Not at all likely Very likely 
2345 
7. The treatment programme will help me to inject less. 
Not at all likely Very likely 
12345 
8. The treatment programme will help me to save money. 
Not at all likely Very likely 
12345 
9. The treatment programme will help nie with relationship problems. 
Not at all likely 
123 
Very likely 
45 
10. The treatment programmes will help nie with psychological problems. 
Not at all likely Very likely 
12345 
I. The treatment programme will help me with child care problems. 
Not at all likely Very likely 
12345 
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Appendix A (ii) 
Revised instructions to the OTI 
Section 1: drug use 
Information is collected regarding the last three days of drug use for each drug 
category. It is important to note that use on the day of interview is not recorded, as it 
is not an example of a full day's use. 
Unlike alcohol, quantities of illicit drugs are not standardized. In the OTI, each drug 
class is scored differently. It is very important that we all use the same system of 
scoring. The units of measurement for each drug category are presented below. 
Heroin 
The unit of measurement is the number of injections (hits) or the number of smokes or 
snorts the client had on the day in question. 
Other opiates 
score injected substances as for heroin. 
In the case of those taken orally, the OTI scores the number of use episodes for that 
day. in the case of liquid preparations, try to elicit the number of times the client took 
the preparation, not the number of bottles drunk. [If the client drank 2 bottles in 4 
episodes, then the score would be 4]. 
In the case of tablets, try to determine how many times that day the client took them. 
[20 tablets taken 10 at a time on 2 occasions would result in a score of 2] 
Cannabis 
The unit of measurement is the number of joints or bongs the client had on the day in 
question. 
Amphetamines 
The unit of measurement is the number of hits, snorts etc. the client had on the day in 
question. 
Cocaine 
The unit of measurement is the number of hits, snorts etc. the client had on the day in 
question. 
Tranquilizers 
The unit of measurement is the number of pills the client had on the day in question. 
Barbiturates 
The unit of measurement is the number of pills the client had on the day in question. 
Hallucinogens 
The unit of measurement is the number of tabs, trips etc. the client had on the day in 
question. 
Inhalants 
The unit of measurement is the number of sniffs the client had on the day in question. 
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Tobacco 
The unit of measurement is the number of cigarettes smoked on the day in question. 
Alcohol 
The unit of measurement is the number of standard drinks the client had on the use 
day. A standard drink may be defined as 120 ml wine, 285 ml beer, or 30 ml spirits. 
For all drug classes: 
When asking about the recent days of use, write down the day and how many days 
before the previous use day it was, e. g. 
Last use ? Friday 
How much ?I hit 
Time before ? Monday (4 days before), (t1=4 days, ql =1 hit). 
Q=q1 +q2/t1 +t2. 
Section 2: HIV risk-taking behaviour 
a) Needle use section 
Questions 2,3, &4 ask about sharing needles. 
record the number of times sharing has occurred whether the needle has been cleaned 
before re-use or not. 
it is important to stress that sharing refers to any other person, including partners. 
Questions 5&6 ask about re-using. 
Re-using refers to borrowing from another person or re-using your own needles. 
b) Sexual behaviour section 
All questions refer to penetrative sex. Do not include oral sex or lesbian sex. 
Question 9 refers to `casual partners', this means anyone who is not a regular partner 
and not a paying client. If the person being interviewed has had sex with prostitutes 
then they are regarded as casual partners. 
Question 10: Paid sex 
Being `paid for sex' refers to any instance where a client has exchanged sex for money 
or for drugs. 
Question 11: Anal sex. 
For this question, count instances of both active and passive anal sex, both with and 
without a condom. 
Section 3: Social Functioning. 
Question 1: 
Include jail, refuges etc. as places of residence. 
Question 3. 
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Include under the term full-time work anyone whose usual employment is permanent 
part-time. 
Questions 4,5, &6 ask about conflict. This refers to arguments, disputes, "hassles 
generally" etc. In the case of questions 4&5, if the person has no family/partner or 
has not been in contact with them for the past six months, then circle N/A and score 
the item as 0. In the case of question 6, if the person has no friends, then circle N/A 
and score the item as 4. This is because it indicates absence of any social support. 
Question 7: 
Close friends would be defined as people the person feels they can rely on. If they have 
a sexual partner, they are included in the estimate. 
Question 11: 
Include both sexual partners and housemates etc. 
Question 12: 
This refers to acquaintances as well as close friends. 
Section 4: Criminality 
The questions are quite straightforward. It is important to stress that you are not 
asking about number of arrests but rather numbers of times each type of crime has 
been committed. Record both frequency and type of crime. Again, it should be stressed 
that all this information will be completely confidential. 
Section 5: Health 
Note that all questions refer to `the last month' except those on gynecological 
problems, which ask about `the last few months'. 
Section 6: Psychological adjustment (GHQ) 
This section is given for self-completion. 
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Appendix A (iii) 
General assessment instrument incorporating the OTI 
Dear Colleague. 
Thank you for agreeing to participate in this pilot evaluation of the New service-wide 
Assessment/outcome evaluation form. 
The form aims to provide the framework for an initial assessment, to collect information 
to make treatment decisions, to formulate care plans. to facilitate brief case presentations. 
to enable outcome evaluation and collect relevant data for the Home Office and Regional 
databases. 
The form is also envisaged as the template for data entry to the Drugs Service 
Information System when it arrives. This means that the pages of the form will be 
identical to the data structure on the computer screen. 
The basic information needed for completing the Home Office and Regional database 
forms are contained In the first three pages and are highlighted (shaded) for your 
convenience. 
The rest of the items are a combination of items from existing drugs service assessment 
forms, the Opiate Treatment Index (OTI) which is becoming established as the standard 
outcome measurement instrument in the area and psychological scales of predictive utility. 
The latter (General Health Questionnaire. Severity of Addiction Scale and the 
Motivational Questionnaire) is to be given to the client for self completion, preferably at 
the first interview. 
There is a summary form to facilitate clinical decision making and presentation of the 
client at clinical meetings. 
Each time you assess a new client please use this new form and also complete the 
evaluation questionnaire and write down any comments suggestions you may have. Your 
feed-back is vital for shaping the assessment process for the service, particularly tailoring 
it to fit the different parts of the service. 
Please return the completed form with your comments to me as soon as you feel you have 
collected sufficient information on each patient. Please feel free to contact me if you 
need clarification or you want to discuss any aspect of this project. 
Many thanks 
Shamil Wanigaratne 
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CAMDEN & ISLINGTON 
Community Health Servioa N}i i Trust 
Your Partnertor Health 
CAMDEN AND ISLINGTON DRUGS SERVICE 
ASSESSMENT FOR TREATMENT AND OUTCOME MEASUREMENT 
This interview schedule comprises: 
1. Treatment History 
2. Drug use 
3. Prescribing plan 
4. Injecting 
5. Sexual behaviour 
6. Criminal activity 
7. Social functioning 
8. Psychological adjustment (GIIQ) 
PLEASE TRY TO COMPLETE ALL OF THESE SCALES WITUIN ONE WEEK OF COMMENCEMENT OF TREATMENT. INSTRUCTIONS F(: 
COMPLETION ARE INCLUDED WITH EACH SCALE. 
IF YOU HAVE ANY PROBLEMS RELATING TO THESE FORMS PLEASE CONTACT SHAMIL WANIGARATNE, HEAD OF CLINICAL 
PSYCHOLOGY OR ANGELA BYRNE, RESEARCH CO-ORDINATOR. 
ASSESSED BY: 
............................................... 
DATE: 
TREATMENT HISTORY 
ARE YOU CURRENTLY IN AN OPIOID TREATMENT? YES NO 
WHAT SORT OF TREATMENT ARE YOU IN? 
NO PREVIOUS TREATMENT METHADONE DETOXIFICATION 
DRUG FREE COUNSELLING THERAPEUTIC COMM. N. A. 
NON-METHADONE TREATMENT 
NOW LONG HAVE YOU BEEN IN OPIOID TREATMENT? YEARS MONTHS 
HOW MANY TIMES HAVE YOU PREVIOUSLY BEEN IN AN OPIATE TREATMENT? 
WHAT SORT OF TREATMENT HAVE YOU PREVIOUSLY BEEN IN? 
NO PREVIOUS TREATMENT METHADONE DETOXIFICATION 
DRUG FREE COUNSELLING THERAPEUTIC COMM. N. A. 
NON-METHADONE TREATMENT 
WHAT WAS THE OUTCOME OF PREVIOUS TREATMENT? 
WIIY ARE YOU SEEKING TREATMENT NOW? 
DRUG RELATED CONTACT IN THE LAST SIX MONTHS 
NONE A&E DRUG TEAM/CUMC" 
GP SOCIAL SERVICES PSYCHIATRIST 
VuJ. UNTARY DRUG AGENCY PRORATIM puty&Tv nre 
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DRUG LISE: 
First, I'm going to ask you some questions about your use of drugs. I want to emphasise that the 
information you give me is completely confidential. 
NB: For all categories, if the client responds that their last use of the drug was more than a month ago, 
score zero for that category. Do not include use on the day of the interview. Please try to record use in 
terms of the specific units of measurement given for each drug. 
IS THE PERSON DRUG FREE:? YES NO IF 1'ES, 110w l. ()N(;? 
DRUG NAME HEROIN OTHER " CANNABIS AAIPIIETAMINI! S COCAINE CRACK 
UNIT OF MFASURI-A F'. NT flits, 01 Al F. S/ )h'101)1 ti Joluts flits, ºaorth «r Mu, Rocks 
(numtw"r of.. ) smokes or Epi odct, o( ace nix- w(a&[a or 
suartt WOýir 
MAIN DRUG? (NIIMRF: R 1-5) 
WAS THIS PRESCRIBED OR NOT? 
(YES/NO/BOTFI) 
HOW OFTEN ? (T'IMES PER 
DAY/K'F: F: K/MONTH 
ON WHAT DAY [)If) YOU LAST USE? 
110N' MANY TIMES 1)11) YOU TAKE --- 
IT ON THAT DAY? 
ON WHAT DAY BEFORE THAT 1)I1) 
YOU USE? 
11011 MANY TIMES 1)11) YOU TAKE: 
ON THAT I)AY? 
AND WHEN WAS THE DAY BEFORE: 
THAT? 
110W MUCII (QUANTITY OK COST 
OF A SESSION) 
KO( !II 
DURATION OF THIS DRUG 
EPISODE? 
NUMISI: R OF DKUC FREE PERIODS 
DURATION OF DRUG FREE 
PERIODS 
AGE. OF FIRST USE 
AGE ADDICTED FROM 
Q-glt q2-II+t2 
INCLUDE STREET METHAIO)NF:, MORPHINE, I'ETIIIUINE, ('OI)F: INI:. INI NOT INCLUDE LF: GALLV OIATINEU 
METIIAIX)NE 
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DRUG USE (CONI'INUL 
Use this section for any category of drug not covered by previous sections. 
DRUG NAME (SPECIFY) 
UNIT OFMEASUREMENT (SPECIFY) 
! }ý: ` 
: fi n. 
iG 
.. }n. :. ý 
"t:: 
<::. 'r.; ::.. t 
^^........ ý.. 
M1vyý+;. ý... 
. 
vt. 
\v 
ä;: ý'<cý'}>i: 3 
\.. K^ý. ýý}! {i}:: r 
:.: oi: x., :., r.,, ti: 
: "'. s.:.. 'r 
vÄ}tii"5. +} ý:: 
i: i%f :" 
fii 
WAS THIS PRESCRIBED OR NOT? 
(YES/NO/BOTH) 
HOW OFTEN ? (TIMES PER 
DAY/WEEK/MONTH 
ON WHAT DAY DID YOU LAST USE? 
HOW MANY TIMES DID YOU TAKE 
IT ON THAT DAY? 
ON WHAT DAY BEFORE THAT DID 
YOU USE? 
HOW MANY TIMES DID YOU TAKE 
ON THAT DAY? 
AND WHEN WAS THE DAY BEFORE 
THAT? 
HOW MUCH (QUANTITY OR COST 
OF A SESSION) 
ROUTE 
DURATION OF THIS DRUG 
EPISODE? 
NUMBER OF DRUG FREE PERIODS 
DURATION OF DRUG FREE PERIODS 
AGE OF FIRST USE 
AGE ADDICTED FROM 
Q-ql+q2+tl+t2 "' "' i' 
DRUG USE (CONTINUED) 
DRUG NAME 
UNIT OF MEASUREMENT 
(number of.. ) 
"TL4Nýf { 
CYilks ;:. + 
`____`; ` 
IARßfl'V1 Ai ä <% 
ra + 
. `
rl;:. "'.: i? ': '"?.? : i>` >s 
?: 1IALLUCCNQC` S 
;< if1bK, '`tr1p6; CtC! 
,; :, }y: r : e... `:, <. <. ti': `": 
.. 
ß.: f..: }: _2 
CND AC, ýPC1ä 
"` i 
n11Y& 3> : ýa;.: e '>, v; Ml ^;..; Y 
t 
'IOllACCO 
%IýýretiCf 
x.,., +,. ae ý: + }', r ±, 
MAIN DRUG? (NUMBER 1-5) 
WAS THIS PRESCRIBED OR NOT? 
(YES/NO/BOTH) 
HOW OFTEN? (TIMES PER 
DAY/WEEK/MONTH 
ON WHAT DAY DID YOU LAST USE? 
HOW MANY TIMES DID YOU TAKE 
IT ON THAT DAY? 
ON WHAT DAY BEFORE THAT DID 
YOU USE? 
HOW MANY TIMES DID YOU TAKE 
ON THAT DAY? 
AND WHEN WAS THE DAY BEFORE 
THAT? 
HOW MUCH (QUANTITY OR COST 
OF A SESSION) 
ROUTE 
DURATION OF THIS DRUG 
EPISODE? 
NUMBER OF DRUG FREE PERIODS 
DURATION OF DRUG FREE PERIODS 
AGE OF FIRST USE 
AGE ADDICTED FROM 
Q=ql+q2+tl+t2 
INCLUDE LSD/ACID/ECSTASY/MAGIC MUSHROOMS 
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'L. COILOL 
ON WHAT DAY 1)11) YOU LAST DRINK ALCOHOL! 
HOW MUCH ALCOHOL 1)11) YOU 
DRINK ON THAT DAY? WINE 
NO OF UNITS CONSUMED 
ON WHICH DAY BEFORE THAT 1)11) 
YOU DRINK ALCOHOL? 
HOW MUCH ALCOHOL. 1)[1) YOU 
DRINK ON THAT DAY? tiVth7: 
NO OF UNITS CONSUMED 
AND WHEN WAS THE DAY BEFORE 
THAT? 
Q= li 2-11+12 
II POL\'URl1C 
TOTAL 
INJECTING 
NB: When asking about sharing needles, record the number of times sharing has occurred whether the ne, 
shared has been cleaned before re-use or not. 
It is important to stress that sharing refers to any other person, including partners. 
How many times have you None 0 
injected in the last month? 
Once a week or less I 
More than once a week, less than once a (:. N 2 
Once a day 
2-3 times a day 
3 
4 
More than 3 times a (la)y 
have you euer injected Yes No 
- 
how many times have you used 
a needle after someone else had 
already cased it? 
None 
Once 
Twice 
3-5times 
6- 10 times 
More flan 10 times 
0 
i 
i 
i 
a 
5 
flow many different people luve None 0 
used a needle before you in the 
last month? I Ixrson 
2 Iwople 2 
3-5people 
6- 10 people 4 
More than 10 people 5 
Ito" man times in the L(SI None 0 
month ILis somconc (Lticd a-- 
needle after You love used it? Once I 
TN ice 2 
3-5 times 3 
6- 10 times 4 
More than 10 times 5 
Il. ý. e yon euer , 14tred a needle? "es 
, 
No 
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Ilo%c often in the List month have Doesn't reuse 0 Sometimes ...... _. .... 3 
you cleaned needles before re- 
using them: ' " Every time Rarely 4 
Often 2 Never 5 
Before using needles again, Doesn't re-use 0 Sometimes 
ýT T 
howoften in the last month did 
you use bleach to clean them? $ Every time 1 Rarely q 
Often 2 Never 5 
Reasons for injecting Cost effective Availibility IV Equip 
Buzz Other 
Peer Pressure Not known 
. ......... 
When last injected 
When did you last share? 
Injection sites 
s Re-using refers both to borrowing from another person and re-using own needles 
DRUG RISK SCORE 
SEXUAL RISK SCORE 
JTOTAL SCORE 7= 
SEXUAL BEIIAVIOUR 
These questioºLs are about your recent sexual behaviour. I eºnplºasise again that any iººfol, ººatio, ºº you gi 
is completely confidential. Some of the following q(lestion. s are quite personal and you (10 tint have to 
answer any question you feel uncomfortable about. 
Ila%c you been sexually active in the Litt month? 
1'Fti NO jJ 
How many people have you had sex with in the List I person 
month? 
2 lwople 2 
3-5{K"ople 3 
6- 10 people 4 
More than 10 people 5 
Do you have a regular partner/partners I YES NO Male/Felualt. '! 
flow often have you used condones when having; 
' 
Fers time 
sex with your reguLºr juilner(s) in the List month ' 
Often 
-- 
2 
SuuiclilncS 1 
RmiN 4 
In e, co c 
IIa%e you had any catilcll Iclrtncl\ in the List nlon(h! 1'I" S No 
NI/F 
Ifow often Iu%C )on teed condoms "hen SAW men time 
sex with casual Ix i1ner, in the List month? 
Often 2 
Sometimes 3 
ILtiON 4 
nl'ilf S 
1111%'e 1ou kid to U %V SCx in cXCIla11ge for nnO11C1 or d ings in he List inn llt ll., 
I\I 
ti i\t 
NIl 
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Text cut off in original 
N 
been paid for sex in the last month? Often 2 
Sometimes 3 
Rarely 4 
Never 
flaue you had anal sex in the last in the last month: 
' YES NO 
how many times have you had anal sex in the last Once 1 
m onth? Twice 2 
3-5 times 3 
6- 10 times 4 
More than 10 times 5 
SOCIAL 
't'hese next few questions concern the social aspects of your life (things like jobs, friends etc) 
... ".., '1. Ifr rent nlerrc I-, vnn I. vri 1 
.' 
'n' II alt' 1 ACI 6 1]101111LC I 
One 
Two 
lilec 2 
Four 
Five or more 
How much of the last six months tuvc you txen unemployed! 
All of the time 
Most of the time 
"3 Some of (lie tun. 
Nunc of the tune 
Half of the time 
-' 
How many different fobs have you had ut the last 6 montlLs'! 
41 
U 
Olle Four Or IIIUIC 
TWO I Nunc 
Three 2 
Flow often in III(. lau( st niumliti Icivvc you had conflict with your tclalrves 
Very ult ii 4 Rarely 
Often Never 
Some trI ý 2 N/A 
[low often w tlir !t `tt m, n(I ILuve you had conflict with your partnrr 
Very Horn 
Often 
4 Rarely 
1 Never 
Someuutr. 2 N/A 
How often to (Ih I: nt , tv utuntlt. ti havr yuu lud cuuflict with your fiirttcls" 
Very cdtrn 4 Katrly 
Often 3 Narr 
Sometimes Z N/A 
Atwut ho" 1LtnV Muse triciid would you esttnuue that you have (Include partnr 
N4 "Ihrer 
Four ur murc 
Mini you are kcvtnf' hmhlrnts ate you sattshed wich the supporl you get 110111 
Ver} satisfied ll Not satisfied 
Sanstied II Very unsaluhrcl 
11 
Jý 
--. -I (I) 
i 
I) 
tt U-100 
4 
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Reasonably OK 2 
About how often do you see your friends? 
Very often (I Rarely 
Often I Never 
Sometimes 2 N/A 
flow many of the people you hang arouikl %% 'Ih now have you known for more than six months? 
None 
l., ess than halt 
About IWf 
l 
_' 
More than halt 
All of the iii 
N/A 
How much of the last six months icwr uu bren living with anyone who uses hcruin? 
All of the time 
Most of the time 
Half of the time 
ýý 
11 Some of the time 
None of the time 11 
110w nativ of the neonle you hing around with now are users (include partner)? 
None U More than hail 3 
Ixss than half I All of them 4 
About halt 2 
SOCIAL 
FIIN('TIONING 
('RIME 
In this section I am interested in any ways that you ma} have had to finance your using. Any infornºali 
you give here is completely confidential and you do not have to all. swer an question if you feel 
uncomfortable about it. 
NB: It is important to stress that you are not asking about number of arrests but but rather number of tirnit". 1 r,. 
type of crime might have been committed. 
Are you currently facing charges? 
__. 
I 
ILCurrent Icgal status 
Property Crime 
[low often, on average, during the List month have you committed a prolMrt) crime: ' 
No property crime 0 More llstn once a week 1 
I, e" than once a %%eek I4 
Once a week 2 
Tick types of crime committed 
Itreak & Enter Stolen car Robben 
Receiving stolen goods Shoplifting OtIoi (tiIM'tifs 
Stolen prescriptions pad 
Ihaling 
Ilow often, on am-age, during; the List month have you sold drugs In someone? 
No drug dealing 0 Mute (lein flint it %% c{. 
IA"ü Own once it %%eck 1 Ikiilý 4 
Once a : eel. 2 
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A-It 
Heroin S{xcd Tranquilksers 
nfanJiLIILI ILill ucinogens Other (Specify) 
Cocaine Karbiturates 
Fraud 
Clow often, on average, 
No fraud 
Less than once a week 
Once a week 
during the last month have 
0 
2 
committed a fraud? 
More than once a week 
Daily 
s iulrncr,! 
.. ý... ý F, ýa ....................... . .. 
Forging cheques Credit Card Other (Specify) 
Forging Prescrip(ium Social Security 
Crimes involving violence 
how often, on average, di 
No violent crime 
Less than once a week 
Once a week 
(tic List month Ue you committed a crime 
0 Flore than once a 
[}ºilv 
2 
Tick tylx's of violent crime committed 
Assault Murder Other (Slwi 
Violent roblwr} Manslaughter 
Armed robber) FLtlk 
ICRIME 
SCORE 
s t"c{. 
i 
.1 
! ýI 
ify) 
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III'AL'I'l! 
An. s%ier yes if you have had any of the following problems in the last month 
CFIYERAL 
INJECTION RELATI; 1) 
PROBLEMS CARI)TO/RLSI'I BATOR Y 
Fatigue/I' neig) loss (h erdose Persistent Cough 
Poor Appetite Abscesses/ Infection Coughing up phelgm 
Weight toss/Underweight Dirty liit(made feel sick) Coughing up blood 
Trouble sleeping Prominent Scar ing/Bruising Wheezing 
Fever Difficult Injecting Sore Throat 
Night Sweats GE: NTTO-URINARY Shortness of Breath 
Swollen Glands Painful Urination ('hest Pains 
J:, undice Loss of Sex Urge Heart Flutters/Racing 
Bleeding Easil) Discharge from Penis/Vagina Swollen Ankles 
Bruising Easily Rash on/around Penis/Vagiiw 
Teeth Problems GYNAECOLOGICAL 
(Women Only) 
Eye/Vision Troubles in the List few months 
Ear/hearing Troubles Irregular Period 
Cuts needing stitches Miscarriage 
NEUROWGIC`Al.. MUSCULO SKF? LETA1. 
ItcatLichcti Joint Pains/Stiffness 
ItLickouts Broken Bones 
Tremors Muscle Pain 
Numbness/Tingling GASPRO INTESTINAL 
Dizziness Nausea 
Fits/Seizures Vomiting 
Dif iiculty Walking Stomach Pain 
Head Injury Constipation 
Forgetting Things Diarrhoea 
TOTAL SCORE 
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GENERAL HEALTH QUESTIONNAIRE 
Please read this carefully: 
I should like to know if you have had any medical complaints and how your'health 
has been in general over the past few weeks. Please answer ALL the. qüestions. on 
the following pages simply by circuling the answer that you think in- st'nearly! applies 
to you. Remember that we want to know about present and recent complains and 
those that you had in the past. 
HAVE YOU RECENTLY: 
i. Bee feeling well and in good health? 
BETTER THAN USUAL.: ý 
. 
<.. SAME As USUA1. ::: WORSE THAN usuAL 
.: ' Macs WORSE THAN usUAL 
2. Been feeling is need of a pick me up? 
NOT AT ALL NO MORE THAN USUAL, RATHER MORE THAN USUAL'. MUCA MORE THAN USUAL 
3. Been feeling run down and out of sorts? 
NOT AT ALL NO MORE TRAN USUAL RATHER MORE THAN USUAL.. :. MUCFU MORE THAN USUAL 
a. Felt that you are UI? 
NOT AT ALL ' NO MORE THAN USUAL. RATHER MORE THAN USUAL" MUCH MORE THAN USUAL 
S. Been getting any pains In your head? 
NOT AT ALL NO MORE THAN USUAL RATHER MORE THAN USUAL MUCH MORE THAN USUAL 
6. Been getting a feeling or tightness or pressure In your head? 
NOT AT ALL' NO MORE THAN USUAL RATHER MORE THAN USUAL: ; MUCH MORE, THAN USUAL 11 
7. Been having hot or cold spells? 
ENOT AT ALL , ". I: NO MORE THAN USUAL RATHER MORE THAN USUAL :: MUCH MORE THAN USUAL` 
8. Lost much sleep over worry? 
NOT AT ALL NO MORE THAN USUAL RATHER MORE THAN USUAL MUCH MORE THAN USUAL' 
9. Had difficulty In staying asleep once you are off: 
NOT AT ALL NO MORE THAN USUAL RATUER MORE THAN USUAL MUCH MORE 71 LW USUAL 
,,,; 
f:; 
, 
1l: 
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10. Felt constantly under strain? 
NOT AT ALL NO MORE THAN USUAL RATHER MORE THAN USUAL MUCH MORE THAN USUAL 
il. Been getting edgy and bad tempered? 
NOT AT ALL NO MORE THAN USUAL RATHER MORE THAN USUAL,,, '. MUCH MORE THAN USUAL 
12. Been getting scared or panicky for nu good reason? 
H. 
- 
NOT AT ALL': 
' 
' NO MORE THAN USUAL I. RATHER MORE; THAN USUAL'. I -MUCH MORE, THAN USUAL 11 
13. Found everything getting on top of you? 
" 
NOT AT ALL NO MORE THAN USUAL RATHER MORE THAN USUAL. J. ' MUCH MORE 't HAN USUAL' 
14. Been feeling nervous and strung up all the time? 
NOT AT ALL NO MORE THAN USUAL RATHER MORE THAN USUAL ; MUCH MORE THAN USUAL 
15. Been managing to keep busy and occupied? 
11 MORE SO T tAN USUAL SAME AS USUAL RATHER LESS THAN USUAL" MUCH LESS THAN USUAL'. 
16. Been taking longer over the things you do? 
QUICKER THAN USUAL' SAME AS USUAL LONGER T HAN USUAL ; °; MUCH LONGER THAN USUAL 
17. Felt on the whole you were doing things well? 
BETTER THAN USUAL ABOUT TIRE SAME LESS WELL. THAN USUAL MUCH LESS WELL 
18. Been satisfied with the way you've carried out your task? 
MORE SATISFIED ' ABOUT THE SAME LESS THAN USUAL 
" 
:: 
":: '" MUCH LESS SATISFIED 
19. Felt that you are playing useful part In things? 
MORE SO TITAN USUAL SAME AS USUAL Lt SS USEFUL THAN USUAL, MUCH IESS USE*1JL 
20. Felt capable of making decisions about things? 
MORE SO TRAN USUAL SAME AS USUAL LESS SO THAN USUAL. 
': MUCH LESS CAPABLE 
21. Been able to enjoy your normal day to day activities? 
MORE SO THAN USUAL SAALE AS USUAL LESS SO THAN USUAL MUCH LESS THAN USUAL 
+. 
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22. Been thinking of yourself as a worthless person? 
NOT AT ALL NO MORE THAN USUAL RATHER MORE THAN USUAL MUCH MORE Th AN USUAL FE: 
- 
23. Felt that life Is entirely hopeless? 
NOT AT ALL NO MORE THAN USUAL RATHER MORE THAN USUAL" MUCH MORE THAN USUAL 
24. Felt that life is not worth living? 
NOT AT ALL 
. 
NO MORE THAN USUAL RATHER MORE THAN USUAL~ , MUCH MORE THAN USUAL 
25. Thought of the possibility that you might do away with yourself? 
DEFINITELY NOT 'I DON'T THINS SO HAS CROSSED MY MIND : r: DEFiNIIELY HAVE 
26. Found at times that you couldn't do anything because your nerves were so bad? 
NOT AT ALL NO MORE THAN USUAL RATHER MORE THAN USUAL ' MUCH MORE THAN USUAL 
27. Found yourself wishing you were dead and away fromit all? 
DEFINITELY NOT I DON'T THINK SO HAS CROSSED MY MIND 
."" 
DEE7N17ILY !! 
-Jl 
28. Found that the idea of taking your own life kept coming into your mind? 
" 
NOT AT ALL NO MORE THAN USUAL RATHER MORE THAN USUAL 
. 
MUCH MORE THAN USUAL 
GIIQ SUMMARY DATA 
ABCD TOTAL 
General Comments on Health 
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Appendix A (iv) 
RELAPSE QUESTIONNAIRE 
Instructions 
Suppose you have made positive changes with regard to your drug taking please 
rate how confident you feel at present in your ability to maintain these changes 
in the following situations. 
1. If you are Feeling "low" (depressed, lonely, frustrated, angry, etc) 
Very confident Not at all confident 
100% 80% 60% 40% 20% 0% 
2. If you have had a "row" (argument, verbally abused, physical fight, etc) 
Very confident Not at all confident 
100% 80% 60% 40% 20% 0% 
3. If someone offers you drugs or puts you under pressure to use drugs (pressure from a 
dealer, another user. friend, etc) 
Very confident Not at all confident 
100% 80% 60% 40% 20% 0% 
4. If you find yourself in a situation where others are using drugs 
Very confident Not at all confident 
100% 80% 60% 40% 20% 0% 
5. If you are feeling good or feel like celebrating 
Very confident Not at all confident 
100% 80% 60% 40% 20% 0% 
6. If you are feeling physically ill 
Very confident Not at all confident 
100% 80% 60% 40% 20% 0% 
7. If you feel like proving to your self that you no longer have a drug problem 
Very confident Not at all confident 
100% 80% 60% 40% 20% 0% 
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Appendix A (v) 
1 
DISSONANCE QUESTIONNAIRE 
Please circle the most appropriate number stating your agreement or disagreement 
with the following statements in terms of feelings about your own drug use during 
the past week. 
1.1 feel guilty about the amount of drugs I use. 
Agree Disagree 
Strongly Strongly 
765432 1 
2.1 feel criticised because of my drug use. 
Agree Disagree 
Strongly Strongly 
765432 1 
3.1 can hardly ever say no if drugs are offered to me. 
Agree Disagree 
Strongly Strongly 
765432 1 
4. When I am not using I hardly ever give it a thought. 
Agree Disagree 
Strongly Strongly 
765432 I 
5. Sometimes my whole being seem to crave for drugs. 
Agree Disagree 
Strongly Strongly 
765432 1 
6.1 enjoy using drugs. 
Agree Disagree 
Strongly Strongly 
765432 1 
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2 
7. When I use drugs I often feel like prolonging the effect by using more or taking another drug. 
Agree Disagree 
Strongly Strongly 
7654321 
8. I am not at all dependent on drugs. 
Agree Disagree 
Strongly Strongly 
7654321 
9. When I use I seem to do so without thinking of the consequences. 
Agree Disagree 
Strongly Strongly 
7654321 
10. Drug taking always takes second place to other things in my life. 
Agree Disagree 
Strongly Strongly 
7654321 
11. My using is always a social thing. 
Agree Disagree 
Strongly Strongly 
7654321 
12.1 don't think 1 need to change my drug taking habits. 
Agree Disagree 
Strongly Strongly 
7654321 
13. When I am using I always think about the next fix. 
Agree Disagree 
Strongly Strongly 
7654321 
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14.1 am some one who would compulsively take any drug available. 
Agree Disagree 
Strongly Strongly 
7654321 
15.1 feel [ am addicted to drugs. 
Agree Disagree 
Strongly Strongly 
765432 
16. Drug taking is too much of a problem for me to be able to handle it on my own. 
Agree Disagree 
Strongly Strongly 
7654321 
17.1 think the way I use drugs is within normal social limits. 
Agree Disagree 
Strongly Strongly 
7654321 
18.1 often find myself taking drugs against my better judgement. 
Agree Disagree 
Strongly Strongly 
7654321 
19. My drug taking makes me very depressed. 
Agree Disagree 
Strongly Strongly 
7654321 
20.1 always know when to stop when I am using drugs. 
Age Disagree 
Strongly Strongly 
7654321 
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21.1 often want drugs badly but I never feel I could pawn possessions, steal, borrow or do any 
thing illegal to get drugs. 
Agree Disagree 
Strongly Strongly 
7654321 
22. I can control my drug taking depending on what I am doing or who I am with. 
Agree Disagree 
Strongly Strongly 
7654321 
23. It never really worries me if I don't know when I will be having my next fix. 
Agree Disagree 
Strongly Strongly 
7654321 
24. My drug taking is hardy ever uncontrolled. 
Agree Disagree 
Strongly Strongly 
7654321 
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Readiness to Change Questionnaire 
CHANGE QUESTIONNAIRE 
The following questionnarie is designed to identify how you personally feP. l about your 
using right now. Please read each of the questions below carefully, and then decide 
Hihether you agree or disagree with the statements. Please circle the. 
-answer of your 
choice to each question. Your answers are completely private and confidential. 
Strongly Disagree Unsure Agree Strongly Official 
Disagree Agree use 
only 
II don't think I use too 
much. 1234 5P 
2 I'm trying to use less than 11234 5A 
used to. 
31 enjoy my using, but 1234 5C 
sometimes I use too much. 
4 Sometimes I think I should 1234 5C 
cut down on my using. 
S It's a waste of time 1234 5P 
thinking about my using. 
61 have just recently 1234 5A 
changed my using habits. 
7 Anyone can talk about 
wanting to do something 
about using, but I am 1234 5A 
actually doing something 
about it. 
81 am at the stage where I 
should think about using 1234 5C 
less drugs. 
9 My using is a problem 1234 5C 
sometimes. 
10 There is no need for me to 
think about changing my I234 SP 
using. 
III am actually changing my I234 5A 
using habits right now. 
12 Using less drugs would be I234 SP 
pointless for me. 
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SEVERITY OF DEPENDENCE SCALE 
Instructions 
Please think of your drug use during a typical recent period of using when you answer these 
questions. 
Please answer by circling one response only. 
1. Did you think that your drug use was out of control? 
NEVER 
OR ALMOST 
NEVER 
SOMETIMES OFTEN 
ALWAYS 
OR NEARLY 
ALWAYS 
2. Did the prospect of missing a dose make you very anxious or worried? 
NEVER ALWAYS 
OR ALMOST SOMETIMES OFTEN OR NEARLY 
NEVER : 
., 
ALWAYS 
. 
3. Did you worry about your drug use? 
NEVER ALWAYS 
OR ALMOST SOMETIMES OFTEN OR NEARLY 
NEVER 
_ 
;;: ALWAYS 
5. How difficult would you find it to stop or go without drugs? 
[IMPOSSIBLE I VERY DIFFICULT I QUITE DIFFICULT I NOT DIFFICULT 11 
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4. Did you wish you could stop? 
Appendix A (viii) 
PLYMOUTH DRUG NAME: No. 
OUTCOME DATE: 
QUESTIONNAIRE STAFF INITIALS: 
cr absence of risk, is indicated by an increase in score. Since we wish to assess 
the client's position at a Improvement 
, 
particular time, the questions are in the present tense, or refer to the previous 
three months. Please see list of 
definitions overleaf. 
SCORE= PDOQ CHECKLIST 11. Is the client's drug use legal? dru s or YES = ot usin If 1 g g n 
Assessed & Closed 
Assessed 
- 
wart list 12. Has the client stopped use of their main 
a i th t3 th ld ? ill I ep s mon n s ega rug 
Is the score entered in the Assessed - case open If not using drugs or YES = 
notes? 
Review No: 
YES NO Reviewed & Closed 13. Has the client's drug use decreased to 
acceptable social limits in the preceding 1 
1. Has the client kept all appointments in the 
3 months? 
If not using drugs or YES= 
preceding 3 months? YES= 1 
2. Is the client now registered with the GP? 14. Is the client's accommodation secure? 
YES= 1 YES- 1 
3. Does the client report the GP as helpful? 15. Has the client stayed at the same 
YES= 1 address for the past 3 months? YES- 1 
4. Does the client appear healthy? 16. Has the client held a job, training in the 
YES= 1 past 3 months? YES- 1 
(includes full-time child care) 
5. Has the client avoided any drug related 17, Does the client now hold a job or 
medical problems in the proceeding 3 1 training? YES= 1 
months? YES= (includes full-time child care) 
6. Is the client committing any drug related 18. Does the client use condoms, or is in a 
crime now? NO= 1 stable monogamous long-term 1 
relationship ('married' in some sense) or 
not having sexual relations? YES- 
7 Has the client been in drug related legal 19. Does the client know how HIV Is 
trouble in the past three months? NO= 1 transmitted? YES= 
8 Does the client inject drugs? 20. Are the client's personal relationships 
If never injected or has stopped = I good or improved in the past 3 months? 1 OR if is injecting score 0 YES- 
9 Does the client share injecting equipment? PLbMOUTII COMMUNITY DRUG SERVICE: If the client has stopped injecting or never 
shared or has stopped sharing = OR if client is sharing score 0 
1 25 WYNDIIAM SQUARE PLYMOUT11 PLt 5EG 
10 Does the client use clean injecting 
TEL: 
- 
(01752) 254103 
equipment', 1 
If the client is not injecting, or does clean = OR if the client is 
01993 
not clearing, score 0 
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F-PDOQ: PLYMOUTH DRUG OUTCOME QUESTIONNAIRE 
DEFINITIONS 
CLIENT 
- 
Any service user with a drug related 
problem 
KEYWORKER 
-A member of staff specifically 
allocated to deliver a service to a client on 
caseload who will be principally responsible for 
supervising the care offered to that client wh; lst 
in treatment 
DRUG RELATED MEDICAL PROBLEMS 
- 
Medical problems which arise as a direct result 
of drug taking e. g abscesses, thrombophlebitis, 
overdose, septicaemia etc. 
DRUG RELATED CRIME 
- 
Any crime which is 
committed principally to procure drugs, e. g. 
chemist break-ins, prescription forgery, burglary 
and theft. This should also include prostitution 
where prostitution would not normally be 
undertaken if there were no drug problems for 
that individual. 
DRUG RELATED LEGAL TROUBLE 
- 
Any 
legal proceedings arising from drug related 
crime (as above) 
LEGAL DRUG USE 
- 
Any drug use which is not 
illicit eg prescribed drugs where those drugs 
are prescribed to that particular individual, 
legally available drugs such as alcohol and 
over the counter" medicines. 
MAIN ILLEGAL DRUG 
- 
The main drug which 
a client reports having difficulty with 
"ACCEPTABLE SOCIAL LIMITS" OF DRUG 
USE 
- 
Where there is a cessation of 
problematic drug use Therefore, where a 
client's drug use is limited to "normal" or 
acceptable use, or total abstinence e. g social 
drinking within safe limits Intermittent use of 
cannabis on a social basis is also included as 
'acceptable' in this definition 
SECURE ACCOMMODATION 
- 
Where the 
client defines his or her accommodation as 
secure 
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GUIDANCE NOTES 
The questionnaire should be completed by the 
keyworker ideally in collaboration with the client 
or as soon after as is practical If there is any 
disagreement or discrepancy in reporting 
between these two people the view of the 
keyworker will be paramount All questions will 
be validated by objective evidence when that is 
available eg urine tests. 
The questionnaire will be helpful to keep clients 
"on track" with their treatment goals. It 
becomes implicit at regular intervals that we 
wish to see steady improvement whilst they are 
in treatment with the service 
The questionnaire must be completed at the 
beginning of treatment and at the end of 
treatment. It should also be repeated at three 
monthly intervals during treatment until that 
case is closed 
Each time the questionnaire is carried out with 
a client it should be noted by date on the inside 
flap of the clients keyworker file. It is the 
responsibility of the keyworker to ensure that 
this questionnaire is carried out as outlined 
Assessment PDOQ to be recorded on 
assessment form on front sheet 
Appendix A (ix) 
TEMPLATE FOR CASE NOTE ANALYSIS 
Name/Study number 
........................ 
Date: 
.......... 
Period 6 week/ 3 months /6 months 
Frequency of attendance 
................... 
Number of attendance 
...................... 
Frequency of Methadone dispensing 
......... 
Level of Methadone prescription 
........... 
Recording of: 
Needle sharing Yes/No (Yes =1/ No = 0) 
Injecting Yes/No 
Unsafe sex Yes /No 
Using on top Yes/No 
Reduction in drug use Yes/No 
Legal problems Yes/ No 
Improvement in personal relationships yes/NO 
Criminal behaviour Yes / No 
Employment Yes / No (yes = 0, No = 1) Secure accommodation Yes /No 
Health problems Yes / No 
Drug related health problems Yes/No 
Other 
...................... 
Urine Analysis 
Test dates 
DRUG + 
- 
+ 
- 
+ 
- 
+ 
- 
Ave 
Opiates 
Methadone 
cocaine 
Amphetamines 
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CASE NOTE TEMPLATE FRONT SHEET 
NAME : 
........................... 
d. o. b. 
............ 
M/F: 
..... 
Ethnic origin: 
............... 
Amount of use: 
............ 
Method of use: 
............ 
Age of first use: 
......... 
Age addicted from: 
........ 
Accommodation: 
.......... 
Employment: 
........... 
Children: 
......... 
Other drugs 
Tobacco 
...... 
Alcohol 
...... 
Crack 
........ 
Traquilizer 
...... 
Cannabis 
....... 
Amphetamines 
..... 
Hallucinogens 
..... 
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Staff opinions questionnaire 
- 
OTI study 
Evaluation Questionnaire 
Name: 
................. 
Date........... 
Name of client 
......................... 
D. O. B. 
......... 
1) Approximate time taken to complete the assessment 
Datas of assessment Time taken 
1) 
2) 
3) 
4) 
2) Aspects or items you found most difficult and why ? (please rate most difficult 
1.2, etc, ) 
3) What aspects of the form was most helpful ? (please rate 1,2.3, etc) 
4) What changes to the assessment do you recommend? 
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Plymouth Drug Outcome Questionnaire 
Evaluation Form 
Name: 
............................. 
Years of experience working with drug users:.......... 
Number of clients in case load 
........ 
1) Ease of administration 
How easy was it to use the questionnaire? 
2) Time taken: on average 
............ 
3) How difficult was it to answer the questions? 
4) Do you think this questionnaire will be useful for your work? 
4a) Can you rate its usefulness 
Very useful 5432I Not at all useful 
4b) Can you rate your satisfaction with it 
Very Satisfied 54321 Not at all satisfied 
5) Would you use it routinely in your work? 
6) What aspects were most helpful? 
7) What aspects were most unhclpful? 
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8) What changes would you recommend to the questionnaire? 
9) Any other comments about the questionnaire and its use 
10) What do you think about outcome measurement? 
11) In what areas do you think is important to measure outcome? 
12) Can you suggest an alternative method of measuring outcome 
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Ethical Information 
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Appendix B (i) 
Participant information from the OTI study 
l \i\ 1 K\I I1 ('111 1.1 (ý1 1 (1\I)ý1f %11: DI CA I. %( 11(1()1. 
1ºI I'ýK1\II'\I ()I I'\l( III%IK\ 
UCE 
KhI. 11; IIý. u.. ýIr;; l MEDICAL 
toci. 1,.,, WIN SCFIOOL 
viii 11171 1: 1 1J514 
Tel 
Information Sheet 
Dr Angela Byrne 
Ms Sarah Davidson 
We are researchers working for University of London Medical School We are 
conducting a study of the methadone programmes and we are asking all new 
clients to take part In order to see how effective the programmes are, it is 
important to talk to clients at various stages of treatment and we would be 
very grateful for your help at this time 
If you agree to take part, we will ask you to fill out some questionnaires and 
we will also need to see you in person to ask you some more detailed 
questions. Each session will take about an hour. 
We would also like to contact people after they have been on the 
programmes for 6 weeks, 3 months and 6 months to ask them the same 
questions in order to see how the programme is affecting different aspects of 
their lives 
You do not have to take part in this study if you do not want to. If you decide 
to take part you may withdraw at any time without having to give a reason. 
Your decision whether to take part or not will not affect your care and 
management in any way. 
We want to assure you that, if you take part, any information given will be 
completely confidential and nobody else will have access to it. 
If you agree to take part, you will receive £10 worth of vouchers, from 
whichever shop you choose (or a phonecard) You will be given a £5 voucher 
after 6 weeks and another £5 voucher after 6 months 
You can choose the time and date of your first session now by asking to see 
the message book for Angela and Sarah held at the front desk 
If you have any doubts or questions about the study, please do not hesitate 
to contact us Thank you for your co-operation 
Yo irs sincerely 
' ill 
Dr Aigeta Byrne Ms Sarah Davidson 
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Appendix B (ii) 
Informed consent form OTI study 
EVALUATION OF THE LOW-TIHRESIHOLD METHADONE PROGRAMME 
AND THE DAILY DISPENSING PROGRAMME. 
CONSENT FORM 
Angela Byrne and Sarah Davidson 
Please read the statement below and if you agree with it, please sign your name in the 
space provided. 
"1 have been informed about the nature of this study and have been given the 
opportunity to ask about it. 
I understand that I am free to withdraw from this study at any time, without giving a 
reason and that it will not affect my treatment in any way. 
l agree to take part in the study. " 
Signed Date. 
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Participant information from the PDOQ study 
Assessment & Outcome Project Information Sheet 
We are carrying out a study to try and improve the way in which you are 
assessed when you come in for treatment and the way in which your 
progress is measured once you are in treatment. 
You would be helping us a great deal if you would participate in the study. 
All that you would be required to do is to fill out five brief questionnaires 
that would take approximately 20 minutes. 
When you fill out the questionnaires please put them in the envelope 
provided, seal it and place them in the box provided. 
At any stage you can decide not to participate in the study. If you decide 
not to participate all you have to do is to return the questionnaires blank. 
Your answers to the questionnaires will be only seen by a researcher. 
The staff who will assess you or your key worker if you arc taken In for 
treatment will not see your answers. As part of the study the researcher 
will scan your clinic notes and make a record of your routine investigations 
including your urine analysis. 
Your decision to participate or not participate in the study will not in 
any way influence your treatment at the clinic. The decisions whether to 
accept you for treatment or the type of treatment offered will be based 
entirely on the assessment interview and the opinions of the clinical 
team. 
Your help in this study will be very much appreciated. 
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Informed consent form PDOQ study 
INFORMED CONSENT FORM 
I understand the purpose of the study and agree to participate in it. 
I understand that participation in the study will not in any way influence the 
treatment I receive from the Camden & Islington Drugs Service. 
I understand that my responses will be entirely confidential from the 
clinicians who might be involved in my care. 
I understand that I can at any time withdraw my participation in the study. 
.................................... 
date:............... 
Signature 
.................................... Name 
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CAMDEN & ISLINGTON 
Community Health Services NHS Tout 
Your Partnerfor health 
LOCAL RESEARCH ETHICS COMMITTEE 
Vezey Strong Building, 112 Hampstead Road, London NW! 2LT 
Tel: 0171 530 3055 Fax: 0171 530 3056 
26 February, 1996 
Ms Shamil Wanigaratne 
[lead of Psychology, Substance Misuse Services 
Camden & Islington Substance Misuse Services 
Vezey Strong Building 
112 Hampstead Road 
Dear Mr Wanigaratne 
Application No: 96/07 
Title: Assessment and outcome measurement in the treatment of opiate addiction 
Thank you for your letter of 20 February enclosing the amended patient information sheet which 
now informs subjects that their notes would be examined and urine analysed as part of the study. 
This is now acceptable to the Local Research Ethics Committee and I am pleased to say approval 
can be given to this project. Please note that the following conditions of approval apply: 
" It is the responsibility of the investigators to ensure that all associated staff including nursing 
staff are informed of research projects and are told that they have the approval of the Ethics 
Committee. 
" If data are to be stored on a computer in such a way as to make it possible to identify 
individuals then the project must be registered under the Data Protection Act 1984. Please 
consult your department data protection officer for advice. 
" The Committee must receive immediate notification of any adverse or unforeseen 
circumstances arising out of the trial. 
" The Committee 11 j receive notification: a) when the study is complete; b) if it fails to start 
or is abandoned; c) if the investigator/s change and d) if any amendments to the study are 
made. 
... 
/page 2 
Rabbi JULIA NEUBERGER: Chairman 
400 LOUIS SMIDT: Chief Exccutivc 
Mr Wanigaratne 
26 February 1996 
Page 2 
With best wishes. 
Yours sincerely 
Stephanie Ellis ýý 
Chairpemon 
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Case study 
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Appendix C (i) 
Service specifications 
PSYCHOLOGY SERVICES 
TO 
CAMDEN & ISLINGTON DRUG SERVICES 
As of Ist April 1993 this is a statement of the clinical psychology service provided 
to the Camden and Islington Drugs Service and will be subject to full review, in 
April 1994. In view of current developments in the Drugs Service it will also be 
reviewed in October 1993. The service will be provided at the Hampstead Road 
Centre, the Needle Exchange and at community settings as appropriate. 
1. SERVICES TO BE PROVIDED 
1.1 Clinical Serviceprovision 
1.1.1 Assessment 
Contribute to the multi-disciplinary assessment of drug users 
and heir' develop assessment Procedures and systems within 
the drugs seMce. 
1.1.2 TreatMent 
Psychological treatment including Interventions on a range, of 
theoretical models including cognitive/behavioral, 
Psychodynamic and Systemic approaches. Service will be 
provided to individuals. couples, families or groups as 
appropriate. 
Contribute to mufti-disciplinary treatment programmes. 
Post-qualification psychologist will undertake some general 
drug work which may involve scripting (max. 5 caseload). 
1.1.3 Designated psychologist to participate in clinical and business 
meetings of Client Services, CHADS and the Needle Exchange 
as appropriate. 
1.2 Sur"c rvisic"n 
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1.2.1 Group Clinical Supervision. 
1.2.2 Individual Clinical Supervision. 
1.2.3 Ongoing supervision workshops on relapse prevention work. 
1.2.4 Ongoing supervision workshops on motivational interviewing. 
1.2.5 Supervision workshops on Assessment. 
1.3 Consultation 
1.3.1 Provision for consultation and advice in-. psychological 
interventions to all staff in drug service. 
1.3.2 Provide a consultation service to other agencies, including non- 
statutory agencies supported by the Trust. 
2. SERVICE DEVELOPMENT 
2.1 Head of Adult Mental Health psychology to participate in Drug Service 
Policy Group. 
2.2 Co-ordinator of Drug Service Psychology to participate in Drug Service 
management meetings as appropriate. 
2.3 Co-ordination of Drug Service Psychology or designated psychologist to 
participate in Drug Service Information Strategy Group. 
2.4 Participate in Information System Project Team. 
2.5 Contribute towards developing new psychological interventions in the, area based on theoretical developments and evaluate such devok monts. 
2. E Contribute to the development of assessment within the service. 
2.7 Participate in Ethnic Minority and Substance, Use Forum. 
2.8 Participate in appropriate working parties including: 
(a) Developing services for Cocaine users. (t') Systematic Care Planning. (c) Client Information and Contract formulation. 
3. RCH AND SERVIC FVAI UATION 
3.1 Co-ordinator 
of Drug Service PsycPto4oay to participate in tht- Drug Service Research Co-ordination Group. 
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3.2 To complete work undertaken on, the following research and evaluation 
projects: 
(a) Intake Group 
(b) Camden Neighbourhood Drop-In 
(c) Hepatitis B Compliance Study. 
(d) Condom use and uptake among IVDU's study 
(e) Long term users drop-in 
(I) Prevalence of Ecstacy use in the adolescent community: 
prevention and treatment 
3.3 Co-ordinator of Drug Service Psychology to participate in the Service Clinical 
Audit Group. 
3.4 AH psychologists to contribute to general audit work in the Drug Service. 
4. TEACHING 
4.1 CONTRIBUTE TO THE ACADEMIC MEETING PROGRAMME OF THE Dc UQ SERVICE. 
4.2 Contribute to multidisciplinary training programme both within and without 
the Drugs Service. 
4.3 Contribute towards teaching research and audit methods to staff within the 
Drugs Service. 
STAFFING LEVELS 
5.1 The above services of management were to be provided by a range. of 
psychology staff with total sessions, at present, of 1.8 w. t. e. 
E. QUAUTY OF SERVICE 
The service will be providbd by quatified- cortical psychotogtsts or clinical 
psychology trainees under the supervision of qualified clinical psychologists. 
The services provided will be monitored and subject to the formal quality 
assurance procedures operating within the Trust psychology services. 
Psychologists in the Drugs Service will participate in the supervision and 
Continuing Professional Development systems of the Trust Psychology 
Service. 
Psychologists will also contribute to the, quality assurance systems and 
procedures within the drug dependence service. 
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Service level agreement 
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Sessional Commitments 
1. 
2. 
3. 
4. 
5. 
6. 
7 
8 
Assessment 3 sessions to multi- 
disciplinary 
2 sessions to 
assessment for 
psychological 
treatment 
Treatment : 10 sessions for general 
psychological 
treatment 
Supervision : 3 sessions for 
supervision 
Consultation : 1 session for 
consultation 
Service Development : 1 session contribution to 
general management 
1 session contribution to 
development of 
assessment systems 
2 session contribution to 
stimulant use 
Research and Service 
Evaluation : 2 session contribution to 
research 
1 session contribution to 
audit 
Teaching : 1 session contribution to 
teaching 
CPD : 3 sessions not to be 
included 
total: 30 (inc CPDI 
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Appendix C (iv) 
Template for staff interviews 
, 
CAMDEN & ISLINGTON 
ccmwm , ty K ska Savica 141 is Tn. 
Your rarlner for Ileal(A 
Dear 
............. 
It is an year since the new psychology service provision was 
implemented. I will be having brief formal meetings with you to 
discuss the service. I would be most helpful if you could 
consider the following areas when you prepare to give me feed- 
back on the service: 
1) General satisfaction with the service. 
2) Is the psychology input meeting the needs of your service? 
3) Your views on psychologists providing a specific input as 
opposed to a generic role. 
4) Limitations of the service. 
5) How it can be further developed. 
Please make a note of any other comments you may have. I look forward to meeting you with you. 
Many thanks 
Shamil wanigaratne 
Head of Clinical Psychology 
Rabbi JULIA NCUDERGERX113,1m^J^ 
WUIS SMIDT. Chie(Eaecwi. e 
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Appendix D 
Diagnostic definitions 
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Post Traumatic Stremme Disorder (PTSD) 
Current definitions 
ICD 10 Definition 
F43.1 Poet-traumatic stress disorder 
This arises as a delayed and/or protracted response to a stressful event or situation 
(either 
short- or long-lasting) of an exceptionally threatening or catastrophic nature, which is likely 
to cause pervasive distress in almost anyone (e. g. natural or man-made disaster. combat, serious 
accident, witnessing the violent death of others, or being the victim of torture, terrorism, 
rape, or other crime). 
Predisposing factors such as personality traits (e. g. compulsive, aethenic) or previous history 
of neurotic illness may lower the threshold for the development of the syndrome or aggravate its 
course, but they are neither necessary nor sufficient to explain its occurrence. 
Typical symptoms include episodes of repeated reliving of the trauma in intrusive memories ("flashbacks") or dreams, occurring against the persisting background of a sense of "numbness" 
and emotional blunting, detachment from other people, unresponsiveness to surroundings, 
anhedonia, and avoidance of activities and situations F43.2 reminiscent of the trauma. Commonly 
there is fear and avoidance of cues that remind the sufferer of the original trauma. Rarely, 
there may be dramatic, acute burets of fear, panic or aggression, triggered by stimuli arousing 
a sudden recollection and/or re-enactment of the trauma or of the original reaction to it. 
There is usually a state of autonomic hyperarousal with hypervigilance, an enhanced startle 
reaction, and insomnia. Anxiety and depression are commonly associated with the above symptoms 
and signs, and suicidal ideation is not infrequent. Excessive use of alcohol or drugs may be a 
complicating factor. 
The onset follows the trauma with a latency period which may range from a few weeks to months (but rarely exceeds 6 months). The course is fluctuating but recovery can be expected in the 
majority of cases. In a small proportion of patients the condition may show a chronic course over 
many years and a transition to an enduring personality change (see F62.0). 
DSM IV Definitions 
309.81 Poettraumatic Stress Disorder 
Diagnostic criteria for 309.81 
A. The person has been exposed to a traumatic event in which both of the following were present: (1) the person experienced, witnessed, or was confronted with an event or events that involved 
actual or threatened death or serious injury, or a threat to the physical integrity of self or 
others. 
(2) the person's response involved intense fear, helplessness, or horror. Note: In children, this 
may he expressed instead by disorganised or agitated behaviour. 
B. The traumatic event is persistently re-experienced in one (or more) of the following ways: (1) recurrent and intrusive distressing recollections of the event including images, thoughts, 
or perceptions. Note: in young children, repetitive play may occur in which themes or aspects of 
the trauma are expressed. (2) recurrent distressing dreams of the event. Note: In children, there may be frightening dreams 
without recognisable content. (3) acting or feeling as if the traumatic event were recurring (includes a sense of reliving the 
experience, illusions, hallucinations, and dissociative flashback episodes, including those that 
occur on awakening or when intoxicated). Note: In young children, trauma-specific re-enactment 
may occur. (4) intense psychological distress at exposure to internal or external cues that symbolize or 
resemble an aspect of the traumatic event (5) physiological reactivity on exposure to internal or external cues that symbolize or resemble 
an aspect of the traumatic event 
C. Persistent avoidance of stimuli associated with the trauma and numbinging of general 
responsiveness (not present before the trauma), as indicated by three (or more of the following: (1) efforts to avoid thoughts, feelings, or conversations associated with the trauma (2) efforts to avoid activities, places, or people that arouse recollections of the trauma (3) inability to recall an important aspect of the trauma (4)markedly diminished interest or participation in significant activities (5) feeling of detachment or estrangement from others. (6) restricted range of affect (e. g., unable to have loving feelings) (7) sense of a foreshortened future (e. g., does not expect to have a career, marriage, children, 
or a normal life span) 
D. Persistent symptoms of increased arousal (not present before the trauma), as indicated by two (or more) of the following: (1)difficulty falling or staying asleep (2)irritability 
or outburst of anger (3)difficulty 
concentrating (4)hypervigilanc 
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(5)exaggerated startle response 
E. Duration of the disturbance (symptoms in Criteria B, C, and D) is more than 1 month. 
F. The disturbance causes clinically significant distress or impairment in social, occupational, 
or other important areas of functioning. 
Specify if: 
Acute: if duration of symptoms is lese than 3 months 
Chronic: if duration of symptoms is 3 months or more 
Specify if: 
With Delayed onset: if onset of symptoms is at least 6 months after the etreeeor. 
Personality Disorders 
ICD 10 
The concept of a personality disorder encapsulates the following: behaviour patterns which tend 
to be persistent and are the expression of an individual's characteristic lifestyle and mode of 
relating to self and others 
Some of these conditions and patterns of behaviour emerge early in the course of individual 
development, as a result of both constitutional factors and social experience, while others are 
acquired later in life. 
These types of condition comprise deeply ingrained and enduring behaviour patterns, manifesting 
themselves as inflexible responses to a broad range of personal and social situations. They 
represent either extreme or significant deviations from the way the average individual 
in a given 
culture perceives, thinks, feels, and particularly relates to others. Such behaviour patterns 
tend to be stable and to encompass multiple domains of behaviour and psychological functioning. 
They are frequently, but not always, associated with various degrees of subjective distress and 
problems in social functioning and performance. 
F60.3 Emotionally unstable vereonality disorder 
A personality disorder in which there is a marked tendency to act impulsively without 
consideration of the consequences, together with affective instability. The ability to plan ahead 
may be minimal, and outbursts of intense anger may often lead to violence or "behavioural 
explosions"; these are easily precipitated when impulsive acts are criticised or thwarted 
by 
others. Two variants of this personality disorder are specified, and both share this general 
theme of impulsiveness and lack of self-control. 
F60.30 Impulsive type 
The predominant characteristics are emotional instability and lack of impulse control. Outbursts 
of violence or threatening behaviour are common, particularly in response to criticism by others. 
F60 F69 DISORDERS OF ADULT PERSONALITY AND BEHAVIOUR 
Includes: explosive and aggressive personality (disorder) Excludes: dissocial personality disorder (F60.2) 
Includes: borderline personality (disorder) 
F60.31 Borderline type 
Several of the characteristics of emotional instability are present; in addition, the patient's 
own self-image, aims, and internal preferences (including sexual) are often unclear or disturbed. 
There are usually chronic feelings of emptiness. A liability to become involved in intense and 
unstable relationships may cause repeated emotional crises and may be associated with excessive 
efforts to avoid abandonment and a series of suicidal threats or acts of self-harm (although 
these may occur without obvious precipitants). 
DSM IV Definitions 
Diaanoetic Featuree 
The essential feature of Borderline Personality Disorder is a pervasive pattern of instability 
of interpersonal relationships. self-image, and affects, and marked impulsivity that begins 
by 
early adulthood and is present in a variety of contexts. 
Diagnostic criteria for 301.83 Borderline Personality Disorder 
A pervasive pattern of instability of interpersonal relationships, self-image, and affects, and 
marked impulsivity beginning by early adulthood and present in a variety of contexts, as indicated by five (or more) of the following: (1)frantic efforts to avoid real or imagined abandonment. Note: Do not include suicidal or self 
mutilating behaviour covered in Criterion S. (2) a pattern of unstable and intense interpersonal relationships characterised by alternating between extremes of idealisation and devaluation (3)identity disturbance. markedly and persistently unstable self-image or sense of self (4) impulsivity in at least two areas that are potentially self-damaging (e. spending, sex, 
substance abuse, reckless driving, binge eating) 
. 
Note: Do not include suicidal or self- 
mutilating behaviour covered in Criterion S. (5) recurrent suicidal behaviour, gestures, or threats, or self-mutilating behavior (G)affective instability due to a marked reactivity of mood (e. g., intense episodic 
dysphoria, 
irritability, 
or anxiety usually lasting a few hours and only rarely more than a 
few days) 
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(7) chronic feelings of emptiness (B) inappropriate, intense anger or difficulty controlling anger (e. g., frequent displays of temper, constant anger, recurrent physical fights) (9) transient, stress-related paranoid ideation or severe dissociative 
symptoms 
Sub. tano" minus* 
F10-F19 DISORDERS DUE TO PSYCHOACTIVE SUBSTANCE USE 
Harmful use 
A pattern of psychoactive substance use that is causing damage to health. The damage may be 
physical. (as in case of hepatitis from the self--administration of injected drugs) or mental (e. g. episodes of depressive disorder secondary t. e heavy consumption of alcohol). 
Diagnostic guidelines 
The diagnosis requires that actual damage should have been caused to the mental or physical 
health of the user. 
Harmful patterns of use are often criticised by others and frequently associated with adverse 
social consequences of various kinds. The fact that a pattern of use or a particular substance 
is disapproved of by another person or by the culture, or may have led to socially negative 
consequences euch as arrest or marital arguments is not in itself evidence of harmful use. 
Flx. 2 Dependence syndrome 
A cluster of physiological, behavioural, and cognitive phenomena in which the use of a substance 
or a class of substances takes on a much higher priority for a given individual than other behaviours that once had greater value. A central descriptive characteristic of the dependence 
syndrome is the desire (often strong, sometimes overpowering) to take psychoactive drugs (which 
may or may not have been medically prescribed), alcohol, or tobacco. There may be evidence that 
return to substance use after a period of abstinence leads to a more rapid reappearance of other 
features of the syndrome than occurs with nondependent individuals. 
Diagnostic guidelines 
A definite diagnosis of dependence should usually be made only if three or more of the following 
have been experienced or exhibited at some time during the previous year: (a) a strong desire or sense of compulsion to take the substance; (b) difficulties in controlling 
substance-taking behaviour in terms of its onset, termination, or levels of use; (c) a physiological withdrawal state (see Flx. 3 and Flx. 4) when substance use has ceased or been 
reduced, as evidenced by: the characteristic withdrawal syndrome for the substance; or use of the 
same (or a closely related) substance with the intention of relieving or avoiding withdrawal 
symptoms; (d). evidence of tolerance, such that increased doses of the psychoactive substance are 
required in order to achieve effects originally produced by lower doses (clear examples of this 
are found in alcohol- and opiate-dependent individuals who may take daily doses sufficient to incapacitate or kill non-tolerant users); (e) progressive neglect of alternative pleasures or interests because of psychoactive substance use, increased amount of time necessary to obtain or 
take the substance or to recover from its effects; (f) persisting with substance use despite 
clear evidence of overtly harmful consequences, such as harm to the liver through excessive drinking, depressive mood states consequent to periods of heavy substance use, or drug-related impairment of cognitive functioning; efforts should be made to determine that the user was 
actually, or could be expected to be, aware of the nature and extent of the harm. 
Narrowing of the personal repertoire of patterns of psychoactive substance use has also been described as a characteristic feature (e. g. a tendency to drink alcoholic drinks in the same way 
on weekdays and weekends, regardless of social constraints that determine appropriate drinking behaviour). 
It is an essential characteristic of the dependence syndrome that either psychoactive substance 
taking or a desire to take a particular substance should be present; the subjective awareness of 
compulsion to use drugs is most commonly seen during attempts to stop or control substance use. 
This diagnostic requirement would exclude, for instance, surgical patients given opioid drugs for 
the relief of pain, who may show signs of an opioid withdrawal state when drugs are not given but 
who have no desire to continue taking drugs. 
The dependence syndrome may be present for a specific substance (e. g. tobacco or diazepam), for 
a class of substances (e. g. opioid drugs), or for a wider range of different substances (as for those individuals who feel a sense of compulsion regularly to use whatever drugs are available 
and who show distress, agitation, and/or physical signs of a withdrawal state upon abstinence). The diagnosis of the dependence syndrome may be further specified by the following five-character 
codes: 
F1x. 20 Currently abstinent 
F1x. 21 Currently abstinent, but in a protected environment (e. g. in hospital, in a therapeutic 
community, in prison, etc. ) Flx. 22 Currently on a clinically supervised maintenance or replacement regime (controlled dependence) 
(e. g. with methadone; nicotine gum or nicotine patch) Fix-23 Currently abstinent, but receiving treatment with aversive or blocking drugs (e. g. naltrexone or disulfiram) Flx. 24 Currently 
using the substance (active dependence) F1x. 25 Continuous 
use Flx. 26 Episodic use (dipsomania) 
DSM IV Definitions 
The Substance-Related Diaorders include disorders related to the taking of a drug of abuse (including 
alcohol), to the side effects of a medication, and to toxin exposure. 
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The Substance-Related Disorders are divided into two groups: the Substance Use Disorders (Substance Dependence and Substance Abuse) and the Substance-Induced Disorders (Substance 
Intoxication, Substance Withdrawal, Substance-Induced Delirium, Substance-Induced Persisting 
Dementia, Substance-Induced Persisting Amnestic Disorder. Substance-Induced Psychotic Disorder, 
Substance-Induced Mood Disorder, Substance-Induced Anxiety Disorder, Substance-Induced Senual 
Dysfunction, and Substance-Induced Sleep Disorder). 
Criteria for Substance Dependence 
A maladaptive pattern of substance use, leading to clinically significant impairment or distress, 
as manifested by three (or more) of the following, occurring at any time in the same 12-month 
period: 
(1) tolerance, as defined by either of the following: 
a) a need for markedly incceaeed amounts of the substance to achieve intoxication or desired 
effect 
markedly diminished effect with continued use of the same amount of the substance (2) withdrawal, as manifested by either of the following: (a) the characteristic withdrawal syndrome for the substance (refer to Criteria A and B 
of the criteria sets for Withdrawal from the specific substances) (b)the same (or a closely related) substance is taken to relieve or avoid withdrawal symptoms (3)the substance is often taken in larger amounts or over a longer period than was intended (4)there is a persistent desire or unsuccessful efforts to cut down or control substance use (5)a great deal of time is spent in activities necessary to obtain the substance (e. g., visiting 
multiple doctors or driving long distances), use the substance (e. g., chain-smoking), Or recover from its effects (6)important 
social, occupational, or recreational activities are given up or reduced because of 
substance use (7)the substance use is continued despite knowledge of having a persistent or recurrent physical 
or psychological problem that is likely to have been caused or exacerbated by the substance (e"g". current cocaine use despite recognition of cocaine-induced depres 9 ion, or continued drinking despite recognition that an ulcer was made worse by alcohol consumption) 
Specify if: 
With Phys 
present) 
iological Dependence: evidence of tolerance or withdrawal (i. e., either Item 1 or 2 is 
without Physiological Dependence: no evidence of tolerance or withdrawal (i. e., neither Item 1 nor 2 is present) 
Course specifiers (see text for definitions): 
Early Full Remission 
Early Partial Remission Sustained Full Remission Sustained Partial Remission On Agonist Therapy In a Controlled Environment 
Substance Abuse 
Criteria for Substance Abuse 
A. 
A maladaptive pattern of substance use leading to clinically significant impairment or distress, as manifested by one (or more) of the following, occurring within a 12-month period: (1) recurrent substance use resulting in a failure to fulfill major role obligations at work, school, or home (e. g., repeated absences or poor work performance related to substance use; substance- related absences, 
hsuspensions, or expulsions from school; neglect of children or o ehold) 
(2)recurrent substance use in situations in which it is physically hazardous (e. g., driving an automobile or operating a machine when impaired by substance use) (3)recurrent substance-related legal problems (e. g., arrests for substance-related disorderly conduct) (4)continued substance use despite having persistent or recurrent social or interpersonal problems caused or exacerbated by the effects of the substance (e. g., arguments with spouse about consequences of intoxication, physical fights) 
B. The symptoms have never met the criteria for Substance Dependence for this class of substance. 
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